'uh‘u a £4" rah-"9".“ ' . ~ 1“ ,2: ’1 3 371, . 231:? 2' 1* .- 771. - ALI-3“ .Iu‘ M {131315. .' »- «fir-J: — h at“? pm A a LY : m. 352?... ;f L23. $36.33;; ‘ . 23%!" ‘ m ”b" "‘ v JIAT‘J'MR J x." file-m ll» LIBRARY . . . M ich isan State Théisféfiafi'i'zrilfiéém __ Umversrty DESIGNING A PACKAGE FOR PHARMACEUTICAL TABLETS IN RELATION TO MOISTURE AND DISSOLUTION presented by Seungyil Yoon has been accepted towards fulfillment of the requirements for the Ph.D. degree in Packaging MM E. 35% V Major Professor’s Signature 777445;~ 5L} SI 0&3 Date MSU is an Affirmative Action/Equal Opportunity Institution PLACE IN RETURN Box to remove this checkout from your record. To AVOID FINES return on or before date due. MAY BE RECALLED with earlier due date if requested. DATE DUE DATE DUE DATE DUE F EBQZIORZUUEE 'I": I. I N ,1 ' . J ’4 -- v . r 1‘! '1 U .1. HA I 9‘1 " 6/01 cJCIRC/DateDuepes-pJS DESIGNING A PACKAGE FOR PHARMACEUTICAL TABLETS IN RELATION TO MOISTURE AND DISSOLUTION By Seungyil Yoon A DISSERTATION Submitted to Michigan State University in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY School of Packaging 2003 ABSTRACT DESIGNING A PACKAGE FOR PHARMACEUTICAL TABLETS IN RELATION TO MOISTURE AND DISSOLUTION By Seungyil Yoon Dissolution can be used as a measure of bioavailability and as a stability- indicating parameter for pharmaceutical tablets. Therefore, it is very important to predict the dissolution of pharmaceutical tablets in a package in order to design a package for stability testing. In order to predict the dissolution, the relationship between dissolution, storage time and relative humidity must be determined. So, tablets were stored in open dishes at two different temperatures (25 and 40°C) and five different relative humidities (O, 50, 65, 75, 90% RH) for 6 months. Dissolution was measured every month for 6 months, and the dissolution was plotted with storage time to determine a dissolution retardation rate (R, dissolution change/day). At each relative humidity, tablets have a specific dissolution retardation rate. Therefore, dissolution retardation rates can be plotted as a function of relative humidity to determine the relationship between dissolution retardation rate and relative humidity. Based on that relationship, a dissolution prediction model can be developed. From the dissolution prediction model, dissolution can be calculated at any relative humidity for a given amount of storage time. The relative humidity of the package headspace changes in the unsteady state, so the dissolution of tablets stored at any condition is very hard to estimate. However, computer programs make it possible. A Windows based dissolution prediction program was developed in this study. The dissolution prediction program can calculate the dissolution change of tablets in a package as a function of storage time. In order to calculate the dissolution change, a pr0prietary moisture prediction program was also developed in the dissolution prediction program. The moisture prediction program can calculate the moisture content of solids in a package and RH of the package headspace. The program can be used to save time and money in a variety of applications such as determining the amount of desiccant and package barrier requirement for a given shelf life. The moisture and dissolution prediction programs were verified by using experimental results. Uncoated drug tablets and silica gel were inserted into LDPE bags and HDPE bottles. The moisture content of the tablets and silica gel was measured as a function of storage time, and then this was compared to the results from the moisture prediction program. The differences between predicted and experimental moisture contents ranged from 0% to 0.39% for tablets and 0.11 to 6.50% for silica gel. Also, dissolution results from the dissolution prediction program were compared with the experimental results to verify the program. The differences between predicted and experimental dissolution ranged from 1.3 to 13.5% for LDPE bags and 0 to 18.3% for HDPE bottles. The differences are fairly large because tablets behave in a variety of manners. In this study, a new theory of the relationship between dissolution retardation and relative humidity is proposed. The Open dish study and computer simulation programs are useful in providing an effective way to select an appropriate package for registration stability testing. DEDICATION This dissertation is dedicated to my wife Youngmi Shin, my family, and my friends. iv ACKNOWLEDGEMENTS I would like to express my gratitude to all those who gave me the possibility to complete this research. I am deeply indebted to my major professor, Dr. Lockhart whose help, stimulating suggestions and encouragement helped me in all the time of research for and writing of this dissertation. I researched for 6 years with him for master and Ph.D. He guided me right things, and I am sure I followed right things. I am so lucky because I met Dr. Lockhart for my career. I am also grateful to thank Dr. Selke for her prompt and thoughtful discussion of this research. We had meetings very often, sometimes every week or every two weeks. She taught me how to approach the correct things. And, I am also grateful to thank Dr. Burgess and Dr. Worden for their research guidance. Initiating a research correctly is very hard and important. They guided me a right path for this research. Also, I want to thank Eli Lilly and Company for giving me the permission to use a product and generous supporting equipment and material used for this research. I have furthermore specially to thank the senior packaging engineer at Lilly, Mark and the senior analytical chemist at Lilly, Sharon for discussing my Ph.D. work. They advised me and sometimes encouraged me to go ahead with my dissertation. Especially, I would like to give my special thanks to my wife Youngmi whose patient love enabled me to complete this work. TABLE OF CONTENTS LIST OF TABLES ................................................................................ viii LIST OF FIGURES .............................................................................. xix LIST OF SYMBOLS ........................................................................... xxvi INTRODUCTION 1 CHAPTER 1 BACKGROUND AND LITERATURE REVIEW (DISSOLUTION PREDICTION MODELS) 6 1. Dissolution profile (The mechanism of dissolution) ................................................ l3 2. Dissolution rate (k) .................................................................................................... 14 3. Dissolution reduction rate (K) ................................................................................... 16 4. Relationship between dissolution reduction rate and moisture content .................... 17 CHAPTER 2 EXPERIMENTAL DESIGN, MATERIALS AND METHODS ......... 19 1. Experimental design .................................................................................................. l9 2. Materials and methods .............................................................................................. 24 CHAPTER 3 RESULTS AND DISCUSSION 42 l. Permeability .............................................................................................................. 45 (1) LDPE bags ............................................................................................................ 48 (2) HDPE bottles ........................................................................................................ 49 2. Moisture content ....................................................................................................... 49 (1) Initial moisture content ......................................................................................... 49 (2) Moisture sorption isotherms ................................................................................. 50 (a) Moisture sorption isotherms of drug X tablets (coated and uncoated) ............. 51 (b) Moisture sorption isotherms of silica gel .......................................................... 54 3. Dissolution ................................................................................................................ 56 (1) Initial dissolution profiles ..................................................................................... 57 (2) Dissolution profiles from open dish study ............................................................ 60 (a) Drug X uncoated tablets stored in open dishes at 40°C .................................... 60 (b) Drug X coated tablets stored in open dishes at 40°C ........................................ 68 (3) Summary of dissolution behavior ......................................................................... 74 CHAPTER 4 DISSOLUTION PREDICTION PROGRAMMING AND VERIFICATION 76 1. Technical review of Nakabayashi’s method ............................................................. 76 2. Dissolution retardation rate (R) ................................................................................. 84 3. Verification of dissolution prediction program ......................................................... 95 (1) Stepwise storage conditions (open dish study) ..................................................... 95 (2) Continuous storage conditions .............................................................................. 99 vi (3) Tablets in LDPE bags without silica gel and tablets with silica gel (0.5 g, l g, and 2 g) stored in LDPE bags at 40°C/90% RH ..................................................... 102 (b) Tablets in HDPE bottles without silica gel and tablets with 0.5 g silica gel stored in HDPE bottles at 40°C/90% RH ............................................................... 106 4. Proposed theory of dissolution retardation as a function of relative humidity ....... 109 CHAPTER 5 PACKAGE DESIGN 112 CHAPTER 6 CONCLUSIONS AND FUTURE WORK 118 APPENDICES Appendix A Background and Literature Review (Moisture and Shelf life Prediction Models) ....................................................................................................................... 123 Appendix B Moisture and Shelf Life Prediction Programming, and Verification ..... 150 Appendix C Tablet Formulation, Manufacturing, and Interaction ............................. 173 Appendix D Summary Tables of Permeability, Moisture Sorption Isotherms, and Moisture Content Verification .................................................................................... 183 Appendix E Dissolution Raw Data and Dissolution Profiles at 25°C ........................ 191 Appendix F Dimensions (Swelling) and Raw Data .................................................... 229 Appendix G Hardness and Raw Data ......................................................................... 241 BIBLIOGRAPHY 257 vii LIST OF TABLES Table 1 Apparent dissolution reduction rate constants (K) of dissolution for prednisolone tablets with various moisture content (N akabayashi et al., 1981) ............................ 18 Table 2 Testing plan for open dish study .......................................................................... 22 Table 3 Comparison of physical properties between drug X fresh tablets and 2 year old tablets ........................................................................................................................ 24 Table 4 Salt solutions used to provide the required range of relative hurnidities ............. 25 Table 5 The combination of components in LDPE bags and HDPE bottles used to verify the moisture and shelf life prediction program ......................................................... 32 Table 6 Dissolution calibration data of drug X ................................................................. 38 Table 7 Stepwise storage conditions used to verify the dissolution prediction model ..... 41 Table 8 Initial moisture content and equilibrium RH of tablets and silica gel ................. 50 Table 9 GAB constants of tablets and Langmuir constants of silica gel .......................... 50 Table 10 Initial dissolution profile data for uncoated tablets ............................................ 58 Table 11 Initial dissolution profile data for drug X coated tablets ................................... 59 Table 12 p-values from t-test using 1 month and 2 month intervals for tablets stored at 40°C/90% RH ........................................................................................................... 61 Table 13 p-values from t-test using 1 month and 2 month intervals for tablets stored at 40°C/75% RH ........................................................................................................... 63 Table 14 p-values from t-test using 1 month and 2 month intervals for tablets stored at 40°C/65% RH ........................................................................................................... 65. Table 15 p-values from t-test using 1 month and 2 month intervals for tablets stored at 40°C/50% RH ........................................................................................................... 66 Table 16 Variation of dissolution for drug X uncoated tablets stored at 40°C (coefficient of variance greater than 0.1 is bold-faced.) ............................................................... 78 Table 17 Dissolution retardation rates (R) of drug X uncoated tablets stored in open dishes at 40°C ........................................................................................................... 91 viii Table 18 Comparison of the results from experimental and predicted dissolution stored at stepwise conditions ................................................................................................... 95 Table 19 The dissolution change calculated from the dissolution prediction program at each RH for a given storage time .............................................................................. 96 Table 20 Dissolution differences between experimentally measured average dissolution and predicted dissolution ........................................................................................ 100 Table 21 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets stored in LDPE bag without desiccant) ................................................................................................................ 102 Table 22 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in LDPE bag containing 0.5 g silica gel) ................................................................................................................. 103 Table 23 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in LDPE bag containing 1 g silica gel) .......................................................................................................................... 104 Table 24 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in LDPE bag containing 2 g silica gel) .......................................................................................................................... 105 Table 25 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in HDPE bottle without desiccant) ................................................................................................................................. 107 Table 26 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in HDPE bottle containing 0.5 g silica gel) ................................................................................................................. 108 Table 27 Initial moisture content of MCC and corn starch ............................................. 144 Table 28 Comparison between experimental and calculated moisture content, and between actual storage time and calculated shelf life of tablets stored in LDPE bags without desiccant .................................................................................................... 166 Table 29 Comparison between experimental and calculated moisture content of tablets and 0.5 g silica gel stored in LDPE bag, and between actual storage time and calculated shelf life. ................................................................................................ 168 Table 30 Comparison between experimental and calculated moisture content of tablets and 1 g silica gel stored in LDPE bag, and between actual storage time and calculated shelf life. ................................................................................................ 169 ix Table 31 Comparison between experimental and calculated moisture content of tablets and 2 g silica gel stored in LDPE bag, and between actual storage time and calculated shelf life. ................................................................................................ 170 Table 32 Comparison between experimental and calculated moisture content of tablets stored in HDPE bottle without silica gel, and between actual storage time and calculated shelf life. ................................................................................................ 171 Table 33 Comparison between experimental and calculated moisture content of tablets and 0.5 g silica gel in HDPE bottle, and between actual storage time and calculated shelf life. ................................................................................................................. 172 Table 34 Drug X tablet formulation ................................................................................ 174 Table 35 Moisture gain (g) of LDPE bags using CaClz at 40°C .................................... 184 Table 36 Moisture gain (g) of HDPE bottles using CaClz at 40°C ................................. 184 Table 37 Moisture gain (g) of HDPE bottle blanks at 40°C ........................................... 184 Table 38 Moisture sorption isotherm data of uncoated tablets at 25°C .......................... 185 Table 39 Moisture sorption isotherm data of coated tablets at 25°C .............................. 185 Table 40 Moisture sorption isotherm data of uncoated tablets at 40°C .......................... 186 Table 41 Moisture sorption isotherm data of coated tablets at 40°C .............................. 186 Table 42 Moisture sorption isotherm data of silica gel at 25°C ..................................... 187 Table 43 Moisture sorption isotherm data of silica gel at 40°C ..................................... 187 Table 44 Moisture content of tablets in LDPE bags without silica gel as a function of storage time ............................................................................................................. 188 Table 45 Moisture content of tablets and 0.5 g silica gel in LDPE bags as a function of storage time ............................................................................................................. 188 Table 46 Moisture content of tablets and 1 g silica gel in LDPE bags as a function of storage time ............................................................................................................. 189 Table 47 Moisture content of tablets and 2 g silica gel in LDPE bags as a function of storage time ............................................................................................................. 189 Table 48 Moisture content of tablets only in HDPE bottles as a function of storage time ................................................................................................................................. 190 Table 49 Moisture content of tablets and 0.5 g silica gel in HDPE bottles as a function of storage time ............................................................................................................. 190 Table 50 Initial dissolution raw data of uncoated tablets ................................................ 192 Table 51 Initial dissolution raw data of coated tablets .................................................... 192 Table 52 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/90% ..... 192 Table 53 Dissolution raw data of coated tablets stored for 1 month at 40°C/90% ......... 192 Table 54 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/75% ..... 193 Table 55 Dissolution raw data of coated tablets stored for 1 month at 40°C/75% ......... 193 Table 56 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/65% ..... 193 Table 57 Dissolution raw data of coated tablets stored for 1 month at 40°C/65% ......... 193 Table 58 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/50% ..... 194 Table 59 Dissolution raw data of coated tablets stored for 1 month at 40°C/50% ......... 194 Table 60 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/0% ....... 194 Table 61 Dissolution raw data of coated tablets stored for 1 month at 40°C/0% ........... 194 Table 62 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/90% ..... 195 Table 63 Dissolution raw data of coated tablets stored for 1 month at 25°C/90% ......... 195 Table 64 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/75% ..... 195 Table 65 Dissolution raw data of coated tablets stored for 1 month at 25°C/75% ......... 195 Table 66 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/65% ..... 196 Table 67 Dissolution raw data of coated tablets stored for 1 month at 25°C/65% ......... 196 Table 68 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/50% ..... 196 Table 69 Dissolution raw data of coated tablets stored for 1 month at 25°C/50% ......... 196 Table 70 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/0% ....... 197 Table 71 Dissolution raw data of coated tablets stored for 1 month at 25°C/0% ........... 197 xi Table 72 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/90% 197 Table 73 Dissolution raw data of coated tablets stored for 2 months at 40°C/90% ....... 197 Table 74 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/75% 198 Table 75 Dissolution raw data of coated tablets stored for 2 months at 40°C/75% ....... 198 Table 76 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/65% 198 Table 77 Dissolution raw data of coated tablets stored for 2 months at 40°C/65% ....... 198 Table 78 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/50% 199 Table 79 Dissolution raw data of coated tablets stored for 2 months at 40°C/50% ....... 199 Table 80 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/0% ..... 199 Table 81 Dissolution raw data of coated tablets stored for 2 months at 40°C/0% ......... 199 Table 82 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/90% 200 Table 83 Dissolution raw data of coated tablets stored for 2 months at 25°C/90% ....... 200 Table 84 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/75% 200 Table 85 Dissolution raw data of coated tablets stored for 2 months at 25°C/75% ....... 200 Table 86 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/65% 201 Table 87 Dissolution raw data of coated tablets stored for 2 months at 25°C/65% ....... 201 Table 88 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/50% 201 Table 89 Dissolution raw data of coated tablets stored for 2 months at 25°C/50% ....... 201 Table 90 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/0% ..... 202 Table 91 Dissolution raw data of coated tablets stored for 2 months at 25°C/0% ......... 202 Table 92 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/90% 202 Table 93 Dissolution raw data of coated tablets stored for 3 months at 40°C/90% ....... 202 Table 94 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/75% 203 xii Table 95 Dissolution raw data of coated tablets stored for 3 months at 40°C/75% ....... 203 Table 96 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/65% 203 Table 97 Dissolution raw data of coated tablets stored for 3 months at 40°C/65% ....... 203 Table 98 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/50% 204 Table 99 Dissolution raw data of coated tablets stored for 3 months at 40°C/50% ....... 204 Table 100 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/0% 204 Table 101 Dissolution raw data of coated tablets stored for 3 months at 40°C/0% ....... 204 Table 102 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/90% . 205 Table 103 Dissolution raw data of coated tablets stored for 3 months at 25°C/90% ..... 205 Table 104 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/75% .205 Table 105 Dissolution raw data of coated tablets stored for 3 months at 25°C/75% ..... 205 Table 106 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/65% .206 Table 107 Dissolution raw data of coated tablets stored for 3 months at 25°C/65% ..... 206 Table 108 Dissolution raw data of uncoated tablets stored for 3 months at25°C/50% .206 Table 109 Dissolution raw data of coated tablets stored for 3 months at 25°C/50% ..... 206 Table 110 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/0% 207 Table 11 1 Dissolution raw data of coated tablets stored for 3 months at 25°C/0% ....... 207 Table 112 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/90% . 207 Table 113 Dissolution raw data of coated tablets stored for 4 months at 40°C/90% ..... 207 Table 114 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/75% . 208 Table 115 Dissolution raw data of coated tablets stored for 4 months at 40°C/75% ..... 208 Table 116 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/65% . 208 Table 117 Dissolution raw data of coated tablets stored for 4 months at 40°C/65% ..... 208 xiii Table 118 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/50% Table 119 Dissolution raw data of coated tablets stored for 4 months at 40°C/50% ..... Table 120 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/0% . Table 121 Dissolution raw data of coated tablets stored for 4 months at 40°C/0% ....... Table 122 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/90% Table 123 Dissolution raw data of coated tablets stored for 4 months at 25°C/90% ..... Table 124 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/75% Table 125 Dissolution raw data of coated tablets stored for 4 months at 25°C/75% ..... Table 126 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/65%. Table 127 Dissolution raw data of coated tablets stored for 4 months at 25°C/65% ..... Table 128 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/50%. Table 129 Dissolution raw data of coated tablets stored for 4 months at 25°C/50% ..... Table 130 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/0% Table 131 Dissolution raw data of coated tablets stored for 4 months at 25°C/0% ....... Table 132 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/90% Table 133 Dissolution raw data of coated tablets stored for 5 months at 40°C/90% ..... Table 134 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/75% Table 135 Dissolution raw data of coated tablets stored for 5 months at 40°C/75% ..... Table 136 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/65%. Table 137 Dissolution raw data of coated tablets stored for 5 months at 40°C/65% ..... Table 138 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/50%. Table 139 Dissolution raw data of coated tablets stored for 5 months at 40°C/ 50% ..... Table 140 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/0% xiv . 209 209 .. 209 209 .210 210 .210 210 211 211 211 211 212 212 .212 212 .213 213 213 213 214 214 214 Table 141 Dissolution raw data of coated tablets stored for 5 months at 40°C/0% ....... Table 142 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/90% Table 143 Dissolution raw data of coated tablets stored for 5 months at 25°C/90% ..... Table 144 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/75% Table 145 Dissolution raw data of coated tablets stored for 5 months at 25°C/75% ..... Table 146 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/65% Table 147 Dissolution raw data of coated tablets stored for 5 months at 25°C/65% ..... Table 148 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/50% Table 149 Dissolution raw data of coated tablets stored for 5 months at 25°C/50% ..... Table 150 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/0% Table 151 Dissolution raw data of coated tablets stored for 5 months at 25°C/0% ....... Table 152 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/90% Table 153 Dissolution raw data of coated tablets stored for 6 months at 40°C/90% ..... Table 154 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/75% Table 155 Dissolution raw data of coated tablets stored for 6 months at 40°C/75% ..... Table 156 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/65% Table 157 Dissolution raw data of coated tablets stored for 6 months at 40°C/65% ..... Table 158 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/50% Table 159 Dissolution raw data of coated tablets stored for 6 months at 40°C/50% ..... Table 160 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/0% Table 161 Dissolution raw data of coated tablets stored for 6 months at 40°C/0% ....... Table 162 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/90%. Table 163 Dissolution raw data of coated tablets stored for 6 months at 25°C/90% ..... XV 214 .215 215 .215 215 .216 216 .216 216 217 217 .217 217 .218 218 .218 218 .219 219 219 219 220 220 Table 164 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/75% . 220 Table 165 Dissolution raw data of coated tablets stored for 6 months at 25°C/75% ..... 220 Table 166 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/65% . 221 Table 167 Dissolution raw data of coated tablets stored for 6 months at 25°C/65% ..... 221 Table 168 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/50% . 221 Table 169 Dissolution raw data of coated tablets stored for 6 months at 25°C/50% ..... 221 Table 170 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/0% 222 Table 171 Dissolution raw data of coated tablets stored for 6 months at 25°C/0% ....... 222 Table 172 Dimensions (mm) of initial tablets ................................................................ 233 Table 173 Dimensions (mm) of tablets stored for 20 days at 40°C/90% ....................... 233 Table 174 Dimensions (mm) of tablets stored for 20 days at 40°C/75% ....................... 233 Table 175 Dimensions (mm) of tablets stored for 20 days at 40°C/65% ....................... 233 Table 176 Dimensions (mm) of tablets stored for 20 days at 40°C/50% ....................... 234 Table 177 Dimensions (mm) of tablets stored for 20 days at 40°C/0% ......................... 234 Table 178 Dimensions (mm) of tablets stored for 20 days at 25°C/90% ....................... 234 Table 179 Dimensions (mm) of tablets stored for 20 days at 25°C/75% ....................... 234 Table 180 Dimensions (mm) of tablets stored for 20 days at 25°C/65% ....................... 235 Table 181 Dimensions (mm) of tablets stored for 20 days at 25°C/50% ....................... 235 Table 182 Dimensions (mm) of tablets stored for 20 days at 25°C/0% ......................... 235 Table 183 Dimensions (mm) of tablets stored for 70 days at 40°C/90% ....................... 235 Table 184 Dimensions (mm) of tablets stored for 70 days at 40°C/75% ....................... 236 Table 185 Dimensions (mm) of tablets stored for 70 days at 40°C/65% ....................... 236 Table 186 Dimensions (mm) of tablets stored for 70 days at 40°C/50% ....................... 236 xvi Table 187 Dimensions (mm) of tablets stored for 70 days at 40°C/0% ......................... 236 Table 188 Dimensions (mm) of tablets stored for 70 days at 25°C/90% ....................... 237 Table 189 Dimensions (mm) of tablets stored for 70 days at 25°C/75% ....................... 237 Table 190 Dimensions (mm) of tablets stored for 70 days at 25°C/65% ....................... 237 Table 191 Dimensions (mm) of tablets stored for 70 days at 25°C/50% ....................... 237 Table 192 Dimensions (mm) of tablets stored for 70 days at 25°C/0% ......................... 238 Table 193 Dimensions (mm) of tablets stored for 180 days at 40°C/90% ..................... 238 Table 194 Dimensions (mm) of tablets stored for 180 days at 40°C/75% ..................... 238 Table 195 Dimensions (mm) of tablets stored for 180 days at 40°C/65% ..................... 238 Table 196 Dimensions (mm) of tablets stored for 180 days at 40°C/50% ..................... 239 Table 197 Dimensions (mm) of tablets stored for 180 days at 40°C/0% ....................... 239 Table 198 Dimensions (mm) of tablets stored for 180 days at 25°C/90% ..................... 239 Table 199 Dimensions (mm) of tablets stored for 180 days at 25°C/75% ..................... 239 Table 200 Dimensions (mm) of tablets stored for 180 days at 25°C/65% ..................... 240 Table 201 Dimensions (mm) of tablets stored for 180 days at 25°C/50% ..................... 240 Table 202 Dimensions (mm) of tablets stored for 180 days at 25°C/0% ....................... 240 Table 203 Average hardness of drug X uncoated and coated tablets ............................. 242 Table 204 p-values from t-test between initial and 7 day aged tablet hardness .............. 243 Table 205 p-values from AN OVA between 7 to 190 day aged tablet hardness ............. 244 Table 206 p—values from t-test between hardness of tablets stored at 25°C and 40°C (p- values greater than 0.05 are bold-faced) ................................................................. 249 Table 207 The results of PVC blister opening tests (the number of broken tablets/the number of trials) ...................................................................................................... 252 Table 208 Hardness (kp) of initial tablets ....................................................................... 253 xvii Table 209 Hardness (kp) of tablets stored at 40°C/90% as a function of storage time .. 253 Table 210 Hardness (kp) of tablets stored at 40°C/75% as a function of storage time .. 253 Table 211 Hardness (kp) of tablets stored at 40°C/65% as a function of storage time .. 254 Table 212 Hardness (kp) of tablets stored at 40°C/50% as a function of storage time .. 254 Table 213 Hardness (kp) of tablets stored at 40°C/0% as a function of storage time 254 Table 214 Hardness (kp) of tablets stored at 25°C/90% as a function of storage time .. 255 Table 215 Hardness (kp) of tablets stored at 25°C/75% as a function of storage time .. 255 Table 216 Hardness (kp) of tablets stored at 25°C/65% as a function of storage time .. 255 Table 217 Hardness (kp) of tablets stored at 25°C/50% as a function of storage time .. 256 Table 218 Hardness (kp) of tablets stored at 25°C/0% as a fimction of storage time 256 xviii LIST OF FIGURES Figure 1 Dissolution of coated aspirin tablets stored for 3 months at 25°C/90% ............. 12 Figure 2 The S-shaped dissolution curve of solid dosage forms (Abdou, 1989) .............. 14 Figure 3 Exponential relationship between % undissolved and stirring time ................... 15 Figure 4 Dissolution rate (k) ............................................................................................. 16 Figure 5 Dissolution reduction rate (K) ............................................................................ 17 Figure 6 Diagram of the experimental design ................................................................... 21 Figure 7 Graphical representation of the humidity sensor placed on the top of desiccator ................................................................................................................................... 26 Figure 8 The sketch of the symmetrical gravimetric analyzer (SGA-IOO) ....................... 30 Figure 9 The moisture gain of HDPE bottles .................................................................... 33 Figure 10 Sketch of the HT-300 hardness tester ............................................................... 36 Figure 11 The calibration curve for the spectrophotometer using drug X ........................ 38 Figure 12 Outline of the experiment ................................................................................. 44 Figure 13 Relationship between water vapor transmission rate (WVTR), permeance, thickness normalized WVTR, and permeability ....................................................... 45 Figure 14 Relationship between water vapor transmission rate (WVTR) and permeance using whole package instead of thickness and area .................................................. 47 Figure 15 WVTR of LDPE bags at 40°C/90% RH .......................................................... 48 Figure 16 WVTR of HDPE bottles at 40°C/75% RH ....................................................... 49 Figure 17 Moisture sorption isotherms of drug X tablets at 25°C .................................... 51 Figure 18 Moisture sorption isotherms of drug X tablets at 40°C .................................... 52 Figure 19 Moisture sorption isotherms calculated by GAB equation for tablets at 25°C and 40°C .................................................................................................................... 53 Figure 20 Moisture sorption isotherm of silica gel at 25°C .............................................. 54 xix Figure 21 Moisture sorption isotherm of silica gel at 40°C .............................................. 55 Figure 22 Moisture sorption isotherms calculated by Langmuir equation for silica gel at 25°C and 40°C .......................................................................................................... 55 Figure 23 The typical dissolution curve constructed experimentally ............................... 56 Figure 24 Initial dissolution profile of drug X uncoated tablets ....................................... 58 Figure 25 Initial dissolution profile of drug X coated tablets ........................................... 59 Figure 26 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/90% (each point is average value for 6 tablets) .............................. 61 Figure 27 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/75% (each point is average value for 6 tablets) .............................. 63 Figure 28 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/65% (each point is average value for 6 tablets) .............................. 64 Figure 29 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/50% (each point is average value for 6 tablets) .............................. 66 Figure 30 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/0% (each point is average value for 6 tablets) ................................ 68 Figure 31 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/90% (each point is average value for 6 tablets) ........................................... 69 Figure 32 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/75% (each point is average value for 6 tablets) ........................................... 71 Figure 33 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/65% (each point is average value for 6 tablets) ........................................... 71 Figure 34 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/50% (each point is average value for 6 tablets) ........................................... 72 Figure 35 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/0% (each point is average value for 6 tablets) ............................................. 73 Figure 36 Dissolution rates (k) of uncoated tablets stored in open dishes for 6 months at 40°C/50% RH ........................................................................................................... 81 Figure 37 Dissolution reduction rate (K) of uncoated tablets stored at 40°C/50% RH 81 XX Figure 38 Dissolution reduction rate as a function of RH (%) ......................................... 82 Figure 39 Dissolution of tablets in HDPE bottles stored at 40°C/90% RH as a function of storage time ............................................................................................................... 84 Figure 40 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/90% (each month has 6 dissolution values) .................................... 86 Figure 41 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/75% (each month has 6 dissolution values) .................................... 86 Figure 42 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/65% (each month has 6 dissolution values) .................................... 87 Figure 43 30 minute dissolution. of drug X uncoated tablets stored in open dishes for 6 months at 40°C/50% (each month has 6 dissolution values) .................................... 87 Figure 44 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/0% (each month has 6 dissolution values) ...................................... 88 Figure 45 Graph ofy = -e" ...................................................................................... 89 Figure 46 Graph of y = -e" + (D,+1) ................................................................................. 89 Figure 47 A typical graph for 30 minute dissolution change as a fimction of storage time ................................................................................................................................... 89 Figure 48 Dissolution retardation rate (R) ........................................................................ 90 Figure 49 Dissolution retardation rate of drug X uncoated tablets at various relative humidities at 40°C .................................................................................................... 91 Figure 50 Dissolution retardation rate (R) as a function of relative humidity at 40°C ..... 93 Figure 51 Algorithm used to calculate the dissolution at various relative humidities ...... 94 Figure 52 Dissolution of tablets stored at stepwise Conditions (I) .................................... 97 Figure 53 Dissolution of tablets stored at stepwise conditions (11) .................................. 98 Figure 54 Dissolution of tablets in LDPE bags stored at 40°C/90% RH as a function of storage time ............................................................................................................. 102 Figure 55 Dissolution of tablets in LDPE bags containing 0.5 g silica gel stored at 40°C/90% RH as a function of storage time ........................................................... 103 xxi Figure 56 Dissolution of tablets in LDPE bags containing 1 g silica gel stored at 40°C/90% RH as a function of storage time ........................................................... 104 Figure 57 Dissolution of tablets in LDPE bags containing 2 g silica gel stored at 40°C/90% RH as a function of storage time. .......................................................... 105 Figure 58 Dissolution of tablets in HDPE bottles stored at 40°C/90% RH as a function of storage time. ............................................................................................................ 106 Figure 59 Dissolution of tablets in HDPE bottles containing 0.5 g silica gel stored at 40°C/90% RH as a function of storage time. .......................................................... 107 Figure 60 The hardness of uncoated tablets stored for 6 months at 40°C as a function of relative humidity ..................................................................................................... 110 Figure 61 30 minute dissolution of uncoated tablets stored for 6 months at 40°C as a function of relative humidity .................................................................................. 1 10 Figure 62 RH of Aclar blister headspace calculated by the moisture prediction program and 30 minute dissolution calculated by the dissolution prediction program as a function of storage time. ......................................................................................... 1 14 Figure 63 RH of the HDPE bottle headspace calculated by the moisture prediction program and 30 minute dissolution calculated by the dissolution prediction program as a function of storage time ................................................................................... 115 Figure 64 RH of a package (P=0.0004 g/day-pkg-ps) headspace calculated by the moisture prediction program and 30 minute dissolution calculated by the dissolution prediction program as a function of storage time ................................................... 117 Figure 65 Graphical representation of linear and nonlinear relationships between M and aw ............................................................................................................................. 130 Figure 66 Graphical representation of changes inimoisture during equilibration between MCC and corn starch .............................................................................................. 144 Figure 67 Graphical representation of moisture transfer and moisture equilibrium in the closed system .......................................................................................................... 145 Figure 68 Hypothetical graphic representation of piecewise linear equations for two sorption isotherms for components A and B ........................................................... 153 Figure 69 Algorithm used to calculate the equilibrium (p/ps)", ...................................... 157 xxii Figure 70 Example of an algorithm used to calculate the relative humidity of the headspace and moisture content of components in a package at each time interval j over the total storage time t ..................................................................................... 159 Figure 71 Algorithm used to determine the GAB or Langmuir constants ...................... 160 Figure 72 Example spreadsheet from the proprietary moisture prediction program ...... 162 Figure 73 Example spreadsheet from the shelf life prediction program ......................... 164 Figure 74 Comparison between experimental and calculated moisture content of tablets stored in LDPE bags without silica gel ................................................................... 166 Figure 75 Comparison between experimental and calculated moisture content of tablets and silica gel (0.5 g) stored in LDPE bags .............................................................. 167 Figure 76 Comparison between experimental and calculated moisture content of tablets and silica gel (1 g) stored in LDPE bags ................................................................. 168 Figure 77 Comparison between experimental and calculated moisture content of tablets and silica gel (2 g) stored in LDPE bags ................................................................. 170 Figure 78 Comparison between experimental and calculated moisture content of tablets stored in HDPE bottles without silica gel ............................................................... 171 Figure 79 Comparison between experimental and calculated moisture content of tablets and silica gel (0.5 g) in HDPE bottles ..................................................................... 172 Figure 80 Graphical representation of the manufacturing of drug X tablets .................. 176 Figure 81 Structural formula of mannitol ....................................................................... 178 Figure 82 Moisture sorption-desorption isotherm of mannitol (Kibbe, 2000) ............... 178 Figure 83 Structural formula of povidone ....................................................................... 179 Figure 84 Moisture sorption isotherm of povidone (Kibbe, 2000) ................................. 179 Figure 85 Structural formula of microcrystalline cellulose (MCC) ................................ 180 Figure 86 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/90% RH (each point is average value for 6 tablets) ...................... 223 Figure 87 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/75% RH (each point is average value for 6 tablets) ...................... 223 xxiii Figure 88 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/65% RH (each point is average value for 6 tablets) ...................... 224 Figure 89 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/50% RH (each point is average value for 6 tablets) ...................... 224 Figure 90 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/0% RH (each point is average value for 6 tablets) ........................ 225 Figure 91 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/90% RH (each point is average value for 6 tablets) .................................. 226 Figure 92 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/75% RH (each point is average value for 6 tablets) .................................. 226 Figure 93 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/65% RH (each point is average value for 6 tablets) .................................. 227 Figure 94 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/50% RH (each point is average value for 6 tablets) .................................. 227 Figure 95 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/0% RH (each point is average value for 6 tablets) .................................... 228 Figure 96 Percent thickness dimension change of drug X tablets as a function of RH (each point is average value for 5 tablets) ............................................................... 231 ~ Figure 97 Percent diameter dimension change of drug X tablets as a function of RH (each point is average value for 5 tablets) ........................................................................ 231 Figure 98 Hardness of drug X uncoated tablets stored at 25°C as a function of storage time (each point is average value for 10 tablets) .................................................... 245 Figure 99 Hardness of drug X coated tablets stored at 25°C as a function of storage time (each point is average value for 10 tablets) ............................................................. 245 Figure 100 Hardness of drug X uncoated tablets stored at 40°C as a function of storage time (each point is average value for 10 tablets) .................................................... 246 Figure 101 Hardness of drug X coated tablets stored at 40°C as a function of storage time (each point is average value for 10 tablets) ............................................................. 246 Figure 102 Hardness of drug X uncoated tablets at 25°C as a function of RH (%) (each point is average value for 10 tablets) ...................................................................... 247 Figure 103 Hardness of drug X coated tablets at 25°C as a function of RH (%) (each point is average value for 10 tablets) ...................................................................... 248 xxiv Figure 104 Hardness of drug X uncoated tablets at 40°C as a function of RH (%) (each point is average value for 10 tablets) ...................................................................... 248 Figure 105 Hardness of drug X coated tablets at 40°C as a function of RH (%) (each point is average value for 10 tablets) ...................................................................... 249 Figure 106 Graphical representation of the tablet squeezing in the thickness and diameter directions by fingers ................................................................................................ 251 Figure 107 Graphical representation of the tablet breaking by fingers ........................... 251 XXV LIST OF SYMBOLS A: surface area AH: absolute humidity at given temperature, g H 20/g dry air a.,,: water activity awn-,0: water activity of air inside package am”): water activity of air outside package ,6: slope of M(%) and aw (or RH(%) or p/p,) Ci: concentration of drug initially in tablet (mg drug initially in tablet/mL medium) Cm: concentration of drug dissolved in medium afier stirring for time s (mg drug ' dissolved in medium/ml. medium) , C3: concentration of drug still left in tablet after stirring for time 5 (mg drug left in tablet/mL medium) D: dissolution (%) at 30 minute stirring time 0,: initial dissolution (%) at 30 minute stirring time EMC: equilibrium moisture content K: dissolution reduction rate (day'I) k: dissolution rate (minute'l k,~: dissolution rate (minute' ) of the initial tablet k,: dissolution rate (minute") at storage time t Z: thickness of material M(%): moisture content (%) (dry weight), g H 20/g dry weight of solid x 100 Mw(%): moisture content (%) (wet weight), g HZO/g wet weight of solid x100 M(%): initial moisture content (%), g H20/g dry weight of solid x 100 M: moisture content (dry weight), g H20/g dry weight of solid MA: moisture content of solid A, g H20/g dry weight of solid A M4,: initial moisture content of solid A, g H20/g dry weight of solid A My. final moisture content of solid A, g H 20/g dry weight of solid A M3: moisture content of solid B, g H 20/g dry weight of solid B M,: initial moisture content, g H 20/g dry weight of solid Mf. final moisture content, g HZO/g dry weight of solid Mm: initial moisture content (wet weight), g H 20/g wet weight of solid m: mass of moisture me: mass of moisture at equilibrium mh: mass of moisture in the package headspace m,-: mass of moisture at initial time mr: total mass of moisture inside package P: permeability of package Pi: initial weight of product Pf. final weight of product p: vapor pressure of water at given temperature Pam: atmospheric pressure at given temperature pm: vapor pressure of water inside package at given temperature pow: vapor pressure of water outside package at given temperature p,: saturation vapor pressure of water at given temperature p/p,: relative water vapor pressure xxvi R: dissolution retardation rate (% dissolution change/day) RH(%): relative humidity (%) s: stirring time t: storage time V: volume of the package headspace W: weight of solid Wd: dry weight of solid WM: dry weight of solid A de: dry weight of solid B W): final weight of solid W5: initial weight of solid w: mass of moisture permeated into the package xxvii INTRODUCTION Pharmaceutical companies must submit stability data for new drug applications (NDA) to the U.S. Food and Drug Administration (FDA) before pharmaceutical products go to market. The submitted stability data must be approved by FDA. FDA recommends that the length of the studies and the storage conditions should be sufficient to cover storage, shipment and subsequent use. Therefore, FDA recommends that drug products be tested in long-term testing (25i2°C, 60-15% RH) for 12 months and accelerated testing (40i2°C, 75i5% RH) for 6 months in the market package. If a significant change occurs due to accelerated testing, a minimum of 6 months’ data from an ongoing 12 months study at an intermediate condition (30i2°C, 60:5% RH) should be included for the initial application. A significant change in dissolution is defined as failure to meet the specification limit for 12 tablets or capsules [USP Stage 2“]. If a significant change occurs during intermediate testing, it may not be appropriate to label the drug product for CRT (controlled room temperature) storage with the proposed expiration dating period even if the stability data from the full long-term studies at 25i2°C, 60i5% RH appear satisfactory. After new drug products obtain market approval from FDA, they can launch to market. Stability data in long-term testing (25i2°C, 60i5% RH) must be reported to ' If the quantities of active ingredient dissolved from the units tested conform to the accompanying Acceptance Table, the requirements are met. Continue testing through the three stages unless the results confirm at either S. or S2. The quantity, Q, is the amount of dissolved active ingredient specified in the individual monograph (USP <71 I> Dissolution). Acceptance Table Stage Number Tested Acceptance Criteria S. 6 Each unit is not less than Q + 5%. $2 6 Average of 12 units (S.+ 82) is equal to or greater than Q, and no unit is less than Q;15%. 33 12 Average of 24 units (S.+ 82+ 8;) is equal to or greater than Q, not more than 2 units are less than Q — 15%, and no unit is less than Q — 25%. FDA annually for the proposed expiration dating period (USP <1196>, 1995 and Guidance for Industry, Stability Testing of Drug Substances and Drug Products, 1998). A package must be designed properly to meet the FDA requirements for accelerated stability testing. Ideally, the packaged product should meet the stability requirement at the end of the six month accelerated storage period. This study shows how to select a suitable package for pharmaceutical tablets by using an open dish study and computer simulation programs focused on moisture content and dissolution. Dissolution is one parameter that may change as a function of temperature, humidity, and storage time. It has been accepted by the United States Pharmacopeial Convention (U SPC) as a measure of bioavailability and as a stability-indicating parameter for solid oral dosage forms. When solid oral dosage forms are packaged in blisters or plastic bottles, they can be protected from environmental hazards such as light, oxygen, and moisture. However, the packages cannot protect them completely, so the properties of solid dosage forms may deteriorate as a function of storage time. Since dissolution is affected by temperature and moisture, determining the relationship among dissolution, temperature, and moisture is very important in designing a package for solid oral dosage forms that will maintain the specification limit of dissolution. To measure this relationship and the effect of the package on it, an experimental program can be conducted. It consists of two parts: an open dish study of the product and a separate evaluation of the permeation behavior of the package. This program differs from and is faster than the stability testing program. In the open dish study, the product is brought to equilibrium quickly with a series of temperature and humidity environments. Once that equilibrium is achieved, the product properties, including dissolution, can be measured. At the same time, the permeability of the package can be measured over the range of temperatures encountered in distribution. Specifically, this information can be obtained for the accelerated storage condition (40°C/75% RH). Then, using mathematical relationships developed by researchers over the last 20 years, and in this research, product researchers and packagers can select a barrier package that will meet the requirements of the accelerated stability testing program. More formally, the hypothesis for this research is that there is a general method for design of a barrier package that will protect the dissolution property of a drug product when it is exposed to ICH (International Conference on Harmonization) accelerated stability conditions. The general hypothesis is supported by the following three subordinate hypotheses: 1. The relationship between moisture content and dissolution of drug tablets can be found using open dish studies. 2. Moisture content and dissolution of drug tablets in a permeable package can be predicted based on the unsteady state vapor pressure of the package headspace. 3. A suitable package for stability testing can be chosen using computer simulation programs. In order to prove the hypotheses, the following steps were taken: 1. Develop mathematical models that can calculate the shelf life, moisture content, and dissolution of drug tablets in a package. 2. Determine moisture sorption isotherm equations. 3. Determine dissolution retardation rates at a variety of relative humidities. 4. Determine permeabilities of packages. In this study, coated and uncoated drug tablets were placed in open dishes at 25 and 40°C at 0%, 50%, 65%, 75%, and 90% RH, for 6 months. The moisture, dissolution, hardness, and dimensions of the tablets were measured at scheduled times during the open dish study. It was found that dissolution, hardness, and dimensions changed as a fimction of moisture and storage time. The relationship between moisture and dissolution obtained from the Open dish study was used to predict the dissolution of tablets in a package as a function of storage time. The hardness and dimensions were used to explain the theory of dissolution retardation as a function of relative humidity. The permeabilities of packages (LDPE bags and HDPE bottles) at 40°C were measured separately. Tablet properties from the open dish study were used along with package permeabilities to design a suitable package for stability testing. In order to formulate the relationship between moisture and dissolution, a property called the dissolution reduction rate (K) was developed by Nakabayashi and coworkers (1981). However, their approach did not work for this study because of variation inherent in the dissolution measurements. While logical in theory, the dissolution reduction rate did not work well enough in practical application to be useful. Therefore, a different approach to formulate the relationship between moisture and dissolution was used in this study. This different approach uses the dissolution retardation rate (R), dissolution change/day. Dissolution is dependent on moisture as well as storage time, so a dissolution retardation rate including storage time is necessary to formulate the relationship with moisture in order to predict the dissolution of tablets in a package as a function of storage time. Dissolution retardation rates must be determined at each relative humidity and temperature. CHAPTER 1 BACKGROUND AND LITERATURE REVIEW (DISSOLUTION PREDICTION MODELS) Literature related to dissolution prediction models is reviewed here. Literature related to moisture and shelf lifeb prediction models is reviewed in Appendix A because shelf life and moisture prediction models are not directly related to dissolution prediction for tablets in a package. They are, however, necessary tools for estimating dissolution shelf life or selection of barrier packages, so the necessary background is provided separately. Dissolution is a critical parameter in determining performance and defining quality control, regulatory compliance, and bioavailability of solid oral dosage forms such as tablets and capsules (see USP <1191>). The U.S. Food and Drug Administration (FDA) requires that any drug product on the market must at all times meet the requirements of the USP monograph or other monographs specifying its properties. Otherwise, it will be recalled from the market. The monograph specifies a dissolution requirement for many products. Compared with the chemical stability of the drug substance in solid dosage forms, the effect of aging on in-vitro dissolution (physical stability) has been neither thoroughly investigated nor fully understood (Chowhan, September 1994). Dissolution prediction models for drug substance particles have been developed by using the film theory (diffusion layer model). The thickness of a drug particle is assumed, and then the model can be developed from Fick’s second law of diffusion. It is a cube-root law as shown in Equation 1 (Higuchi, 1963). b . . . . . . . . . Shelf life IS defined as the time requrred to reach the final morsture content from the Inlllal moisture content. fire] 3 DC. (1) 3 Ph W. =w0 “If/3’ kr3=[ where w = the particle weight at time t, wo = the initial particle weight, k = the composite rate constant, p = the density of the particle, D = the diffusion coefficient, C, = the solubility, h = the diffusion layer thickness Almeida et al. (1997) demonstrated the inadequacy of the cube-root law (Equation 1) to predict the dissolution of ibuprofen, as the assumptions associated with this model are not valid in the case of multisized powders. Wang and Flanagan (1999) showed that an assumption used in the derivation of the cube-root law may not be accurate under all conditions for diffusion-controlled particle dissolution. They found the cube-root law was most appropriate when particle size is much larger than the diffusion layer thickness. A two-thirds-root expression (Equation 2) applied when the particle size is much smaller than the diffusion layer thickness. The square-root expression (Equation 3) is intermediate between these two models. 4;: “20C W2 3 = Wri 3 "k2 3’ kr-r =[—£) —" (2) 3 p 1,2 WI 2 =Wri‘2 'kr 2’ kl 2 =(fl) _D2_ (3) 2 k'p where k ’ = the constant These models (Equations 1-3) are just for drug substance particles. If a drug is mixed with excipients, and then compressed to form a tablet, the models cannot be applied to predict the dissolution of the tablet because it is impossible to determine the diffusion layer thickness. F u et al. (1976) developed a mathematical model for the estimation of the drug release rate from drug-polymer composite tablets. The drug-polymer composite tablets do not disintegrate in the dissolution medium, but the drug can dissolve into the medium through the polymer. The model (Equation 4) predicts the drug released from a drug- polymer composite tablet as a function of storage time: ~ M (v exp: —Da mt)” “Mfl D3,. 1) M(Q) —[28a 2 ":zsol—— 2:0— (4) where Z = half of the thickness of the drug-polymer composite tablet, a = the radius of the drug-polymer composite tablet, D = the difiusion coefficient of the drug in the drug- polymer composite tablet, t = storage time, a", = the roots of Jg(aa) = 0; Jo = the zero- (2n + 1);: order Bessel function, A, = 23 Siepmann et al. (1998) also developed a dissolution prediction model for swollen hydroxypropyl methylcellulose (HPMC) tablets numerically by using finite differences. The model was used to calculate the required shape and dimensions of HPMC tablets to achieve desired drug release profiles. The model mentioned above cannot be applied to starch based (or sugar based) tablets because these tablets disintegrate. If tablets lose their original shape, the prediction model cannot be used. Based on review of the literature, it can be concluded that there is no available dissolution prediction model that can predict the dissolution of aged tablets stored at a specific condition for a certain amount of time. It may be impossible to develop. So, the dissolution behavior as a function of storage time has only been determined by stability testing. Taborsky-Urdinola et al. (1981) reported the effects of packaging and storage in multiple-unit and unit-dose containers on the dissolution rate of prednisone tablets. USP prednisone dissolution calibrator tablets that were packaged in polyethylene bags and unpackaged (open dish) tablets were selected to compare their dissolution. Both sets of tablets were placed in a tropical microenvironment of approximately 40 °C and 85% relative humidity for three months. Dissolution was measured at pre-determined intervals during storage. This study clearly demonstrated that packaging and storage affect product integrity. It showed a relationship between dissolution of the pharmaceutical product and the moisture barrier of its packaging. The dissolution of tablets stored in open dishes decreased a lot more quickly than the dissolution of tablets stored in packages. Her study is very useful to understand the dissolution behaviors among opened, low barrier packaged and high barrier packaged tablets. However, she did not explain how much dissolution was different as a function of package barrier and how dissolution changed as a function of storage time. Her study does not predict the dissolution behavior of tablets in a package. Chowhan (March 1994) reported that the particle size, aqueous solubility, drug substance concentration, excipients and their concentration in the formulation, and the process used in manufacturing all play a significant role in determining drug product dissolution. And, Chowan (September 1994) reported the factors affecting in vitro dissolution of tablets include formulation, manufacturing method, processing variables, in-process controls, and dissolution method. Tablets formulated, manufactured, and processed differently were stored at differing storage conditions for differing storage times in open dishes. His study is helpful for selecting the initial tablet formulations, but does not predict the dissolution behavior of aged tablets in a package. As mentioned above, much research on developing pharmaceutical dosage forms has been done, and is still being done for each new product. However, the dissolution behavior of aged tablets in a package has still not been fiilly investigated and understood. It has been established that the dissolution of tablets in a package is changed as a function of storage conditions and storage time, but little research has been done to find how much the dissolution of tablets in a package is changed as a fimction of storage conditions and storage time. When the dissolution shelf life of solid dosage forms was estimated, fit factors, critical storage condition, and dissolution reduction rate were used. Moore and Flanner (1996) presented two new fit factors to compare the difference between the percent drug dissolved per unit time for a test and a reference formulation. The fit factors are denoted by f, and f2, and they can be defined by Equation 5 and Equation 6. x 100% (5) -—0.5 n f2 =5010g [1+12w,(R,—T,)2:l x100 (6) n i=1 where, R, = the reference dissolution at stirring time point t T, = the test dissolution at stirring time point t n = the number of sampling (stirring time) points w, = the optional weight factorc ° It can be used to minimize the analysis error. 10 Equation 5 is a perturbation of the relative error formula. It can approximate the percent error between reference and test dissolution profiles. The percent error is zero when two profiles are identical and increases proportionally with the dissimilarity between the two profiles. Equation 6 is a logarithmic transformation of the sum of squares error. It takes the average sums of squares of the difference between reference and test dissolution profiles and fits the result between 0 and 100. The fit factor (73) is 100 when two profiles are identical and approaches zero as the dissimilarity increases. Moore and Flanner said the fit factor (f2) may provide a linear relationship if it is plotted as a function of storage time; then the dissolution shelf life can be predicted by extrapolation. However, it is hard to get a linear relationship between either fit factor (f, or f2) and storage time. The dissolution was used to decide the failure point of solid dosage forms and the moisture content at the failure point was used to estimate the dissolution shelf life (Qian, 1996, Wu, 1996, Kokitkar, 1997, Adams, 1999, Yoon, 2000, Thomas, 2000, Suemag, 2001). Adams (1999) stored hydroxypropyl methyl cellulose coated aspirin tablets in open dishes for 90 days at three different temperatures (25, 30, and 40 °C) and several different relative humidities. Dissolution and moisture content were measured at planned intervals. If the dissolution fell below a specification limit at a condition, that condition was used for a failure storage condition. So, the package was designed to maintain the package headspace below that failure storage condition for a desired dissolution shelf life. However, it has been found that the dissolution is not dependent on moisture content alone. Figure 1 shows dissolution for 3 months storage time for a coated aspirin. The tablets reached equilibrium moisture content in 6 days. Even though the moisture content 11 at 6 days and 90 days were the same, dissolution at 6 days and 90 days was not the same. Therefore, the dissolution is not dependent on moisture alone. It depends on storage time as well as moisture. 125 1. ----- 2...----.M-.--..-- --m----_.u - . .- I-.. MW: ;' A p -—kf——> A S Mechanism (1) where A is the amount of drug in the tablet, kd is the disintegration rate constant, A p is the amount of drug in the small particles (after disintegration). A, is the amount of drug in solution and k, is the dissolution rate constant. When the fresh tablet is dropped into the dissolution medium, it is disintegrated immediately. So, the disintegration rate (kd) can be ignored for the fresh tablet. The mechanism (1) can be simplified as shown in mechanism (II). 14 A p —> As Mechanism (II) where k is the dissolution rate. Equation 7 can be used to determine the dissolution rate (k). The dissolution rate (k) is an apparent first-order kinetic rate. C. = C.- -e"° (7) The dissolution profile shown in Figure 3 is plotted with % undissolved versus stirring time to represent the exponential Equation 7. 100% (Ct) 75% — U Q 2 3 g 50% F U C :3 25% ~ 0% . . 3 0 10 20 C1) Stirring time (ninutes) Figure 3 Exponential relationship between % undissolved and stirring time The concentration of drug (C,, mg drug left in tablet/mL medium) still left in the tablet afier stirring time s can be calculated by Equation 7 and the concentration of drug 15 dissolved in the medium (Cm, mg drug dissolved in medium/mL medium) afier stirring time s can be calculated by Equation 8. C,,, = C,- — C,- .e“’“ ' (8) The natural log is applied to both sides of Equation 8, then it is rearranged to get a dissolution rate (k) as shown in Equation 9. C ,- _ By plotting the data as ln[C/(C,~-C,,J] vs. stirring time (s), a dissolution rate (k) can be determined as shown in Figure 4. InICI/(Cr-Cnd] N O 5 10 15 20 25 30 stirring time (a) Figure 4 Dissolution rate (k) 3. Dissolution reduction rate (K) The theory of the dissolution rates as a function of storage time has not been explained clearly yet. So, the relationship between dissolution rate and storage time should be determined experimentally. Nakabayashi used an exponential relationship 16 (first order kinetics) between dissolution rate and storage time. Obviously, the relationship is very dependent on the product formulation. Equation 10 can be used to fit the relationship between dissolution rate (k) and storage time (t). k, =ki-e'K" (10) The natural log is applied to both sides of Equation 10, then it is rearranged to get a dissolution reduction rate (K) as shown in Equation 11. 1n[7'::—_]=—K-r (11) By plotting the data as ln[k/kJ vs. storage time (t), a dissolution reduction rate (K) can be determined as shown in Figure 5. storage time (t) 0 30 60 90 120 150 180 o r 1 1 1 1 1 -3 - ..___.-. ______..-_. ... __-__ .. .. .. . .. _ . _. _ .W .. _ .. Figure 5 Dissolution reduction rate (K) 4. Relationship between dissolution reduction rate and moisture content Nakabayshi and coworkers used the multiple regression method to determine the relationship between the dissolution reduction rate, moisture, and temperature. Table 1 17 shows the dissolution reduction rates for various moisture contents at 25, 40, and 50°C and Equation 12 shows the equation determined from a multiple regression method. Table l Apparent dissolution reduction rate constants (K) of dissolution for prednisolone tablets with various moisture content (Nakabayashi et al., 1981) Temperature, °C M (%) Dissolution Reduction Rate, K 25 4.77 0.0049 25 5.60 0.0091 40 3.54 ' 0.0037 40 4.12 0.0055 40 4.64 0.0092 40 5.41 0.0165 50 3.10 0.0038 The constants of Equation 12 can be determined by using a multiple regression function in a statistics computer program. an = 4.5241+3.4936-lnM-4556.0491/T (12) where T is the absolute temperature ( °K) They found that each term of Equation 12 was statistically significant, and the multiple correlation coefficient was as high as 0.994. Thus, Equation 12 was considered to be suitable for expressing the dependence of the K value on moisture and temperature. 18 CHAPTER 2 EXPERIMENTAL DESIGN, MATERIALS AND METHODS 1. Experimental design Open dish exposure at various relative humidities causes faster dissolution change than the stability testing that is done with tablets in a package. In this study, therefore, the product and package are tested separately, then their experimental data are combined to predict the product properties in package as a function of storage time. First, tablets were stored in open dishes at 25 and 40°C at 0, 50, 65, 75, and 90% RH for 6 months. They were tested to determine the relationship between moisture content and dissolution for 6 months. Second, the permeabilities of packages (LDPE bags and HDPE bottles) were determined. Finally, the product results (initial moisture content, sorption isotherms, relationship between moisture content and dissolution) and package permeabilities were used to design a barrier package. The product tablets were 2 years old, so it was necessary to determine if they still met specifications before using them in this study. First, the product quality was tested in terms of moisture, dissolution, and hardness. After determining that the product could be used for this study, initial moisture contentsd and sorption isotherms were measured. These are better to be measured prior to preparing the storage conditions for the open dish study. Based on the initial moisture content and sorption isotherm, initial equilibrium relative humidity can be determined. Storage conditions above initial equilibrium relative humidity are recommended because tablet deterioration may be more " In this study, initial moisture content is defined as a moisture content of the tablets which are inserted into a package. 19 severe than at low humidities. After determining the storage conditions, tablets were set up in open dishes for dissolution, hardness, and dimension measurement. Figure 6 shows the diagram of the experimental design. Careful attention to matching the solid and broken lines with the description in the following text will help the reader to visualize the several relationships that exist among the parts of the 'work. The solid lines all represent the main theme of the research, from beginning through “Design a Package”. The dotted and dashed lines represent the application of theories and procedures which are tools for accomplishing the main task. Figure 6 also shows the package part of the work (permeability) and the product part of the work (moisture content, dissolution, dimensions, and hardness). Permeability and moisture content are used to verify the shelf life and moisture prediction program. These are all connected by dotted lines. Permeability, moisture content, and dissolution are used to verify the dissolution prediction program. These are all connected by a solid line. Moisture content, dissolution, dimensions, and hardness are used to explain the dissolution behavior as a function of relative humidity. These are connected by dashed lines. Table 2 shows the testing plan for the open dish study. The package permeability and product/package set up for the model verification were started with the open dish study at the same time. 20 Product quality test I Determine initial moisture contents and sorption isotherms v Prepare the storage conditions for open dish study based on the sorption isotherm data l l I I T j Permeability Moisture content Dissolution Dimensions Hardness l and HDPE bottles I l o lnrtraldrssolutron for . Thickness coated and uncoated tablets . Dissolution profiles (Dissolution as a function of stirring time): coated and uncoated tablets at 40°C and 25°C a oaaaooaoooouaoooaaoooooono.one-oooooooaaoo -——----- 5 ......... -L _______ L___.l_ V . Diameter l . By hardness tester . By blister package I I I I I I I I .I I V In order to verify Moisture prediction program Shelf life prediction program Product & package setup 0 Tablets in LDPE bags without silica gel and tablets with silica gel (0.5 g, 1 g, 2 g) in LDPE bags 0 Tablets in HDPE bottles without silica gel and tablets with silica eel (0.5 2) in HDPE In order to verify Dissolution prediction program . Tablets in LDPE bags without silica gel and tablets with silica gel (0.5 g, l g, 2 g) in LDPE bags . Tablets in HDPE bottles without silica gel and tablets with silica gel (0.5 g) in HDPE bottles . Tablets in open dishes at stepwise conditions In order to explain the dissolution retardation as a function of RH Figure 6 Diagram of the experimental design Design a package 21 Table 2 Testing plan for open dish study Storag: time (months) Prior to open dish study 1 2 3 I 4 5 I 6 Initial moisture contents (coated and . . uncoated tablets, silica gel), Moisture Package permeabllrty Ll sorption isotherms (coated and uncoated tablets, silica gel at 25°C/40°C), Dissolution (calibration curve, initial dissolution profiles for coated and uncoated tablets), Initial hardness, Initial Product and package were set up for the model verification I I Finding the relationship between moisture and dissolution dimension . Tests of tablet properties k _ Stora e conditions D) D(200rpm, 90% D,H,d D,H D,H,d D,H m),H D,H,d D. D(200rpm, 75% D, H,d D,Hl D, H,d D,H ”pH D,H,d D, thoorpm 40°C 65% D, H, d D, H D, H, d D, H 1L” H D, H, d D, Dow 50% D, H, d D, H D, H, d D, H .29, H D, H, d D, thoOrpm. 0% D,H,d D,H D,H,d D,H .Jm, D,H,d D, D(200rpm, 90% D,H,d D,H D,H,d D,H ”th D,H,d Dr D(200rpm, 75% D, H,d D,H D, H,d D,H ”pH D,H,d D9 D(200rpm, 25°C 65% D, H, d D, H D, H, d D, H ILrLH D, H, d D, 9000an 50% D,H,d D,H D,H,d D,H ".1:er D,H,d D, Dawn“. 0% D,H,d D,H D,H,d D,H ”£er D,H,d D: the dissolution testing of coated and uncoated tablets using lOOrpm for 30 minute stirring (6 samples for each condition at each testing) 0000an m): the dissolution of coated and uncoated tablets using lOOrpm for 30 minute stirring and 200rpm for additional 30 minute stirring (6 samples for each condition) H: the hardness of coated and uncoated tablets (10 samples for each condition at each testing) d: the dimension of coated and uncoated tablets (5 samples for each condition at each testing) During dissolution tests, it was recognized that dissolution of tablets stored at 40°C changed very rapidly as a function of storage time. Dissolution is defined as a physical property of tablets, so dissolution must be explained by physical phenomena such as a physical interaction among ingredients in tablets. Excipient and drug particles compressed into tablets are disintegrated by the dissolution medium. If the disintegration 22 time increases, the dissolution value will decrease (Carstensen et al., 1980). The dissolution value can be changed physically or chemically. Physically, excipients and drug in tablets can interact such as in crosslinking. Also, a drug can be degraded chemically. This causes the dissolution value of the drug to decrease. In order to make sure that the dissolution changed only by physical interactions, tablets needed to be disintegrated completely in the medium to allow all the drug in the tablet to dissolve into the medium. If the drug in the tablets is dissolved completely, the dissolution value must be the same as for the initial tablets (D = 100%) if there is no chemical degradation. Therefore, tablets at 5 months storage time were stirred using 200 rpm for an additional 30 minutes after the dissolution testing was done to be sure they dissolved completely. Some of the tablets did not reach 100% dissolution because they did not disintegrate completely, but some tablets did disintegrate completely, So they reached 100% dissolution. This meant the drug in 5 month aged tablets did not degrade chemically. See Appendix E. Dissolution Raw Data and Dissolution Profiles at 25°C for more information. 23 2. Materials and methods (1) Drug X coated and uncoated tablets - Drug X coated and uncoated tablets were obtained from Eli Lilly and Company (Indianapolis, IN). The tablets were formulated with drug substance X, and the excipients mannitol (63%), microcrystalline cellulose (MCC) (18%), croscarmellose sodium, povidone, purified water, magnesium stearate, and color mixture yellow for coated tablets (see Appendix C for detailed information). Mannitol can be obtained from hydrogenation of glucose. Glucose is a monosaccharide, so mannitol is a saccharide derivative. Mannitol is used as a diluent in formulating tablets. The superdisintegrant, croscarmellose sodium, was used to make tablets disintegrate quickly in the medium. Magnesium stearate used as a lubricant is hydrophobic but it enhances tablet granulation processing characteristics. Table 3 shows that the physical properties of drug X 2 year old tablets are close to those of drug X fresh tablets. Table 3 Comparison of physical properties between drug X fresh tablets and 2 year old tablets Moisture content Dissolution at 30 minutes Hardness Coated I Uncoated Coated I Uncoated Coated I Uncoated Fresh z2% | * 100% | * 9kp I * 2years old 2.31% | 1.93% 95.9% | 96.2% 9.21 kp | 8.9 kp *Data for uncoated tablets were not available. 24 (2) Storage conditions Two different temperatures (25 and 40°C) and 5 different relative humidities (0, 50, 65, 75, 90%) were used for the open dish study. The relative humidities (50, 65, 75, and 90%) were prepared by saturating deionized water with salts (Fisher Scientific, PA) and 0% RH was prepared by using calcium chloride (CaClz, desiccant) in glass desiccators. Table 4 shows the list of the salts used to provide the desired range of relative humidities. ASTM E 104-85 shows how to prepare the salt solutions and the expected RH values for selected salt solutions. Table 4 Salt solutions used to provide the rguired range of relative humidities 25°C Salts Amount used Nominal RH Actual RH Actual RH by humidity sensor by moisture content Calcium Chloride N/A 0% N/A 1.3 — 1.5% (CaClz) Magnesium Nitrate l300g/500ml 52.9%:0.2% 50% N/A , M mom—61120) DI water Sodium Nitrite 350g/500ml 64.3% 65% N/A (NaNOz) DI water Sodium Chloride 300g/500ml 75.3%d:0. 1% 75% N/A (NaCI) DI water Potassium Nitrate 500g/500ml 93.6%:0.6% 93% N/A (KNO3) DI water , 40°C Salts Amount used Nominal RH Actual RH Actual RH by humidity sensor by moisture content Calcium Chloride N/A 0% N/A 2.9 - 4.1% (CaCIz) Magnesium Nitrate l300g/500ml 48.4%i0.4% 50% 47 — 52% . __(_Mg(N03)2o6HZO) DI water Sodium Nitrite 350g/500ml 61.3% 64% 63 — 66% (NaNOz) DI water Sodium Chloride 300g/500ml 74.7%i0. 1% 75% 73 - 74% ('NaCl) DI water Potassium Nitrate 500g/500ml 89%: I .2% 89% 86 — 89% ’ (KN03) DI water N/A: It was not measured. 25 Environmental chambers (25 and 40°C) in which temperature and relative humidity are controlled automatically were used. Desiccators were stored in those 25 and 40°C chambers. In order to make sure that each saturated salt solution reached the desired relative humidity, a humidity sensor was placed in the lid of the desiccator until equilibrium was reached. The stick-shaped humidity sensor was fitted with a rubber stopper. Then it was placed in the top of desiccator as shown in Figure 7. Salt Solution Figure 7 Graphical representation of the humidity sensor placed on the top of desiccator The humidity sensor is connected to a humidity transducer by wire. The humidity transducer detects the voltage change from the sensor. The accuracy of the humidity sensor is i3% from 0-90% RH between 15 °C and 50 °C (59 to 122 °F). The humidity is detected by the voltage change (4.0 mA to 20.0 mA). The 4.0 to 20.0 mA output is proportional to 0% RH to 100% RH. Also, the relative humidities for 6 months were measured by using the moisture content of tablets and moisture sorption isotherm curve. Periodically, the moisture 26 content of tablets was measured, and applied to the moisture sorption isotherm curve to determine the equilibrium relative humidity. Table 4 shows actual relative humidities determined by this method. There is good agreement. It means desiccators kept the desired RH well. (3) Sealing, integrity testing, and volume measuring of packages The LDPE bags (3” x 3”) were heat sealed by an impulse heat sealer (248C, Sencorp Inc.). The LDPE film sheet was cut and folded, and then two sides were impulse heat sealed for two seconds. After tablets were inserted into the LDPE bags, the top was also heat sealed. The HDPE bottles (50 mL) were induction heat sealed by an induction heat sealer (LM328502, ENERCON Inc.) after the tablets were inserted into the bottles. In order to make sure packages were sealed properly, the integrity of packages was tested visually for induction heat sealed HDPE bottles and by using methylene blue for impulse heat sealed LDPE bags. Afier each moisture and dissolution test, the methylene blue was injected into LDPE bags until it covered the seal all around the package. The methylene blue was allowed to remain in contact with the seal edge for approximately 10 seconds. The sealed area was visually examined. In order to determine the volume of LDPE bags and HDPE bottles, water was injected into LDPE bags and poured into HDPE bottles, and then water was poured into a 100 mL volume flask to measure the volume. The bag was visually flattened to make the bag volume the same as the actual bag volume containing tablets. 27 (4) Permeability The permeabilities of LDPE bags and HDPE bottles were measured using calcium chloride. See procedures ASTM D 895-94 or USP 24 <671> for more information. Calcium chloride (CaClz) was regenerated at 110°C for 24 hours to have 0% water vapor pressure, and inserted into the LDPE bags and HDPE bottles. It was assumed that the internal water vapor pressure was zero. Five LDPE bags containing calcium chloride and two LDPE bags containing glass beads were stored in a 90% RH desiccator in the 40°C chamber, and five HDPE bottles containing calcium chloride and two HDPE bottles containing glass beads were stored in the 40°C/75% chamber. There was not enough space for HDPE bottles in the 90% RH desiccator, so the bottles were stored in the 40°C/75% chamber. The bags and bottles were taken out periodically and the moisture gain was measured using a balance (R3008, Sartorius Inc., sensitivity: i0.00005g). (5) Moisture content (3) Initial moisture content The initial moisture contents of tablets and silica gel were determined by using a Computrac MAX 2000 (Arizona Instrument Inc., AZ) at a temperature of 103°C for 6 hours. Tablets were ground by mortar and pestle, and then placed on the weighing pan. The granules of silica gel were not ground. The Computrac MAX 2000 has the heating pan on the top and the balance on the bottom. Therefore, drying and weighing tablets and silica gel can be achieved at the same time. The moisture change is expressed by using a graph (weight change vs time) on the screen. 28 (b) Moisture sorption isotherms The moisture sorption isotherms of tablets and silica gel were constructed using a SGA-100 Symmetrical Gravimetric Sorption Analyzer (VTI Corporation, FL) (see Figure 8). The SGA-100 Symmetrical Gravimetric Sorption Analyzer is a continuous gas flow adsorption instrument for obtaining moisture sorption isotherms at temperatures ranging from 5°C to 60°C at ambient pressure. It has the capability of performing sorption isotherms at relative humidities from 0% to 98%. The SGA-100 has an option to dry the sample to determine the initial moisture content. However, 60°C is not a high enough temperature to dry out the tablet and silica gel completely. Therefore, the initial moisture content would be better to be determined before samples were placed on weighing pan in the analyzer, and then Equation 20 in Appendix A can be used to calculate the equilibrium moisture content if the initial moisture content, and the initial and final weights of the tablet and silica gel are available. The tablet is placed on the quartz sample holder, then the sample holder is attached to a hang down wire connected to a sensitive microbalance. The temperature is controlled by a constant temperature bath (sensitivity: i0.01°C) which circulates water inside the walls of the aluminum block. The humidity is controlled by the wet Mass Flow Controller (MFC 1 in Figure 8). The humidifier is maintained at constant temperatures (25 or 40°C) to make a saturated stream of humidity. At the beginning of each run, the equilibrium criteria must be determined. For example, if a weight % change does not occur for a given time (e.g., 10 minutes), then the relative humidity is increased to the next step. Therefore, the user must determine the 29 weight % change and the specific amount of time. These conditions are maintained until the sample weight reaches equilibrium. There is a way to determine the minimum equilibrium weight gain. The noise level for SGA-100 is 1 micrograrn (0.001 mg), so any reading at that level is noise. For example, 0.001 mg (noise level) 200 mg (sample weight) x100 = 0.0005% If a 200 mg sample is used, 0.0005% weight change can happen as a result of background noise. Therefore, a larger weight % change than 0.0005% must be selected. I \ . PU FIG E EXHAUST 7T0 cm? W 1- I W HUIIIIDIFIER Figure 8 The sketch of the symmetrical gravirnetric analyzer (SGA-IOO) (The sketch was obtained from VTI, and it is modified to simplify.) where, SI, 82, S3, and S4 = Solenoid Valves MFC l and MFC 2 = Mass Flow Controllers DPA = Dew Point Analyzer RTD = Resistance Platinum Thermometer CTB = Constant'Temperature Bath Principles of operation for SGA-I 00 A dry gas source (nitrogen, air) passes through a 2 micron filter and splits into two lines. One of the lines, called the purge line, is connected to the microbalance chamber. The flow rate of the gas continuously purging the microbalance chamber is regulated by a rotameter. The second line is connected to two solenoid valves which are provided for shutting on and off the flow to the mass flow controllers which are used to accurately control the flow of the dry gas. One of the streams (MF C 1) flows through the humidifier. The second mass flow controller (MFC 2) provides a dry gas stream (see Figure 8). The gas leaving the humidifier is mixed with the dry stream via a static mixer. The dew point of the mixed stream is measured with the dew point analyzer (DPA); Two solenoid valves downstream from the DPA redirect the stream either to the aluminum block or to the vent. The stream entering the aluminum block is equilibrated with the temperature of the block and is equally divided into two streams. One of the streams enters the sample compartment of the aluminum block. The other stream enters the reference compartment of the block“. In each of the compartments, a 100 Ohm Resistance Platinum Thermometer (RTD) is provided for measuring temperature of the ‘ If the weight of a sample is larger than the capacity of the balance, a counter weight is used. The balance measures the difference in weight between the two pans, and the software adds the counter weight to the difference to get the actual sample weight. 31 process stream. Based on the temperature and dew point, the relative humidity is determined. The sample weight changes during adsorption are measured with a Cahn D-200 microbalance (sensitivity: i0.001mg) and recorded in a computer with Flow System sofiware. The Cahn balance has a capacity of 3.5 grams and is sensitive to changes as small as l microgram. (c) Verification of moisture simulation program Packages (LDPE bags and HDPE bottles) were used to verify the shelf life and moisture prediction models. The uncoated tablets and silica gel were inserted into the LDPE bags and HDPE bottles, and they were stored at 40°C/90%. Table 5 shows the combination of componentsf in each package. Seven different LDPE bags and HDPE bottles were used for each combination. See Appendix D for raw data of the weight of components in LDPE bags and HDPE bottles. Table 5 The combination of components in LDPE bags and HDPE bottles used to verify the moisture and shelf life prediction program LDPE bags HDPE bottles | Contents Tablets only I Tablets + 0.5 g 7 Tablets + 1 Tablets + 2 Tablets only Tablets + 0.5 7 7 silica el silica el silica el 7 silica el Before the tablets and silica gel were inserted into the package, the initial weights of tablets, silica gel and package were measured using a balance (sensitivity: i0.00005 g). At each weighing time, the total weight of the package and contents was measured first, then the package was opened, and the tablets were removed for weighing. r It is defined as dry solids such as tablets, capsules, and desiccant. 32 The moisture gain of LDPE bags alone was determined by blanks when the permeability was determined. It was 0.02 g, and assumed to be the same for all tests. See Appendix D for raw data. The moisture gain of HDPE bottles alone was also determined by blanks when the permeability was determined. Figure 9 shows the moisture gain of empty HDPE bottles as a function of storage time. As explained, the moisture gain of each of the packages and the tablets was determined. If they are subtracted from the total moisture gain, the moisture gain of the silica gel can be calculated without measuring the weight of silica gel. The silica gel in LDPE bags and HDPE bottles is hard to remove for measuring the weight because it is small granules. (see example calculations below.) 0.025 -, _, , . g 0.02 _ C 3 0015 2 ' _ y=6E-05x+0.012 3 R2=0.9973 .2 0.01 _ O a g 0.005 _ O m 0 50 100 150 200 Storage time (days) Figure 9 The moisture gain of HDPE bottles The following example calculation shows how to calculate the moisture content of tablets and silica gel by using Equation 23 from page 125, rewritten here for convenience. 33 . . . W f ' (M1 + 1) Mo1sture content based on the dry weight of sol1d: M (%) = W -1 x 100 Calculation of the moistmontent of tabletgnd silica gel in the packages Example 1. Tablets and silica gel in LDPE bags Initial weight Final weight _ . Package: 1.1690g . Package (calculated): 1.1890g . Tablets: 3.7642 g . Tablets: 3.7872 g . Silica gel: 0.5010g . Silica gel (calculated): 0.6063 g . Total: 5.4342 g . Total: 5.5825g . Initial moisture content (tablet: 1.9312%, silica gel: 3.03%) The final weight of package = 1.1690g + 0.02 g = 1.1890g (moisture gain of LDPE bag: 0.02 g) The final weight of silica gel = 5.5825g — 3.7872 g — 1.1890g = 0.6063g By using the moisture content equation, the M(%) of tablets and silica gel can be calculated. 3.7872 - (1 + 0.019312) 3.7642 — 0.6063 - (1 + 0.0303) 0.5010 _ M(%)tablets = [ l] X 100 = 2.550/0 M(%)smca 3,, =[ 1] x 100 = 24.68% Example 2. Tablets and silica gel in HDPE bottles Initial weight Final weight . Package: 13.9370g . Package (calculated): 13.9498g . Tablets: 3.7643g . Tablets: 3.7431 g . Silica gel: 0.5032 g . Silica gel (calculated): 0.5386g . Total: 18.2045g . Total: 18.2315g . Initial moisture content (tablet: 1.93 12%, silica gel: 3.03%) 34 The final weight of package = 13.9370g + 0.01284g = 13.9498g (moisture gain of HDPE bottle afier 14 days = 0.00006 x 14 days + 0.012 from the equation in Figure 9) The final weight of silica gel = 18.2315g — 3.7431 g — 13.9498g = 0.5386g By using the moisture content equation, the M(%) of tablets and silica gel can be calculated. 3.7431'03‘0-0‘9313—1 x100=l.36% 3.7643 - 0.5386 . (1 + 0.0303) _ 11 x100 = 10.28% 0.5032 1 M (%)tablets = |: M (%) silica gel = [ (6) Dimensions The dimensions of tablets stored at all conditions (25 and 40°C at 0%, 50%, 65%, 75% and 90%) were measured by using a digital caliper (CD-6” BS, Mitutoyo Inc., sensitivity: 21:0.005mm). Each time, five tablets were selected to measure the dimensions (thickness and diameter) for each condition. The tablet has a score. The dimensions were always measured at the same position relative to the score. The dimensions were measured initially, and these dimensions were compared to the dimensions of aged tablets. See Appendix F for raw data of tablet dimensions. (7) Hardness The hardness of tablets stored at all conditions (25 and 40°C at 0%, 50%, 65%, 75% and 90%) was measured by HT-300 Hardness tester (Key lntemational, Inc., NJ). Each time, ten tablets were selected to measure the hardness at each storage condition. As with the dimensions, the score was used as an index to assure that the hardness was 35 always measured at the same position. See Appendix G for raw data of the tablet hardness. Figure 10 shows a sketch of the PIT-300 hardness tester. The plunger moves at a constant speed towards the specimen. As soon as the plunger touches the specimen and produces a force on the load cell, a linearly increasing force is produced until the specimen breaks. Then the decreasing signal from the load cell indicates to the microprocessor to determine the hardness value. spindle plunger spring unit load cell specimen, - Figure 10 Sketch of the PIT-300 hardness tester (The sketch was obtained from the company brochure, and it was modified to simplify.) motor Measuring range: 0.5-30 kp (kilopond) or 5-300 N (1kg = 9.807N) Resolution: 0.1 kp Accuracy: il% over the entire readout measuring range Also, the effect of hardness of tablets on opening blisters was tested using PVC blister packages. A Klockner — Pentapack blister thermoform-fill-sealer was used to thermoform PVC blisters, fill tablets, and seal blisters. PVC film (10 mil) was used to thermoform blisters and 1.9 mil aluminum foil laminated with paper was used for the backing film. Tablets at equilibrium at each condition (25 and 40°C at 0, 50, 65, 75 and 90% RH) were packaged into the blister. One tablet was placed in each blister, and then the blister was heat-sealed to the backing film by the thermoform-fill-sealer. The tablets 36 packaged into the blister were used to test whether they had enough hardness to be pushed out of the blisters without breaking. (8) Dissolution In accordance with the USP monograph for drug X, experiments were carried out with 1000 mL of 0.02N HCl dissolution medium, apparatus 1 (rotating basket), and 100 rpm speed for the stirrer. One tablet was used per vessel and six vessels were used for each storage humidity and temperature combination. (a) Dissolution medium (0.02N HCl) In order to prepare 1 liter 0.02N HCl, 1.7 mL of concentrated HCl (3 7%) was added to a flask and diluted to 1 liter with purified water. The dissolution medium was deaerated using helium sparging before testing. (b) Reference standard solution For the drug X tablets, the linearity of the response was determined using eight standard preparations of drug X in the concentration range of 6% to 164% of the 20mg dose. If 20mg drug X is dissolved in the 1000 mL medium completely, the concentration of drug X in the medium is 100%. The drug X reference standard was weighed, then transferred into a 1000 mL volumetric flask. Table 6 shows the concentrations (mg/mL) to make the entire concentration (%) range. The drug X reference standard was dissolved in 0.02N HCl dissolution medium by using a sonicator. The absorbance of the solutions 37 was measured by using a UV spectrophotometer (HP8453, Agilent Inc.), then plotted as absorbance vs. % concentration as shown in Figure 11. Table 6 Dissolution calibration data of drug X Concentration Response Concentration (%). (mg/mL) (absorbance) 6.58% 0.001315 0.0396795 16.44% 0.003287 0.0988455 32.87% 0.006573 0.192289 65.73% 0.013146 0.395215 92.91% 0.018581 0.561377 98.60% 0.019719 0.583967 131.46% 0.026292 0.775347 164.33% 0.032865 0.979527 Concentration (%) = Dissolution (%) 1.2 ~ ---------- Response (absorbance) O O) 1 - y = 0.5944x + 0.0009 R2 = 0.9998 0% 50 % 1 00% 150% 200% Concentration (%) Figure 11 The calibration curve for the spectrophotometer using drug X Calculation fl % dissolution Example. The absorbance of tablets at the 30 minute stirring time: 0.5724. Therefore, by the equation in Figure l 1, dissolution can be calculated. 0.5724 — 0.0009 % Dissolution = x 100 = 96.14% 0.5944 38 (c) Dissolution sampling A VK 7010 six vessel dissolution sampling apparatus (V ankel, NC) was used for sampling drug solution. The prepared dissolution medium (0.02N HCl) was poured into the vessels, then they were covered to increase the temperature to 37i0.5°C. The temperature was checked with a Curette thermometer (20-40°C, i0.15°C) (YSI Inc., OH). Tablets were placed into 40 mesh standard baskets (Vankel, NC), then they were immersed into the medium (see USP <711> for information about dissolution). After the dissolution sampling apparatus was run, the vessels were covered again to keep the constant temperature. Samples were collected every 10 minutes with 10 mL syringes (Becton Dickinson and Company, NJ). A 0.5 um pore size hydrophilic PTFE filter (Millipore Inc., MA) was attached to the syringe, then about 3 mL sample was flushed through the filter because there may be dust from a manufacturing process. By flushing the filter, the dust can be removed. Then, the remaining 7 mL sample was collected into 10 mL disposable glass tubes. The new filter was used in collecting samples each time. About 10 mL dissolution medium was removed from the vessel at each sampling and it was-not replaced. For the second sampling, the volume of the dissolution medium was 990 mL, and for the third sampling, the volume of the dissolution medium was 980 mL. Therefore, the percent dissolution at 20 and 30 minutes stirring time should be corrected by using Equation 13. V _ _ _V n-l I... (n I) ..]+_. C, (13) V V , m ml= Corrected % Dissolution = C,' where, C" = uncorrected concentration at sample interval n V,,, = original medium volume (mL) n = sample interval V, = sample volume (mL) 39 C,- = uncorrected concentrations of previously removed sample aliquots Calculation of the corrected % dissolution Example. Dissolution at 10 minutes stirring time: 68.23% Dissolution at 20 minutes stirring time: 93.97% (uncorrected) Dissolution at 30 minutes stirring time: 96.15% (uncorrected) [1000mL—(2—1)~10mL] + IOmL IOOOmL 1000mL [1000M ‘43 “ ”'10le + 10’“ (68.23 + 93.97) = 95.85 1000mL 1000mL Corrected %Dissolution = 93.97 68.23 = 93. 71 Corrected %Dissolution = 96.15 The dissolution of tablets stored at 25 and 40°C at 0, 50, 65, 75 and 90% RH was measured at every month for 6 months. The resulting data were used to determine the dissolution retardation rate (R). (d) Dissolution measuring (absorbance) Based on the USP monograph for drug X tablets, the UV spectrophotometer was used to measure the UV absorbance at the wavelength of maximum absorbance, 275 nm, of filtered portions of the solution under test. The cell having 1 cm path length was used. The absorbance of the blank obtained from the dissolution medium was measured first, then it was subtracted from the absorbance of the initial and aged tablets to get the true absorbance of drug X. (e) Verification of dissolution prediction model In order to verify the dissolution prediction model, uncoated tablets were placed in open dishes using stepwise storage conditions. Also, they were packaged into LDPE bags and HDPE bottles for continuous storage conditions. 40 i. Tablets in open dishes - stepwise storage conditions The uncoated tablets were placed in open dishes at 40°C/50% initially, and they were transferred to 40°C/65% afier one month, and so on as shown in Table 7. When they were transferred to another condition, the dissolution was measured. Table 7 Stepwise stora e conditions used to verify the dissolution prediction model Storage time (months) Storage Conditions 50%(1 month) 50%(1 month), 65%(1 month) 50%(1 month), 65%(1 month), 75%(1 month) 50%(1 month), 65%(1 month), 75%(2 months) 50%(1 month), 65%(1 month), 75%(1 month), 90%(1 month) 50%(1 month), 65%(1 month), 75%(3 month) 50%(1 month), 65%(1 month), 75%(1 month), 90%(2 month) Utth-b-bWN—t ii. Tablets in packages - continuous storage conditions The uncoated tablets were packaged into LDPE bags and HDPE bottles to verify the dissolution prediction model. They were the same as those used to verify the moisture prediction model. After the moisture gains of tablets were measured, they were tested for dissolution. Each package has the same number of tablets, 15 tablets, but each package has a different total tablet weight because of the variation of individual tablet weights. To make a single continuous smooth plot, the average weights of tablets were used for the moisture content and dissolution prediction. 41 CHAPTER 3 RESULTS AND DISCUSSION Figure 12 shows the outline of the whole experiment that has been done for this research. It is placed here because it is especially relevant to the discussion in this chapter. Parts of the figure refer to this chapter only. Other parts are found in other places in the dissertation. Their location and relevance to the whole are described in the following text and the figure. Careful attention to matching the solid and broken lines with the description in the following text will help the reader to visualize the several relationships that exist among the parts of the work. The solid lines all represent the main theme of the research, from beginning through “Design a Package”. The dotted and dashed lines represent the application of theories and procedures which are tools for accomplishing the main task. Figure 12 shows the package part of the work (permeability) and the product part of the work (moisture content, dissolution, dimensions, and hardness). Permeability and moisture content were used to verify the shelf life and moisture prediction program. These are all connected by dotted lines. Permeability, moisture content, and dissolution were used to verify the dissolution prediction program. These are all connected by a solid line. Moisture content, dissolution, dimensions, and hardness were used to explain the proposed theory of dissolution retardation as a function of relative humidity. These are connected by dashed lines. Dimensions and hardness are not directly related to the main purpose of this research (dissolution shelf life), so they are attached as Appendices. The verification for the moisture and shelf life prediction programs is attached in Appendix B, and the verification for the dissolution prediction program appears in 42 Chapter 4. Experimental results and discussion of permeability, moisture content, and dissolution are presented in this chapter. 43 Experimental results and discussion 1 1 1I 1 7 Permeability Moisture content Dissolution Dimensions Hardness I l T I l . Permeabilities . Initial moisture . Initial dissolution for . Thickness of LDPE bags content of coated, coated and uncoated . By hardness tester . Diameter . By blister package and HDPE uncoated tablets, tablets . . bottles and silica gel . Dissolution profiles (see Append1x F) (see Appendix G) . Moisture sorption (Dissolution as a isotherms of function of stirring time): coated, uncoated coated and uncoated tablets, and silica tablets at 40°C and 25°C gel at 25°C/40°C (see Appendix E for : dissolution profiles at 25°C) . Dissolution retardation (30 minute dissolution as a function of storage time): uncoated tablets at 40°C (see Chapter 4) . Relationship between dissolution retardation I l I I I I l I I I I I I I I l I I I I .l rate (R) and RH(%) (see Chapter 4) I _ 1 ............ S..............'L__.__...__..-L_.....__.._L_--1- 1': 1 Verification for Verification for Proposed theory of Moisture prediction program Dissolution prediction program dissolution retardation Shelf life prediction program (see Chapter 4) as a function of RH (see Appendix B) . Tablets in LDPE bags (see Chapter 5) Product & package setup without silica gel and tablets . Tablets in LDPE bags without with silica gel (0.5 g, l g, 2 silica gel and tablets with silica g) in LDPE bags gel (0.5 g, l g, 2 g) in LDPE . Tablets in HDPE bottles bags without silica gel and tablets . Tablets in HDPE bottles with silica gel (0.5 g) in without silica gel and tablets HDPE bottles with silica gel (0.5 a) in HDPE Design a package Figure 12 Outline of the experiment 44 l. Permeability Raw data used to determine WVTR are attached in Appendix D. Figure 13 shows a standardized traditional relationship among water vapor transmission rate (WVTR), permeance, thickness normalized WVTR, and permeability. This relationship assumes a homogeneous material in sheet form of some thickness 8. WVTR is divided by the partial pressure difference between the inside and outside of the package to calculate the permeance, and then the permeance is multiplied by the package wall thickness to calculate the permeability (see ASTM E96). The permeability for a given material is a constant value at the same temperature. If the package is stored at a high relative humidity, the WVTR will be high due to the large partial pressure difference, and vice versa. Therefore, the permeability is always the same at the same temperature. WVTR (water vapor transmission rate) (quantity) x Ap’ (area)(time) x g Permeance Thickness Normalized WVTR (quantity) (quantity) (thickness) (area)(time)(Ap) (area) (time) I —l x Permeability x AP (quantity) (thickness) (area)(time)(Ap) Figure 13 Relationship between water vapor transmission rate (WVTR), permeance, thickness normalized WVTR, and permeability 45 The pharmaceutical industry does not follow the traditional practice of assuming the package to be a homogeneous sheet of some thickness 8. Bottles are a complex combination of varying bottle wall thickness and closure combinations. Blisters are therrnoformed from sheet, and therefore have varying wall thickness always less than that of the starting sheet. Furthermore, barrier blisters are not homogeneous in construction, but rather have two or more materials laminated or coextruded. Use of the model for packages made of a homogeneous sheet has no practical value. Therefore, the pharmaceutical industry practice is to use the whole package unit instead of the thickness and area of the package to determine WVTR and permeability. USP <671> Containers-Permeation sets the common practice for the drug industry. Bottles, pouches and blisters are all tested as whole package units without reference to thickness or closure. They are also tested at a single temperature and humidity, which mandates a single partial pressure differential (40). Thus, the USP test yields a water vapor transmission rate (WVTR) which is labeled as “Permeation” in USP terms. This construction is very limited in comparison with the relationship described in Figure 13. It is also too limited for use in development of the theories and application treated in this research. USP <671> has a built-in discontinuity which makes it very difficult to compare blister or pouch permeation with bottle permeation. Blister and pouch permeation is reported as weight gain per package (single pouch or single blister) per day. Bottles are reported as weight gain per liter (of bottle volume) per day. A bottle tested may contain any number of product units (e. g. 7 to 500) and it may be of any volume, 45 mL to 500 mL, for example. In any case, bottle permeation (a WVTR) is reported as mg/L/day. A 46 blister or pouch usually contains only one product unit. Blister permeation (WVTR) is reported as mg/cavity/day; the cavity is the equivalent of 1 unit of product (capsule, tablet, etc.). This makes it very difficult to compare permeation performance between bottles and blisters. The need to compare these values is great when planning package changes between bottles and blisters. Industry practice is moving toward the comparison of bottles and blisters on a permeation per product unit basis. This trend is anticipated in this research. This research is intended for application to bottles, blisters and pouches at any relative humidity at a single temperature. Therefore, the permeance property of packages is modeled in Figure 14. In this research WVTR was determined as a quantity per whole package per a unit of time, so the units for WVTR and permeance are not the same as in Figure 13. In this work permeance is treated as the permeability of the package. WVTR Permeance (quantity) X Ap"l (quantity) (time) mackage) (time) @ackageflAp) Figure 14 Relationship between water vapor transmission rate (WVTR) and permeance using whole package instead of thickness and area In this study, WVTR was determined as a quantity per whole package per unit of time instead of quantity per package area per unit of time. Then this WVTR was divided by partial pressure differential to obtain permeance as quantity per package per unit partial pressure differential per unit time. The total'weight increase of each package was measured for 5 LDPE bags and 5 HDPE bottles at each testing time, then it was reduced by the weight increase of the blank to calculate the net moisture gain. The net moisture gain was plotted as a function 47 of storage time. WVTR was determined by a trend line as shown in Figure 15 and Figure 16. When the WVTR was determined, the point (0,0) was not included because at this point the package was not yet at steady-state conditions at 40°C. (1) LDPE bags 1.6 -. . A e 3 1.4 « 5 1.2 ~ 0 u 1 — g 0.8 a '3 0.6 _ E 04 4 y-0.0227x+0.1541 R2 = 0.9937 g 02 4 o 1 r 1 1 I 3 0 1O 20 30 40 50 60 Storage time (days) [ 0 Experimental moisture gain —WVTR (grams/day) Figure 15 WVTR of LDPE bags at 40°C/90% RH Calculation of the permeability of the LDPE bags WVTR = 0.0227 grams/day-package Vapor pressure difference = 90% RH - 0% RH = 90% RH (or 0.9 p,) Therefore, Permeability = 0.0227 g x 1 = 0.0252 g at 40°C day- package 0.9 ps day- package - ps 48 (2) HDPE bottles 0.06 1 0.05 ~ 0.04 4 0.03 « 0.02 ~ y = 0.0012x - 0.0009 R2 = 0.9993 g 0 10 20 30 40 50 Time (days) 0.01 4 Net moisture gain (9) 0 Experimental moisture gain —WVTR (grams/dam Figure 16 WVTR of HDPE bottles at 40°C/75% RH Calculation of the permeability of the HDPE bottles WVTR = 0.0012 grams/dayopackage Vapor pressure difference = 75% RH - 0% RH = 75% RH (or 0.75 p,) Therefore, Permeability = 0.0012 g x 1 = 0.0016 g at 40°C day- package 0.75 ps day- package. ps 2. Moisture content (1) Initial moisture content Table 8 shows the experimentally measured initial moisture content of tablets and silica gel, and the calculated equilibrium relative humidity at each initial moisture content. The equilibrium relative humidity can be determined by the moisture sorption isotherm curves or their equations such as GAB or Langmuir equations (see Appendix A 3.(2)(a) GAB equation and (b) Langmuir equation). The equilibrium relative humidities of 49 tablets were determined by the GAB equation and those of silica gel were determined by the Langmuir equation. Table 8 Initial moisture content and guilibrium RH of tablets and silica gel Uncoated tablets Coated tablets Silica gel M 1.93% 2.31% 3.03% RH at M,- at 25°C 31.72% 40.96% 4.31% RH at M,- at 40°C 34.23% 42.62% 4.31% (2) Moisture sorption isotherms The sigmoid-shaped moisture sorption isotherms of tablets fit well with the GAB equation, and the hyperbolic-shaped moisture sorption isotherms of desiccants such as silica gel fit well with the Langmuir equation over the range of relative humidities between 10% and 90%. The choice of equation depends on the shape of the moisture sorption isotherm. Therefore, the GAB equation was used to describe the relationship between the moisture content of drug X tablets and water activity (aw) (i.e., p/p, or %RH/lOO), and the Langmuir equation was used to describe the relationship between the moisture content of silica gel used in this experiment and aw (i.e., p/p, or %RH/ 100). Table 9 shows the GAB constants of drug X tablets and Langmuir constants of silica gel used in this experiment. Table 9 GAB constants of tablets and Langmuir constants of silica gel GAB constants Langmuir constants Wt". Cg K Wm CL Uncoated tablets at 25°C 0.0141 18 75.771 1 0.919386 Uncoated tablets at 40°C 0.013392 113.2096 0.933012 Coated tablets at 25°C 0.014513 297.5468 0.915190 Coated tablets at 40°C 0.014100 324.3921 0.920041 Silica gel at 25°C 1.440803 0.498612 Silica gel at 40°C 0.819364 0.924676 50 (a) Moisture sorption isotherms of drug X tablets (coated and uncoated) Figure 17 shows the moisture sorption isotherms of coated and uncoated tablets at 25°C and Figure 18 shows the moisture sorption isotherms of coated and uncoated tablets at 40°C. The coated and uncoated tablet isotherms are almost the same, but the moisture sorption isotherm of coated tablets is a little higher because of the coating material (4% of tablet). Tablets were formulated with 63% mannitol and 18% microcrystalline cellulose. If the temperature is increased, the water vapor sorption of mannitol and celluloses decreases at the same pressure (exothermic process). The moisture sorption isotherms are almost the same as shown in Figure 19. In practice, a single sorption isotherm may be able to be used to describe the water-solid interaction for both coated and uncoated tablets at both 25°C and 40°C in this temperature range as a function of relative humidity. M(%) MOO-#OIGVGCD d O 1 3 20 4o 60 80 100 RH (%) O 0 Experimental M (%) of uncoated tablets l Experimental M (%) of coated tablets — Calculated M (%) by GAB equation for uncoated and coated tablets Figure 17 Moisture sorption isotherms of drug X tablets at 25°C 51 1 M(%) O-ANOJAOICDVODO O 20 40 60 80 100 RH (%) 0 Experimental M (%) of uncoated tablets I Experimental M (%) of coated tablets —— Calculated M (%) by GAB equation for uncoated and coated tablets Figure 18 Moisture sorption isotherms of drug X tablets at 40°C The isotherms in Figure 19 from topmost to lowest are in the order: coated tablets at 25°C, coated tablets at 40°C, uncoated tablets at 25°C, uncoated tablets at 40°C. The difference in moisture content between highest and lowest at 50% RH is 0.18%. This is calculated from the values below: M(%) of coated tablets at 25°C/50% RH: 2.67% M(%) of coated tablets at 40°C/50% RH: 2.60% M(%) of uncoated tablets at 25°C/50% RH: 2.57% M(%) of uncoated tablets at 40°C/50% RH: 2.49% 52 3 - 7 . 6 - S 5 i 2 4 . 3 ‘ Coated tablets at 25°C 2 , Coated tablets at 40°C ‘ Uncoated tablets at 25°C 1 « Uncoated tablets at 40°C 0 T r r 1 1 1 1 I r 1 0 10 20 30 40 ‘ 50 60 70 80 90 100 RH(%) Figure 19 Moisture sorption isotherms calculated by GAB equation for tablets at 25°C and 40°C 53 (b) Moisture sorption isotherms of silica gel Figure 20 and Figure 21 show the experimental (dots) and calculated (solid line) moisture sorption isotherms determined by the Langmuir equation. There is fairly good agreement between experimental and calculated moisture sorption isotherm data. Also, the GAB equation was tried to fit moisture sorption isotherms. However, there is little difference between the sorption isotherms calculated from the Langmuir and GAB equations (see Appendix D). Therefore, the simple Langmuir equation was used for silica gel sorption isotherms. The moisture sorption isotherms at 25°C and 40°C are plotted together in Figure 22. Silica gel is an exothermic material. When the material absorbs water, the material gives off heat. At the same RH (%), the amount of water that can be absorbed in the material at 40°C is less than that at 25°C. Therefore, if temperature is increased, the water vapor sorption is decreased as shown in Figure 22. i / 40 e % ‘ I , ; 30 3 a e 20 a / 5 10 . O o 7 T T T i 0 20 40 60 80 100 RH(%) 0 Experimental M (%) Calculated M (%) by Langmuir equation Figure 20 Moisture sorption isotherm of silica gel at 25°C 54 501‘" - -~ ~ ~» ~~ —- —~ ~ ~, 40 ‘ e ’ e i 0 . I 30 4 ’ g e 5 l 20 . i O 1 10 . ° l 0 , , . . J 0 20 40 60 80 100 RH(%) 0 Experimental M (%) Calculated M (%) by Langmuir equation Figure 21 Moisture sorption isotherm of silica gel at 40°C 50 ----.—-——--4~—~—.~-~«~—-—~----—-»-—~-9- - » ”flu—w... 25°C E 40 « 40°C : 30 i i =3 2 20 a 10 i O r f r 1 1 0 20 40 60 80 100 RH (%) Figure 22 Moisture sorption isotherms calculated by Langmuir equation for silica gel at 25°C and 40°C 55 3. Dissolution In this study, the initial tablet is defined as tablets which are inserted into a package. When the initial drug X coated tablet is dropped into the dissolution medium (0.02N HCl), the coating material dissolves quickly in the medium and the croscarmellose sodium (CAS) among granulesg swell to 4-8 times. This makes tablets rapidly disintegrate to coarse particles. Also, CAS in the granules swells quickly, making coarse particles disintegrate into fine particles of excipients. The'dissolution mechanism of drug X uncoated tablet is exactly the same except for dissolving the coating material. During dissolution testing, it was observed that the time required for tablet wetting and disintegration is very short for the initial tablets. If the first dissolution sample is collected at a 10 minute stirring time, the regions “Mechanical Lag and Wetting”, “Disintegration”, and “Disaggregation” cannot be obtained. Therefore, the S- shaped dissolution curve of Figure 2 on page 14 can be represented in practice as shown in Figure 23. Dissolved Stirring Time Figure 23 The typical dissolution curve constructed experimentally Coated tablets aged at 40°C at 50-90% RH require a lot more disintegration time than initial tablets, perhaps because the coating material is degraded physically or 3 See Appendix C l. Formulation for the term “granules”. 56 chemically, or excipients are crosslinked to each other above about 50% RH. Uncoated tablets aged at 40°C at 50-90% RH require a lot more disintegration time than initial tablets as well. If an aged tablet is dropped into the dissolution medium, the tablet is wetted and swollen by the medium in the same way as the initial tablet. However, the aged tablet does not disintegrate rapidly but disintegrates slowly. From this, the following can be deduced: a. The intermolecular forces between excipients and drug may be increased due to the crosslinking of excipients. b. The hydrophilicity and swelling property of disintegrants may be decreased, so the boundaries between excipients and drug cannot be weakened quickly by uptake of water. 0. The porosity of tablets may be decreased, so the water has difficulty getting into excipients to make them swell, and disintegrate. (1) Initial dissolution profiles Table 10 and Figure 24 show the initial dissolution profile for drug X uncoated tablets, and Table 11 and Figure 25 show the initial dissolution profile for drug X coated tablets, illustrating how tablets dissolve over 30 minutes at 100 rpm. At each stirring time, six samples were measured, and the average dissolution is represented by the solid line. Dissolution for uncoated tablets at the 10 minute stirring time reaches 81%, but dissolution for coated tablets at the 10 minute stirring time reaches only 51%. The dissolution behavior was observed visually. The initial uncoated tablets started to 57 disintegrate immediately afler they were dropped into the medium and the disintegration proceeded quickly. However, the initial coated tablets took a little time to start to disintegrate. That is why the dissolution at the 10 minute stirring time for coated tablets was lower than that for uncoated tablets. However, they reached about the same dissolution at the 30 minute stirring time. Table 10 Initial dissolution profile data for uncoated tablets Dissolution Time Apparatus Position * Conditions (min) 1 l 2 1 3 4 I 5 l 6 Avg. SD Dissolved i 0 0% 0% 0% 0% 0% 0% 0% 0.0% Basket 10 68.2% 81.4% 87.3% 88.8% 84.3% 77.2% 81.2% 7.6% 31100 rpm 20 93.7% 95.4% 94.9% 95.8% 93.8% 95.2% 94.8% 0.9% 30 95.9% 96.5% 95.9% 97.1% 95.3% 96.7% 96.2% 0.6% 100% 1"‘"”"” - -~ ’5 75% « e 8 2 g 50% . 5 25% 4 0% . . . 0 10 20 30 40 Stirring time (minutes) 0 Dissolution measured experimentally — Average dissolution Figure 24 Initial dissolution profile of drug X uncoated tablets 58 Table 11 Initial dissolution profile data for drug X coated tablets Dissolution Time Apparatus Position Conditions (min) 1 | 2 I 3 I 4 5 6 Avg. SD Dissolved 0 0% 0% 0% 0% 0% 0% 0% 0.0% Basket 10 61.7% 63.0% 32.2% 59.4% 72.9% 16.1% 50.9% 21.8% at100 rpm 20 95.5% 96.8% 96.6% 95.4% 96.6% 92.9% 95.6% 1.5% 30 96.5% 97.2% 89.5% 96.7% 97.7% 97.6% 95.9% 3.1% 1°°°’"1"“""" ~—- ~— — v-~— we“ -~ 0 75% ~ , i , . 0 50% 5 o O 25% « O 0% T I I I I 1 0 5 1O 15 20 25 30 35 Stirring time (minutes) 9 Dissolution measured experimentally —— Average dissolution Figure 25 Initial dissolution profile of drug X coated tablets 59 (2) Dissolution profiles from open dish study The dissolution of drug X tablets stored in open dishes at 40°C decreased quickly over the 6 month experiment, but the dissolution of drug X tablets stored in open dishes at 25°C did not change over the 6 months. Figures 26-30 show the average dissolution at 10, 20, and 30 minutes stirring time obtained for drug X uncoated tablets stored for 6 months at 40°C/90%, 75%, 65%, 50%, and 0%. They show the trend of dissolution reduction as a function of storage time. Figures 31-35 show the profiles obtained for drug X coated tablets stored for 6 months at 40°C/90%, 75%, 65%, 50%, and 0%. See Appendix E for the dissolution raw data including data variability (standard deviation) and the dissolution profiles of tablets stored for 6 months at 25°C/90%, 75%, 65%, 50%, and 0%. (a) Drug X uncoated tablets stored in open dishes at 40°C Figure 26 shows the dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/90% and the decrease in the dissolution profiles as a function of storage time. The solid line represents the dissolution profile of the initial tablets. The 30 minute dissolution of uncoated tablets stored for 6 months is still higher than the 75% dissolution specification limit in USP monograph. In terms of dissolution, uncoated tablets passed the 6 month 40°C/90% testing. However, they failed the hardness testing (see Appendix G. Hardness). 60 75% 50% Dluolved 25% 0% 10 20 Stirring time (minutes) 30 40 I t=initial x t=l month 0 t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 26 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/90% (each point is average value for 6 tablets) Dissolution at the 30 minute stirring time for months 0-6 was statistically analyzed using ANOVA. The p-value was 7.0E-11. Statistically, they are Significantly different because the p-value is lower than 0.05. Next, dissolution at the 30 minute stirring time for months 0 and 1, 1 and 2, etc., was statistically analyzed using t-tests as shown in Table 12. Table 12 pcvalues from t-test using 1 month and 2 month intervals for tablets stored at 40°C/90% RH Storage time 0 and 1 1 and 2 2 and 3 3 and 4 4 and 5 5 and 6 (month) p-value 1.0E-01 2.1E-06 8.6E-01 3 .2E-01 7.5E-03 1.9E-01 Storage time 0 and 2 1 and 3 2 and 4 3 and 5 4 and 6 (month) p-value i 3.3E-06 2.9E-05 3.3E-01 9.5E-04 4.9E-04 61 The p—values from t-tests between 1 and 2 months, and between 4 and 5 months are less than 0.05, so they are significantly different. However, the others are not significantly different because the p-values are greater than 0.05. By inspection of Figure 26, it can be seen that average dissolution values decrease as a fimction of storage time. They decrease within a small range of dissolution change with a large variation. Table 12 shows p-values from t-tests using 2 month intervals are generally less than 0.05. Therefore, it can be concluded that the dissolution decreased as a function of storage time, but the decrease did not occur in a uniform manner. Figure 27 shows the dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/75%. The dissolution profiles decreased as a function of storage time. The solid line represents the dissolution profile of the initial tablets. The dissolution at 40°C/75% decreased more quickly than at 40°C/90%. There are many proposed reasons such as crosslinking and swelling. See Chapter 4.4. Proposed theory of dissolution retardation as a function of relative humidity for a detailed discussion. 62 "no/o “WW _ ...._ _. ———I [/7 .... x 75% TX _l_e'.:f' 0' -::'-:'. v'x > .11" .- e 50% .a w" ,9 a ,' ,:' .'.A a ’l ' - . a 1” . XI ex "'6': . 25% '+;‘ .- 005 1 T I 1 0 10 20 30 40 Stirring time (minutes) I t=initia| x t=l month 0 t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 27 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/75% (each point is average value for 6 tablets) Dissolution at the 30 minute stirring time for months 0-6 was statistically analyzed using ANOVA. The p-value was 8.6E-08. Statistically, they are significantly different because the p-value is lower than 0.05. Next, dissolution at the 30 minute stirring time for months 0 and 1, 1 and 2, etc., was statistically analyzed using t-tests as shown in Table 13. Table 13 p-values from t-test using 1 month and 2 month intervals for tablets stored at 40°C/75% RH Storage time 0 and l l and 2 2 and 3 3 and 4 4 and 5 5 and 6 (month) p-value 3.5E-05 2.4E-03 6.7E-01 6.6E-01 l . l E-Ol 9.4E-01 Storage time 0 and 2 1 and 3 2 and 4 3 and 5 4 and 6 (month) p-value 3.0E-08 3.3E-02 8.6E-01 5.3E-02 4.0E-02 63 The p-values from t-tests between 0 and 1 month, and between 1 and 2 months are less than 0.05, so they are significantly different. However, the others are not significantly different because the p-values are greater than 0.05. From inspection of Figure 27, it can be seen that average dissolution values decrease as a function of storage time. They decrease within a small range of dissolution change with a large variation. Table 13 shows p-values from t-tests using 2 month intervals are generally less than 0.05 and close to 0.05. Therefore, it can be concluded that the dissolution decreased as a function of storage time. Figure 28 shows the dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/65%. The dissolution profiles decreased as a function of storage time. The solid line represents the dissolution profile of the initial tablets. 100% ———I ........ x ax ....... 75% r’ , .o ‘8 ' ' " .+ 3 50% " a a- 5 .' ..0 OX. 25% -- _, - '_ .-.-31f: ml" 0% , 1 , 0 10 20 30 4O Stirring time (minutes) I t=initial x t=l month 0 t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 28 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/65% (each point is average value for 6 tablets) 64 Dissolution at the 30 minute stirring time for months 0-6 was statistically analyzed using ANOVA. The p-value was 8.3E-08. Statistically, they are significantly different because the p—value is lower than 0.05. Next, dissolution at the 30 minute stirring time for months 0 and 1, l and 2, etc., was statistically analyzed using t-tests as shown in Table 14. Table 14 p-values from t-test using 1 month and 2 month intervals for tablets stored at 40°C/65% RH Storagetime Oandl land2 2and3 3and4 4and5 5and6 (month) p—value 1.4E-06 9.9E-04 2.3E-Ol 5.9E-02 1.2E-Ol 9.7E-Ol Storage time 0 and 2 1 and 3 2 and 4 3 and 5 4 and 6 (month) p-value 6.7E-05 1.7E-03 2.9E-03 1.4E-03 1 .5E-01 The p-values from t-tests between 0 and 1 month, and between 1 and 2 months are less than 0.05, so they are significantly different. However, the others are not significantly different because the p-values are greater than 0.05. From inspection of Figure 28, it can be seen that average dissolution values decrease as a function of storage time. They decrease with a large variation. Table 14 shows p-values from t-tests using 2 month intervals are generally less than 0.05 and close to 0.05. Therefore, it can be concluded that the dissolution decreased as a function of storage time. Figure 29 shows the dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/50%. The dissolution profiles decreased as a function of storage time. The solid line represents the dissolution profile of the initial tablets. 65 1 00% 75% 50% Dissolved 25% 0% Sfirring time (minutes) 40 I Finitial x t=l month I t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 29 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/50% (each point is average value for 6 tablets) Dissolution at the 30 minute stirring time for months 0-6 was statistically analyzed using ANOVA. The p-value was 1.0E-10. Statistically, they are significantly different because the p-value is lower than 0.05. Next, dissolution at the 30 minute stirring time for months 0 and 1, 1 and 2, etc., was statistically analyzed using t-tests as shown in Table 15. Table 15 p-values from t-test using 1 month and 2 month intervals for tablets stored at 40°C/50% RH Storage time 0 and l l and 2 2 and 3 3 and 4 4 and 5 5 and 6 (month) p-value 2.2E-02 5.9E-07 1 813-01 7.7E-01 7.9E-03 l .4E-Ol Storage time 0 and 2 l and 3 2 and 4 3 and 5 4 and 6 (month) p—value 7.4E-08 7.8E-03 1.9E-02 4.4E—02 2.4E-05 66 The p-values from t-tests between 0 and 1 month, between 1 and 2 months, and between 4 and 5 months are less than 0.05, so they are significantly different. However, the others are not significantly different because the p-values are greater than 0.05. From inspection of Figure 29, it can be seen that average dissolution values decrease as a function of storage time. They decrease with a large variation. Table 15 shows all p- values from t-tests using 2 month intervals are generally less than 0.05. Therefore, it can be concluded that the dissolution decreased as a function of storage time. Figure 30 shows the dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/0%. The dissolution profiles do not change as a function of storage time. The solid line represents the dissolution profile of the initial tablets. Dried tablets may exhibit little hydrogen bonding (no physical interaction among excipients). Therefore, uncoated tablets stored in open dishes at 40°C/0% RH were not affected by temperature and storage time, so they disintegrated rapidly. There is little moisture in the tablets, so it is assumed there is no physical reaction among excipients induced by moisture. 67 1 00% 75% 8 2 § 50% 5 25% 0% . . . O 10 20 30 40 Stirring time (minutes) I t=initial x t=l month I t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 30 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 40°C/0% (each point is average value for 6 tablets) (b) Drug X coated tablets stored in open dishes at 40°C The dissolution of drug X coated tablets stored in open dishes at 40°C behaved very differently compared with drug X uncoated tablets. The coated tablets did not i follow the dissolution theory (S-shaped dissolution change as a function of stirring time), so the dissolution at the 30 minute stin'ing time did not change regularly as a function of storage time. Figure 31 shows the dissolution of 1 month and 2 month aged coated tablets stored at 90% RH at the 10 minute stirring time are greater than the dissolution of the initial coated tablets at the 10 minute stirring time. 68 100% ~ 75% 50% Dluolved 25% 0% O 10 20 30 40 Stirring time (minutes) I t=initial x t=l month I t=2 months + t=3 months 6 t=4 months A t=5 months * t=6 months Figure 31 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/90% (each point is average value for 6 tablets) When coated and uncoated tablets were stored at 40°C/90%, they both swelled by absorbing moisture. The swelling of excipients can make boundaries among excipients weak. That was why the tablets disintegrated rapidly. It caused the high dissolution value at the 10 minute stirring time. Afier 3 months, the dissolution of coated tablets at the 10 minute stirring time was lower than that of the initial coated tablets even if they still swelled. Dissolution and disintegration are generally directly proportional, if the tablet disintegrates slowly, dissolution is low. A logical reason for increased disintegration time is the following: The properties of the coating material (color mix yellow) might be degraded. It is soluble in water, so the initial coated tablets started to disintegrate rapidly afier being dropped into the medium. However, aged coated tablets did not disintegrate rapidly. They took a longer time to start to disintegrate. They swelled without any disintegration. 69 The coating material was observed to behave like a plastic film. This means the coating material was degraded either chemically or physically. When aged coated tablets started to disintegrate, the coating material was broken out suddenly. After that, aged coated tablets disintegrated rapidly. Therefore, the disintegration of aged coated tablets happened suddenly, not gradually. For the dissolution of aged coated tablets, the disintegration starting point was very important. Figures 32-34 show very low dissolution of aged coated tablets at the 10 minute stirring time. The aged coated tablets did not disintegrate at all for about 6-8 minutes of stirring time, and then started to disintegrate suddenly. The profiles do not show a general decrease in dissolution as a function of storage time. The aged coated tablets did not dissolve according to the dissolution theory. The dissolution is very much dependent on the disintegration starting point. 70 100% w I X 75% r- .1; '0 «0’ 5",.” ‘A a .s/ o I . > -'- ‘L\ a 50% .324 L a 7’ 22"" 25% “4T1. x‘. r'. 0% fii T 1 20 3O 40 Stirring time (minutes) I t=initial x t=l month I t=2 months + t=3 months 0 F4 months A t=5 months * t=6 months Figure 32 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/75% (each point is average value for 6 tablets) 1000/o 1 , . 75% u .x 2 six i 50% 4 ...l ;" + a ,- 4,: I... ‘44. c .‘ 5"." o X-' 13‘ 25/0 .-;'.-X’ ‘r‘r'. f . 3 i‘y'gvz. 00/0 I r 1 20 30 40 Stirring time (minutes) I Finitial x t=l month I t=2 months + t=3 months 0 t=4 months A t=5 months * F6 months Figure 33 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/65% (each point is average value for 6 tablets) 71 100% l 75% AAA ‘33 '5 'O* 3.. 1 a 50% (4'. fl - ’ ' .. i . o . til” '.' '1’.’.xc 25% “ v. 1 ...; i. .".:‘o' .' 1": v ,,‘°. ‘23:“: .......... 0% 1....3“?????¥f' 0 10 20 30 40 Stirring time (minutes) I t=initial x t=l month I t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 34 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/50% (each point is average value for 6 tablets) The dissolution for the aged coated tablets stored at 40°C/90% RH is high at the 10 minute stirring time. The coating material may be cracked by the tablet swelling, so it does not behave like a plastic film. The dissolution for the aged coated tablets stored at 40°C/75%, 65%, and 50% RH is low at the 10 minute stirring time; the swelling at those conditions is not enough to crack the coating material. This low dissolution value can occur due to a degradation of the coating material and physical interaction among excipients. Figure 35 shows the dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/0%. They did not swell and they lost moisture. Dried tablets exhibit little hydrogen bonding (no physical interaction among excipients). Therefore, 72 tablets disintegrated rapidly. From Figure 35, it can be explained that the coating material may be degraded physically or chemically. Dissolution at the 20 and 30 minute stirring time is almost the same between the initial and aged tablets. However, dissolution at the 10 minute stin'ing time is different between initial/1 month aged tablets and 2-6 month aged tablets. This shows clearly the dissolution difference caused by the coating material. There is little moisture in the tablets, so it is assumed there is no physical reaction among excipients affected by moisture. That is why the dissolution of aged tablets at the 20 and 30 minute stirring time is close to that of the initial tablets. The reason can be explained why the dissolution of aged coated tablets at the 10 minute stirring time decreases as a function of storage time. That is because the coating material is degraded by a high temperature (40°C), so the disintegration starting point took a longer time. 100% _ _ .. _ ._,-_____---,.-. ...--- ,W ..-...W. ...._._ .-..--sw__v.._,_.-w-.__._......W ”war.-." . .. . .-.-.- ,. .. . . . .. . . . . . 75% 50% Diaeolved 25% 0% T H l l 10 20 30 40 Stirring time (minutes) I t=initial x t=l month I t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 35 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 40°C/0% (each point is average value for 6 tablets) 73 (3) Summary of dissolution behavior Drug X coated and uncoated tablets dissolve differently in the medium depending on the storage conditions. In comparison with the initial tablets, tablets stored at 40°C/90% and 0% RH dissolve similarly. Tablets stored at 40°C/75%, 65% and 50% RH dissolve differently in the medium from those stored at 40°C/90% and 0% RH. They do dissolve similarly to each other (see Figures 24 - 35 for the initial tablets, uncoated tablets, and coated tablets). For uncoated tablets, dissolution profiles for initial, 90%, and 0% RH (Figures 24, 26, 30) look similar to each other. They show the dissolution is still high at 6 months storage time. And, dissolution profiles for 75%, 65%, and 50% RH (Figures 27, 28, 29) look similar to each other. They show that dissolution decreased rapidly as a function of storage time for 6 months. So, dissolution profiles obtained from initial, 90%, and 0% RH (Figures 24, 26, 30) look different in comparison with dissolution profiles obtained from 75%, 65%, and 50% RH (Figures 27, 28, 29). Coated tablets show the same behavior. For both coated and uncoated initial tablets, there may be no change in physical interactions among excipients because they have been stored at ambient conditions. So, dissolution at the 30 minute stirring time is high (96% for both coated and uncoated tablets). And, for both coated and uncoated tablets stored at 0% RH, there may be no physical interactions among excipients because there is little moisture in tablets. So, tablets stored at 0% RH behaves like the initial tablets. Finally, for both coated and uncoated tablets stored at 90% RH, there may be physical interactions such as crosslinking. However, the swelling may counteract crosslinking among excipients. 74 Also, the swelling may be able to crack the coating material, so aged coated tablets disintegrate rapidly to reach high dissolution. Therefore, the dissolution of the initial tablets, and tablets stored at 0% and 90% RH behaves similarly. For tablets stored at 75%, 65%, and 50% RH, there may be physical interactions such as crosslinking, so dissolution decreases rapidly as a function of storage time. Therefore, dissolution of tablets stored at 75%, 65% and 50% RH behaves similarly. See Chapter 4.4. Proposed them of dissolution retardation Motion of relative humidity for more information. 75 CHAPTER 4 DISSOLUTION PREDICTION PROGRAMMING AND VERIFICATION The dissolution is affected by the following five major factors (Abdou, 1989): a. Formulation b. Manufacturing process c. Packaging and storage conditions d. Dissolution apparatus e. Test parameters The final dosage form, the tablet, is considered in this study, so the factors a and b can be removed because the same formulation and manufacturing process are used for all tablets. Also, if the same dissolution method is used consistently, the factors d and e are assumed to be constant, so they can be removed. Therefore, the effect of aging on in- vitro dissolution is assumed to depend only on packaging and storage conditions such as moisture, temperature, oxygen, light and storage time. In this study, the product is moisture sensitive. The packages such as plastic bags or bottles cannot protect against temperature, but they can protect against light by using amber color or opaque walls. Therefore, if the relationship among dissolution, moisture, and storage time is found, the in-vitro dissolution of products in a package can be predicted at a specific temperature. 1. Technical review of Nakabayashi’s method As explained in Chapter 1, Nakabayashi’s dissolution reduction rate (K) represents the log ratio of dissolution rates [lnflc/kJ] as a function of storage time. If the 76 relationship between dissolution reduction rate (K) and RH (or M) is determined, the dissolution at any storage RH for any storage time can be calculated. Nakabayashi and coworkers used a multiple regression method to determine the relationship between the dissolution reduction rate, moisture, and temperature. Nakabayashi and coworkers determined the dissolution rate (k) by plotting data In[ C /(C ,~ - C,,)] versus stirring time. They presented dissolution determinations resulting from samples of three tablets taken every 2 minutes stirring time from about 2 minutes to 16 minutes. From this, they presented straight line plots of ln[C/(C,~ - C,,,)] versus stirring time. There is very little variation indicated in the data even if they used the rotating basket model for the dissolution method. The basket dissolution method has poor mixing system, so it is hard to reproduce data (Ross and Rasis, 1988). Nakabayashi et al. made no statement of variation at all. Many of the points (average of 3) fall exactly on the trend lines. However, the variation in dissolution is known to be large, especially at stirring times of less than 30 minutes. In this study, six tablets were taken every 10 minutes for a total of 30 minutes stirring time. Variation in this study is high, especially at the 10 minute stirring time for short term aged tablets, and at the 20 and 30 minute stirring time for long term aged tablets as shown in Table 16. Short term (Initial-l month aged) tablets disintegrate quickly, so the short term aged tablets at the 10 minute stirring time are very active, causing a large variation at that stirring time. However, tablets at the 30 minute stirring time disintegrate completely, and reach almost the maximum dissolution value, so, have little variation. Long term (2 months-6 months aged) tablets disintegrate slowly. The long term aged tablets before the 10 minutes stirring time are inactive, so dissolution at 77 that stirring time is low, and variation is small. Tablets beyond 10 minutes stirring time are very active. They rapidly disintegrate into small particles, and the drug in the particles dissolves into the medium. During this process, the dissolution value for each ' tablet is variable. Table 16 Variation of dissolution for drug X uncoated tablets stored at 40°C (coefficient of variance greater than 0.1 is bold-faced.) Stirring time Drug X uncoated tablets stored at 40°C/90% RH (minutes) Initial 1 mo. 2 mo. 3 mo. 4 mo. 5 mo. 6 mo. SD 7.6 3 7.2 5.2 5.6 5.7 3.6 Mean 81.2 84.9 71 68.6 66.7 58.3 53.7 Coef. of 0.094 0.035 0.101 0.076 0.084 0.098 0.067 10 variation SD 0.9 1.6 2.4 2.8 3 3.2 2.4 Mean 94.8 94.66 87.7 86 84.5 78.7 75.9 Coef. of 0.009 0.017 0.027 0.033 0.036 0.041 0.032 20 variation SD 0.6 0.9 1.1 1.7 2 2.2 2 Mean 96.2 96.88 91.3 91.5 90.4 86.2 84.5 Coef. of 0.006 0.009 0.012 0.019 0.022 0.026 0.024 30 variation Drug X uncoated tablets stored at 40°C/75% RH Initial 1 mo. 2 mo. 3 mo. 4 mo. 5 mo. 6 mo. SD 7.6 12.1 3.7 5.2 4 1.9 3.2 Mean 81.2 31 16.8, 19.2 14.8 12.3 11.3 Coef. of 0.094 0.390 0.220 0.27 1 0.270 0.154 0.283 10 variation SD 0.9 7.2 4.7 11.8 18.4 11.3 11.3 Mean 94.8 767 65.2 62.4 52.8 47.5 37.8 Coef. of 0.009 0.009 0.072 0.189 0.348 0.238 0.299 20 variation SD 0.6 3.3 2.5 4.7 6.6 10.4 5.7 Mean 96.2 86.7 79.9 80.9 79.4 70.6 71 Coef. of 0.006 0.038 0.031 0.058 0.083 0.147 0.080 30 variation 78 Table 16 Variation of dissolution for drug X uncoated tablets stored at 40°C (coefficient of variance greater than 0.1 is bold-faced.) (Continued) Drug X uncoated tablets stored at 40°C/65% RH 1 mo. 2 mo. 3 mo. 4 mo. 5 mo. 6 mo. 1 mo. SD 7.6 5.2 2.7 0.8 1.4 1.4 0.7 Mean 81.2 34.5 17.3 11.9 10.4 7.5 7.63 Coef. of 0.094 0.151 0.1-56 0.067 0.135 0.187 0.092 10 variation SD 0.9 2 13 14 12.7 5.1 8.4 Mean 94.8 81.9 54 45 28.5 17.9 19.8 Coef. of 0.009 0.024 0.241 0.311 0.446 0.285 0.424 20 variation SD 0.6 1.7 9.6 16 15.3 7.1 11.3 Mean 96.2 88.9 70.5 60.9 41.6 29.8 29.6 Coef. of 0.006 0.019 0.136 0.263 0.368 0.238 0.382 30 variation Drug X uncoated tablets stored at 40°C/50% RH 1 mo. 2 mo. 3 mo. 4 mo. 5 mo. 6 mo. 1 mo. SD 7.6 10 5.4 9.3 3.2 3.3 2 Mean 81.2 65.3 30 23.1 20.5 15.7 13.6 Coef. of 0.094 0.153 0.180 0.403 0.156 0.210 0.147 '0 variation SD 0.9 1.7 3 17.2 7.1 14.3 9.4 Mean 94.8 91.8 73.7 58.4 60.8 34.8 22.6 Coef. of 0.009 0.019 0.041 0.295 0.117 0.411 0.416 20 variation SD 0.6 1.5 2.7 18.5 6.9 19.2 12.3 Mean 96.2 94.5 I 80.3 69.4 71.8 44.2 29.4 Coef. of 0.006 0.016 0.034 0.267 0.096 0.434 0.418 30 variation Drug X uncoated tablets stored at 40°C/0% RH 1 mo. 2 mo. 3 mo. 4 mo. 5 mo. 6 mo. 1 mo. SD 7.6 5.5 2.9 7.5 7.4 5.6 3.7 Mean 81.2 65.2 56.3 68.4 64.1 61.9 65.5 Coef. of 0.094 0.084 0.052 0.110 0.115 0.090 0.056 10 variation SD 0.9 1.3 0.9 0.8 1.1 1 0.8 Mean 94.8 95.3 89.6 95.4 95.5 95.1 95.8 Coef. of 0.009 0.014 0.010 0.008 0.012 0.01 1 0.008 20 variation SD 0.6 0.9 0.9 0.3 0.7 0.8 1.6 Mean 96.2 96.9 90.4 97 97.5 96.9 96.1 Coef. of 0.006 0.009 0.010 0.003 0.007 0.008 0.017 30 variation SD: standard deviation from six dissolution (%) values Mean: Mean of six dissolution (%) values Coef. of variation: coefficient of variation (SD/Mean) 79 As shown in Table 16, there is a large variation in dissolution using the basket method (average coefficient of variation: 0.041 at 90%, 0.157 at 75%, 0.192 at 65%, 0.187 at 50%, 0.035 at 0%). The average coefficients of variation for 40°C at 75%, 65%, and 50% RH are four times higher than those of variation for 40°C at 90% and 0% RH. If the coefficient of variation in Table 16 is higher than 0.1, the value is in bold. There are many more bold-faced values at 75%, 65%, and 50% RH than at 90% and 0% RH. The coefficient values at intermediate relative humidities (50, 65, and 75% RH) are higher than at either 0% or 90% RH. Therefore, it is hard to determine the dissolution rate (k) with In[ C /(C ,- - C,.)] and stirring time for tablets stored at 40°C at 75%, 65%, and 50% RH (lack of fit). Figure 36 shows an example of the relationship between In[ C /(C , - C m) ] and stirring time obtained from drug X uncoated tablets stored for 6 months at 40°C/50% RH. There was a poor relationship between ln[C/(C,~ - C,.)] and stirring time, and dissolution rates (k) did not change regularly as a function of storage time. 80 InICI/(CI-Cm)] O L 0 1o 20 30 stirring time (minutes) 0 (t = initial) A (t = 1 month) I (t = 2months)A (t = 3 months) 0 (t = 4 months) * (t = 5 months) 0 (t = 6 months) — (dissolution rate) Figure 36 Dissolution rates (k) of uncoated tablets stored in open dishes for 6 months at 40°C/50% RH The log ratio of dissolution rates (In[ k/kJ) was plotted as a function of storage time to determine the dissolution reduction rate (K) as shown in Figure 37. storage time (days) 0 30 60 90 120 150 180 210 0 I I u 1 1 1 I . I -1 , E a: 'E‘ 2 y = -0.0119x + 0.1649 ‘ - q R2 = 0.9347 . -3 - 0 Calculated ln[k/kJ — Dissolution reduction rate Figure 37 Dissolution reduction rate (K) of uncoated tablets stored at 40°C/50% RH 81 Next, dissolution reduction rates (K) were plotted as a function of relative humidity giving the relationship shown in Figure 38. >3 3 y = 0.00009x + 0.0072 2! C , .9 233 y = -0.0009x + 0.0699 3 0'01 i y = 0.0008x — 0.0258 1 ‘ .5 \. ; g y=-0.0001x+0.0126 (I) . .2 o 0 . (Initial! equilibrium RH . 0 25 50 75 100 RH (%) Figure 38 Dissolution reduction rate as a fiinction of RH (%) By using the relationship in Figure 38, the dissolution of tablets in a package is to be calculated as a function of storage time. The linear relationship between dissolution reduction rate and relative humidity can be expressed as Equation 14. K=a~RH(%)+b (14) Substitute Equation 14 into Equation 10: kt = ki .e—(U'RH(o/o)+b)'t (15) Substitute Equation 15 into Equation 8: .. —( ~RH(%>+b)-r. Cm =C,- —C,- 071"“? a 13" (16) Equation 16 was used to calculate the dissolution at 30 minutes stirring time for a time interval (t) in the dissolution prediction program. 82 Example calculation: [5 tablets in HDPE bottle stored at 40 CC/90% RH Initial dissolution rate (ki): 0.111 At storage time 0, the dissolution at 30 minutes stirring time is: Cm = 1 — 1 x e_[0'1 ' ”X3" = 0.9642 (96.42% dissolution) After 1 day, the relative humidity of HDPE bottle headspace is 34.63%. m ... = 0.964 (96.4% dissolution) So, the dissolution of tablets at 34.63% RH is changed to 96.4% for 1 day. The dissolution decreased by 0.02% from the initial dissolution. After 2 days, the relative humidity of HDPE bottle headspace is 35.44%. C -1-lx e_[0’l 1 Ixe-(0.0008x35.44—0.0258)x1 1x30 m _ = 0.9639 So, the dissolution of tablets at 35.44% RH is changed to 96.39 for 1 day. The dissolution decreased by 0.03% from the initial dissolution, and so on. For 6 days, the accumulated dissolution change is 0.19% (0.02% + 0.03% + 0.04% + 0.05% + 0.05% + 0.06%). Therefore, the dissolution decreased to 96.23% from 96.42%. Dissolution results using Nakabayashi’s method with this data show poor agreement between calculated and experimental results, as shown in Figure 39. This is an illustration of results (tablets in LDPE bags without silica gel, tablets in LDPE bags with 0.5 g, 1 g, 2 g silica gel, tablets in HDPE bottles without silica gel, and tablets in HDPE bottles with 0.5 g silica gel). 83 1250/0 2,,..W-,_3-~,-.-_3-,--,-_.-_. ”23-3-40 -.. WWW. .--”.-.m- .-..-.M. -- 3. .........-....._..- ._ m a: g, 100% C X g \N‘ .2 75% 4 1 a o ......... '6' E . _ .... ' 9 ‘ 3 3 509 . . " C o . ’ f 2 I 2 ' ' g 25% .2 o z 0% 1 I T fl 0 50 100 150 200 Storage time (days) 0 Experimentally measured dissolution ---- Relative humidity of the package headspace — Predicted dissolution using dissolution reduction rate (K) Figure 39 Dissolution of tablets in HDPE bottles stored at 40°C/90% RH as a function of storage time — Nakabayashi method Therefore, in this study, the method for prediction of dissolution of tablets in a package was approached differently by using the dissolution retardation rate (R). 2. Dissolution retardation rate (R) Dissolution is dependent on moisture as well as storage time, so a rate representing dissolution change as a function of storage time must be determined. The theory of the dissolution change as a function of storage time has not been explained clearly in the literature, so the rate must be determined experimentally at various relative humidities to determine the relationship between the rate and relative humidity. 84 As explained in Chapter 3.3 (2) Dissolution profiles from open dish study, the 30 minute dissolution of drug X, both coated and uncoated tablets, stored in open dishes at 25°C did not change over the 6 month period, but it did change at 40°C except for 40°C/0% RH. For the coated tablets stored at 40°C, it was hard to determine the relationship between the 30 minute dissolution and storage time because the coated tablets dissolved suddenly, not gradually. They did not follow the dissolution theory. However, uncoated tablets stored at 40°C did follow the dissolution theory. Figures 40- 44 show 30 minute dissolution values of uncoated tablets stored at 40°C as a function of storage time. Based on empirical data fitting methods, it must be determined how the 30 minute dissolution changes as a function of storage time. A polynomial equation can be applied to determine the relationship between the 30 minute dissolution and storage time. A better fit can be made by using the polynomial equation. However, there is no method to compare the relationships obtained from a variety of relative humidities (50, 65, 75, and 90% RH). The relationship between the 30 minute dissolution and storage time can be assumed to follow zero order kinetics (linear relationship) or first order kinetics (exponential relationship). The dissolution prediction model using first order kinetics can make better results for drug X uncoated tablets. So, the first order kinetic was chosen to treat the relationship. The average initial 30 minute dissolution (D;) of uncoated tablets is 96.23%. 85 t 0 c ’ t : £75%~ _3_ O (D .9. °50%~ g .E E 025%— 0') 00/0 l l L l l l J o 30 60 90120150180 21o storage time (days) Figure 40 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/90% (each month has 6 dissolution values) O c 2 . 2 0 o O _ g 75% Q i . : E 50% ~ ° ‘5 .E g 25% ~ 0% l l 1 L 1 L l O 30 60 90 120 150 180 210 storage time (days) Figure 41 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/75% (each month has 6 dissolution values) 86 8 s o ’ . 3 75 /0 +— £ . 8 0 0 o .2 0 . E 50% ~ ° 2 g z .- . . . S 25% ~ 3 ‘ 0') 0 00/0 1 1 1 1 1 1 J 0 30 60 90 120 150 180 210 storage time (days) Figure 42 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/65% (each month has 6 dissolution values) 5 o ‘ ’ g g 75/0 "‘ . O . E . 3 3 “4'3 50% — ’ 8 E o 0 8 25% « . i 0% H l T l T l l O 30 60 90 120 150 180 210 storage time (days) Figure 43 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/50% (each month has 6 dissolution values) 87 0 C E 75% ~ 0 m .2 3 50% ~ *5 .E g 25% - 00/0 1 T T T l l j 0 30 60 90 120 150 180 210 storage time (days) Figure 44 30 minute dissolution of drug X uncoated tablets stored in open dishes for 6 months at 40°C/0% (each month has 6 dissolution values) As can be seen in Figures 40-44, the variability of 30 minute dissolutions is large, especially for 40°C/75%, 65%, and 50% RH. This large variability can make it hard to determine the relationship between the 30 minute dissolution and storage time. In order to make the relationship, an exponential equation can be applied. Figure 45 shows a general exponential graph (y = -e"). If plotted function moves up the y-axis as much as 1+D,- (initial dissolution value), an equation (y = -e" + D; +1) can be obtained as shown in Figure 46. 88 "2 r 6 \ .3- _1_ Figure 45 Graph of y = -e" Figure 46 Graph of y = -e" + (D,H) The equation shown in Figure 46 can be applied to make the relationship between the 30 minute dissolution and storage time. Figure 47 shows a typical graph for dissolution change as a function of storage time. 50% « D = —D,-eR’ + (D,- +100%) 25% ~ 30 minute dissolution 0% 7* I 1 0 30 6O 90 120 150 180 210 storage time (days) Figure 47 A typical graph for 30 minute dissolution change as a function of storage time 89 Equation 17 represents the relationship between the 30 minute dissolution and storage time. R denotes the dissolution retardation rate. R must be determined at each relative humidity. D = -D,.eR’ +(D,- +100%) (17) In order to get the dissolution retardation rate (R), Equation 17 is rearranged. Plots of the 30 minute dissolution on a logarithmic scale, against storage time on the abscissa with a linear scale, yield a straight line. In 0“ =—Rt (18) 1),-—1)+1000/o By plotting In[D/(D,~-D+100%)] versus storage time (t), the dissolution retardation rate (R) can be determined using a trend line as shown in Figure 48. storage time (days) 0 30 60 90 120 150 180 J_ 43.1 ~ -O.3 ~ -O.5 ~ ln[Dr/(DI-D+100%)] -o.7 Figure 48 Dissolution retardation rate (R) Figure 49 shows dissolution retardation rates determined at various relative humidities at 40°C. The dissolution retardation rate at 40°C/65% is greatest. It means that the dissolution of tablets stored at that condition decreases most quickly as a function 90 of storage time. And, the dissolution retardation rate at 40°C/90% is lowest. See 4. Proposed theory of dissolution retardation as a function of relative humidig for more information. This result is different from previous research at the School of Packaging in Michigan State University, and from Nakabayashi (1980) and Kadir (1986). They concluded that the dissolution decreased more rapidly if tablets are stored at a high temperature and high relative humidity. See Chapter 1. Background and literature review for more information. storage time (days) 0 30 60 90 120 150 180 210 0 1k 1 1 1 i L 1 4; _0'1 _\ o A o y=-0.0006x-0.039 " *3 R2: . '{a‘ -02 . . A (1 09415) g '03 . 1 °- . A y=-0.0011x-0.0785 $ - (R2=0.8684) 5 -0.4 ~ 1 E A o y = -0.0028x - 0.0013 s -0.5 ~ ‘ . (R2=0.9446) -0.6 ~ y=-0.0031x-0.0511 -07 __,-_._,,.,_ ., ,. , ' """ ' " (R2=0%37) O 90% A 75% A 65% 0 50% Figure 49 Dissolution retardation rate of drug X uncoated tablets at various relative humidities at 40°C Table 17 shows dissolution retardation rates (R, % dissolution change/day) at 40°C. Table 17 Dissolution retardation rates (R) of drug X uncoated tablets stored in open dishes at 40°C , [ RH [ 0% l 50% | 65% | 75% | 90% | I Dissolution retardation rate 0 I 0.0028 I 0.0031 I 0.0011 I 0.0006 I (% dissolution change/day) 91 ('2 (I) To predict the dissolution of tablets in a package, the dissolution retardation rate (% dissolution change/storage time) as a function of relative humidity must be determined. Figure 50 shows the relationship between the dissolution retardation rate and relative humidity. Based on 6 month experimental results, it is assumed that the dissolution of tablets stored below the initial equilibrium relative humidity does not change. Dissolution when stored in open dishes at 40°C/0% did not change for 6 months (see Figure 30). The tablets in the HDPE bottle containing 0.5 g silica gel did not reach the initial equilibrium RH for 3 months, and the dissolution did not change below that initial equilibrium RH (34.23%) (see Figure 57). Even though there is no 6 month dissolution data between 0% RH and initial RH (34.23%), it is assumed in this study that the dissolution of drug X uncoated tablets stored below initial conditions does not change for 6 months at 40°C. So, a zero value of the dissolution retardation rate is applied to calculate the dissolution of tablets between 0% RH and initial equilibrium RH (34.23% RH). The piecewise equations shown in Figure 50 are used to calculate the dissolution retardation rate at any RH according to Equation 19. R=a-RH(%)+b (19) where a and b = constants of the equation between R and RH (%) Substitute Equation 19 into 17. % Dissolution (D) = -D,. -e[“'R”(%)+b1" + 0,- +100% (20) Equation 20 can be used to calculate the 30 minute dissolution at any RH. 92 5. '1"! y = 0.00002x + 0,0013 y = -0.0002x + 0.0161 / y = 0.0001776x - 0.00608 0.002 F /‘ y = -0.0000333x + 0.0036 Jnitial equilibrium RH. Dissolution retardation rate (R) 0 20 40 60 80 1 00 RH (%) Figure 50 Dissolution retardation rate (R) as a function of relative humidity at 40°C Example Calculation The following shows how to calculate the dissolution using the dissolution retardation rate at 40°C/50% RH for 30 days. D(%) = —96. 23% - .210-000’ 77 MOW-006081 '30 + 96.23% +100% = 91.57% The dissolution prediction program works with the moisture prediction program. At each time interval, the tablets in a package have a different moisture content associated with the equilibrium headspace RH (%) at that time interval. So, the dissolution prediction program calculates the dissolution of tablets at each equilibrium RH(%) (or (p/pjm) determined by the moisture prediction program at each time interval j. Figure 51 shows the algorithm used to calculate the dissolution at various relative humidities. The dissolution changes for a time interval at various RHs are summed for a 93 storage time, and then the accumulated dissolution change is subtracted from the initial dissolution to calculate the dissolution of tablets stored for storage time t. Input Data . Initial dissolution (D,) . Constants of the relationship between dissolution retardation rate and RH . Time interval (i) . Storage time (t) A Equilibrium RH,.1(%) (or w/pjmflj) from the moisture prediction part Calculate 30 minute dissolution using a time interval j. -R1-I -°/ +b-t ..ela nj(°) ] + Dnj = —D, 0,- +100% Calculate 30 minute dissolution change from the initial dissolution value. an = Di - Dnj ——p n=n+1 Figure 51 Algorithm used to calculate the dissolution at various relative humidities 94 3. Verification of dissolution prediction program The stepwise storage conditions and continuous storage conditions were used to verify the dissolution prediction model. (1) Stepwise storage conditions (open dish study) In order to verify that dissolution is dependent on moisture content as well as storage time, stepwise storage conditions can be used. In addition to that, results from stepwise storage conditions at 40°C were used to verify the dissolution prediction program. Table 18 shows the stepwise storage conditions, dissolution obtained experimentally and the dissolution calculated by use of the dissolution prediction program. The experimental dissolution was measured when tablets were transferred to another condition. Table 18 Comparison of the results from experimental and predicted dissolution stored at stepwise conditions (at 40°C) No. Storage time Experimental Predicted Storage Conditions (months) Dissolution (avg) Dissolution 1 l 93% 87.8% 50%(1 month) 2 2 77% 78.4% 50%(1 month), 65%(1 month) 3 3 69% 74.7% 50%(1 month), 65%(1 month), 75%(1 month) 4 4 63% 70.9% 50%(1 month), 65%(1 month), 75%(2 months) 5 4 61% 73.0% 50%(1 month), 65%(1 month), 75%(1 month), 90%(1 month) 6 5 42% 66.9% 50%(1 month), 65%(1 month), 75%(3 month) 7 5 26% 71.2% 50%(1 month), 65%(1 month), 75%(1 month), 90%(2 month) Stepwise (l): 1, 2, 3, 4, and 6 (Results are plotted in Figure 52) Stepwise (ll): 1, 2, 3, 5, and 7 (Results are plotted in Figure 53) 95 Example calculation Table 19 shows the predicted dissolution changes from the initial dissolution value, and they are calculated by the dissolution prediction program at each RH for a given storage time. Table 19 The predicted dissolution change from the initial dissolution value calculated by the dissolution prediction program at each RH for a given storage time Storage time 1 month 2 months 3 months 4 months 90% 1.7% 3.5% 5.3% 7.2% 75% 3.7% 7.5% 11.5% 15.6% 65% 9.4% 19.7% 31.0% 43.4% 50% 8.4% 17.6% 27.6% 38.4% The following shows an example calculation using value in Table 19 of the dissolution of tablets stored at 50% for 1 month 65% for 1 month and 75% for 2 months. [96.23% (initial dissolution) —- 8.4% change for 1 month at 50% — 9.4% change for 1 month at 65% — 7.5% change for 2 months at 75%] = 70.93% The dissolution decreases to 70.93% from 96.23%. Table 18 also shows the effect of storage time. Compare rows 3, 4 and 6. In all three rows, the tablets were stored in open dish at 50% and 65% RH for 1 month each. But they were stored at 75% RH for 1, 2 and 3 months respectively. The tablets reached equilibrium with 75% RH within 2-3 days. They remained at equilibrium for l, 2 and 3 months. The increased time at 75% equilibrium resulted in progressively lower dissolution: 69%, 63%, 42%. This is strong evidence that the dissolution is time dependent and that this dependence is not linear. Similarly, rows 5 and 7 of Table 18 96 show the effect of time at equilibrium at another relative humidity (90%). Here dissolution changed from 61% after 1 month to only 26% after 2 months at 90%. Figure 52 and Figure 53 show the experimental and predicted dissolution. They show there is fairly good agreement until 4 months. However, beginning at 4 months storage time, the experimental and predicted results diverge sharply. At that time, high moisture absorption may accelerate the physical interaction such as crosslinking among excipients. Perhaps there is a threshold level of interaction between time and moisture content. This mechanism must be explained in the future. 100% _..- _ . . ..... 5 N A x 1: 750/6 0 ~‘_‘~“ ~~\‘-_ _ .2 D 50% A q, X 5 E x r g 25% X (‘0 : 00/0 I I I l f l: 0 1 2 3 4 5 6 Storage time (months) + dissolution stored at 50% for 1 month, 0 dissolution stored at 50% for 1 month and 65% for 1 month, Cl dissolution stored at 50% for 1 month, 65% for 1 month, and 75% for 1 month, A dissolution stored at 50% for 1 month 65% for 1 month and 75% for 2 months, X dissolution stored at 50% for 1 month, 65% for 1 month, and 75% for 3 months, —I— dissolution calculated by the dissolution prediction program Figure 52 Dissolution of tablets stored at stepwise conditions (I) at 40°C 97 1 00% $ 75% M 8 2 X X 35 X 50% 25% 30 minute Dissolution 00/0 I I T f l Storage time (months) + dissolution stored at 50% for 1 month, 0 dissolution stored at 50% for 1 month and 65% for 1 month, El dissolution stored at 50% for 1 month, 65% for 1 month, and 75% for 1 month, A dissolution stored at 50% for 1 month, 65% for 1 month, 75% for 1 month, and 90% for 1 month, X dissolution stored at 50% for 1 month, 65% for 1 month, 75% for 1 month, and 90% for 2 months, —I— dissolution calculated by the dissolution prediction program Figure 53 Dissolution of tablets stored at stepwise conditions (II) at 40°C Open dish storage at 40°C with stepwise transition from one humidity to the next higher one reveals an interaction among moisture content, relative humidity and time that has not yet been fully explained. The prediction methods developed in this work do not account for this unexplained mechanism. However, when the product is packaged in a container closure system, and stored at a single temperature and humidity, for example 40°C, 75% RH, the resulting dissolution can be predicted fairly well using the technique described here. The following section on continuous storage conditions explains this. 98 (2) Continuous storage conditions Uncoated tablets stored in LDPE bags and HDPE bottles at 40°C/90% RH were also used to verify the dissolution prediction program. The relative humidity of the package headspace in the LDPE bags and HDPE bottles changed quickly, so one day time intervals were used to calculate the dissolution at those relative humidities. The dissolution calculated using the dissolution retardation rate (R) shows fairly good agreement with experimentally measured trends in dissolution as shown in Figures 54-59. Table 20 shows dissolution differences between experimentally measured dissolution and predicted dissolution. They may occur from the 30 minute dissolution variability. The dissolution of aged uncoated tablets at 40°C/75%, 65%, and 50% RH has a large variation (see Figures 40-43). So, dissolution retardation rates determined from that data can 031186 error. 99 Table 20 Dissolution differences between experimentally measured average dissolution and predicted dissolution of tablets in package stored at 40°C/90% RH Storage time (days) 44 58 83 104 136 161 Tablets in LDPE Dexp 75.7% 80.0% 77.3% bags without Dealc 90.8% 89.8% 88.1% desiccant Dame... 15.1% 9.8% 10.8% % demm 19.9% 12.3% 14.0% Tablets in LDPE Dcxp 80.3% 71.7% bags with 0.5 g Dcaic 88.1% 86.1% desiccant Um...“ 7.8% 14.4% % Damn... 9.7% 20.1% Tablets in LDPE Dexp 78.5% 72.8% bags with l g chc 87.5% 84.7% desiccant demnc. 9.0% 1 1.9% % Damn...“ 11.5% 16.3% Tablets in LDPE D...xp 86.3% 70.0% bags with 2 g Dcalc 87.5% 84.7% desiccant Ddifimcc 1.2% 14.7% % Dmflcm 1.4% 21.0% Tablets in HDPE Deg 86.4% 80.0% 76.6% 57.2% 46.0% bottles without chc 83.9% 76.6% 70.4% 62.5% 57.6% desiccant Dam... -2.5% -3.4% -6.2% 5.3% 11.6% % Um..."cc 2.9% 43% -8.1% 9.3% 25.2% Tablets in HDPE Data 96.2% 96.7% 96.4% 93.2% 91.2% bottles with 0.5 g 2%., 96.2% 96.1% 94.5% 88.5% 81.8% desiccant demm 0% -0.6% 4.9% 4.7% -9.4% % Dame"... 0% -O.6% -2.0% -5.0% 40.3% Dcxp: Experimentally measured average dissolution Dale: Predicted dissolution democ: Difference in dissolution between Dexp and Dcalc (Dcalc - Dup) % deffcmncei % Dissolution difference fi'om experimentally measured average dissolution (Ddifl'ca-nce/Dexpx 100) The moisture content of tablets increased as a function of storage time, and dissolution decreased as a function of the moisture content of tablets and storage time. Figures 54-59 show relative humidity (dotted line) of the package headspace, experimentally measured dissolution (dots), and predicted dissolution (solid line) of 100 tablets in LDPE bags and HDPE bottles. The following shows an example dissolution calculation using the dissolution retardation rate determined at each relative humidity. Example calculation: [5 tablets in LDPE bags stored at 40 °C/90% RH At storage time 0, the dissolution at 30 minutes stirring time is: D(%) = —96.23% - e0 + 96.23% +100% =100% After 1 day, the relative humidity of the LDPE package headspace is 45.61%. So, the dissolution at that RH (%) is changed to 99.81% for 1 day. The dissolution decreases by 0.19% from the initial dissolution. D(%) = -96.23% - eIO'OOOl776X45'61—0'006081'l + 96.23% +100% = 99.81% After 2 days, the relative humidity of the LDPE package headspace is 52.57%. 80, the dissolution at that RH (%) is changed to 99.73% for 1 day. The dissolution decreases by 0.27% from the initial dissolution, and so on. D(%) = —96.23% . ei°-°°°°2"52°57+°'°°'31" + 96.23% +100% = 99.73% After 3, 4, 5, and 6 days, the relative humidities of the LDPE package headspace are 57.35%, 60.89%, 63.65%, and 65.88%. The dissolution decreases by 0.28%, 0.29%, 0.30%, and 0.30% at each relative humidity. For 6 days, the accumulated dissolution change is 1.63% (0.19% + 0.27% + 0.28% + 0.29 + 0.30% + 0.30%). Therefore, the dissolution decreases to 94.60% from 96.23%. 101 (a) Tablets in LDPE bags without silica gel and tablets with silica gel (0.5 g, 1 g, and 2 g) stored in LDPE bags at 40°C/90% RH Figure 54 shows results from LDPE bags without silica gel. The predicted relative humidity of the package headspace changed quickly. Tablets reach 75% RH in 13 days. Table 21 shows experimentally measured and predicted dissolution of tablets at the 30 minute stirring time, and relative humidity of the package headspace. I i 0 8 100% 3- x i 8 § .‘ ....... a. """""""" 5 «5 75% . . .. ‘ , e X : O I I ,’ o i n: , z 3 50% r: . .2 ' i a 2 25% o a 2 l o 0% . r . a i 0 20 40 60 80 100 Storage time (days) 0 Experimentally measured dissolution --- Relative humidity of the package headspace — Predicted dissolution using the dissolution retardation rate (R) Figure 54 Dissolution of tablets in LDPE bags stored at 40°C/90% RH as a function of storage time Table21 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets stored in LDPE bag without desiccant) Storage time Experimental Dissolution (%) Predicted Predicted (days) I 2 3 4 5 6 Avg. Dissolution (%) RH (%) 44 79.9 70.9 63.6 86.1 71.0 82.8 75.7 90.8 84.5 58 85.1 78.3 81.8 82.4 73.7 78.7 80.0 89.8 86.0 83 81.4 82.7 76.1 77.1 69.1 77.8 77.4 88.1 87.6 102 Figure 55 shows results from LDPE bags with 0.5 g silica gel. Tablets desorbed moisture initially, and again reached the initial moisture content after 5 days. The dissolution is assumed not to change for 5 days. When the dissolution prediction program was run, the dissolution for the first 5 days was calculated as equal to the initial dissolution. Table 22 shows experimentally measured and predicted dissolution of tablets at the 30 minute stirring time, along with the relative humidity of the package headspace. (it 125% —-~~--"-~~"--~~ W.-.“ W e -.- ~ -~ - e .. e M 0 at g 100% 8 a. ------- '0' """" ... "5 75% _ . v ’ - ’ % a: . ’ 0 m . 3 50% , ’ g a g . E 25% J O l a r .9 . a 00/0 fl T t T 1 O 20 40 60 80 100 Storage time (days) 0 Experimentally measured dissolution --- Relative humidity of the package headspace - Predicted dissolution using the dissolution retardation rate (R) Figure 55 Dissolution of tablets in LDPE bags containing 0.5 g silica gel stored at 40°C/90% RH as a function of storage time Table 22 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a fimction of storage time (tablets in LDPE bag containing 0.5 g silica eel) Storage time Experimental Dissolution (%) Predicted Predicted (days) | 2 3 4 5 6 Avg. Dissolution (%) RH (%) 58 82.2 77.0 85.6 77.1 83.3 76.8 80.3 88.9 84.1 83 74.0 65.4 74.2 74.9 75.3 66.6 71.7 87.1 86.5 103 Figure 56 shows results from LDPE bags with 1 g silica gel. Tablets desorbed moisture initially, and again reached the initial moisture content after 10 days. The dissolution is assumed not to change for 10 days. When dissolution prediction program was run, the dissolution for the first 10 days was calculated as equal to the initial dissolution. Table 23 shows experimentally measured and predicted dissolution of tablets at the 30 minute stirring time, along with the relative humidity of the package headspace. 1250/0.___-__-- - “...... —-~ -~-~m~w~ ~ -~~ ”w” m :l: a :100% x 3 _ _ H .2 75% , . , """ 3 ° :1: . ' ' ‘ m " '5 50% ,1 C o _g , g 25% f, a ’ '2 i 0 00/0 r r I 1 fi' 0 20 40 60 80 100 Storage time (days) 0 Experimentally measured dissolution --- Relative humidity of the package headspace — Predicted dissolution using the dissolution retardation rate (R) Figure 56 Dissolution of tablets in LDPE bags containing 1 g silica gel stored at 40°C/90% RH as a function of storage time Table 23 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in LDPE bag containing 1 silica gel) Storage time Experimental Dissolution (%) Predicted Predicted (days) 1 2 3 4 5 6 Avg. Dissolution (%) RH (%) 58 78.6 75.3 81.8 84.6 75.4 75.1 78.5 88.1 81.0 83 66.2 80.1 64.6 68.4 79.4 78.0 72.8 86.l 84.8 104 Figure 57 shows results from LDPE bags with 2 g silica gel. Tablets desorbed moisture initially, and again reached the initial moisture content after 19 days. The dissolution is assumed not to change for 19 days. When dissolution prediction program was run, the dissolution for the first 19 days was calculated as equal to the initial dissolution. Table 24 shows experimentally measured and predicted dissolution of tablets at the 30 minute stirring time, along with the relative humidity of the package headspace. Dissolution or RH of package HS 125% , 100% 75% 50% 25% 0% an". “ f l i 20 40 60 80 100 Storage time (days) 0 Experimentally measured dissolution ----- Relative humidity of the package headspace — Predicted dissolution using the dissolution retardation rate (R) Figure 57 Dissolution of tablets in LDPE bags containing 2 g silica gel stored at 40°C/90% RH as a fimction of storage time. Table 24 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in LDPE bag containing 2 silica gel) Storage time Experimental Dissolution (%) Predicted Predicted (days) | 2 3 4 5 6 Ang Dissolution (%) RH (%) 58 88.2 80.9 90.1 89.6 81.9 87.0 86.3 87.5 72.1 83 78.7 63.6 73.4 70.1 68.5 65.5 70.0 84.7 80.1 105 (b) Tablets in HDPE bottles without silica gel and tablets with 0.5 g silica gel stored in HDPE bottles at 40°C/90% RH Even if tablets were packaged in relatively high barrier HDPE bottles, the dissolution decreased a lot in 160 days. Figure 58 shows the predicted relative humidity of the package headspace as a function of storage time. Predicted dissolution using the dissolution retardation rate is in the range of experimentally measured dissolution of tablets in HDPE bottles without silica gel. Table 25 shows measured and predicted dissolution of tablets at the 30 minute stirring time. 125% _ -m m - ,. {D I g 100% u x U 3. no- 75% O I I: O 50% c .9 2 0 g 25% .2 0 00/0 F l j l 0 50 100 150 200 Storage time (days) O Experimentally measured dissolution -—-- Relative humidity of the package headspace — Predicted dissolution using the dissolution retardation rate (R) Figure 58 Dissolution of tablets in HDPE bottles stored at 40°C/90% RH as a function of storage time. 106 Table 25 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in HDPE bottle without desiccant) Storage time Experimental Dissolution (%) Predicted Predicted (days) 1 2 3 4 5 6 Avg. Dissolution (%) RH (%) 58 81.5 91.2 90.2 88.7 80.3 86.5 86.4 83.9 58.5 83 74.2 78.9 77.8 80.2 84.0 84.9 80.0 76.6 63.1 104 78.2 60.3 82.9 81.2 74.0 82.8 76.6 70.4 65.9 136 62.3 75.7 65.3 49.4 43.3 47.4 57.2 62.5 69.2 161 29.4 59.7 57.4 30.5 69.6 29.6 46.0 57.6 71.2 Figure 59 shows results from HDPE bottles with 0.5g silica gel. Tablets desorbed moisture initially, and again reached the initial moisture content at 75 days. The dissolution is assumed not to change for 75 days. Figure 59 shows dissolution changes using the dissolution retardation rate are a little over estimated for tablets in HDPE bottle containing 0.5 g silica gel. Table 26 shows experimentally measured and predicted dissolution of tablets at the 30 minute stin'ing time. 1250/0 ~.-..A-____._--~---u- -“A--.. .. ...w....... - -_.__-_.----__-_-- .- (I) 1 ° 100% a g N o a .. 75% o 8 50% , .4 - ' ‘ c g - 0 o . . o a ‘ . t 2 .- a o 25% . .. ‘ ' .3 . « - g . ‘ . 0% r r 1 ; 0 50 100 150 200 Storage time (days) 9 Experimentally measured dissolution ----- Relative humidity of the package headspace — Predicted dissolution using the dissolution retardation rate (R) Figure 59 Dissolution of tablets in HDPE bottles containing 0.5 g silica gel stored at 40°C/90% RH as a function of storage time. 107 Table 26 Experimentally measured and predicted dissolution of tablets at 30 minutes stirring time as a function of storage time (tablets in HDPE bottle containing 0.5 g silica gel) Storage time Ex erimental Dissolution (%) Predicted Predicted (days) | 2 3 4 5 6 Avg. Dissolution (%) RH (%) 58 97.2 96.5 96.4 96.7 95.4 95.3 96.2 96.2 29.1 83 97.1 97.1 96.2 96.2 95.7 97.7 96.7 96.1 36.2 104 95.5 96.9 95.9 96.5 95.7 98.1 96.4 94.5 41.6 136 94.4 93.5 92.0 93.7 93.4 92.2 93.2 88.5 48.6 161 91.4 92.8 91.7 81.4 95.6 94.3 91.2 81.8 53.2 108 4. Proposed theory of dissolution retardation as a function of relative humidity The phenomenon of dissolution change as a function of RH and storage time is better understood if we develop a model for dissolution retardation. The mechanism of tablets aging as a function of storage time at a certain amount of moisture content has not been understood in terms of physical interactions among excipients. In this section, a theory of drug X dissolution retardation as a function of relative humidity is proposed. Drug X tablets consist of 63% mannitol and 18% microcrystalline cellulose (MCC). Mannitol is a saccharide derivative. Mannitol may be crosslinked by absorbing moisture. Sugars are generally hydrophilic and therefore interact readily with water. The physical form of the sugar affects the interaction of the saccharide with water (Derbyshire et al., 2001 ). Tablet crosslinking may affect tablet hardness and dissolution. In this experiment, the dissolution of tablets stored above 50% RH at 40°C decreased as a function of storage time. The reason for the dissolution reduction may be that the structure inside the tablets was changed. Tablets might be crosslinked above 50% RH at 40°C. The crosslinking occurs through increase of intermolecular forces among excipients, and these may become stronger as a function of storage time. The dissolution did not decrease for tablets stored at 25°C at O, 50, 65, 75, and 90% RH. Based on the above explanation, tablets may be crosslinked above 50% RH at 25°C, but the intermolecular forces of tablets stored at 25°C may not be as strong as those of tablets stored at 40°C. In fact, they may be not strong enough to affect crosslinking and dissolution during the 6 months time of this experiment. The interaction of 109 temperature and moisture may accelerate the crosslinking of tablets, then it may increase intermolecular forces. Also, cellulose can form a large aggregate structure held together by hydrogen bonding (N akai, 1977). This may increase the intermolecular forces among excipients. Figure 60 shows hardness as a function of relative humidity and Figure 61 shows the 30 minute dissolution as a function of relative humidity. Together, they show the dissolution of harder tablets is low. The hardness may increase if intermolecular forces are increased. Tablets having strong intermolecular forces are disintegrated slowly, so the dissolution at the 30 minute stirring time is low. As intermolecular forces decrease at even higher RH, the tablet sofiens and dissolution increases. Thus, there isopeak in intermolecular forces around 45-65% RH at 40°C. At the same conditions, the hardness reaches a maximum and dissolution reaches a minimum. 12.0 -. 100% 10.0 a C A 8 75% g 8.0 i g j; 3 3 6.0 4 '13 50% c 2 13 :1 «‘5 4.0 4 .5 I g 25% — 2.0 4 m 0'0 T I l i 00/0 1 I T i 0 25 50 75 100 0 25 5O 75 100 RH (%) RH (%) Figure 60 The hardness of uncoated Figure 61 30 minute dissolution of uncoated tablets stored for 6 months at 40°C as a tablets stored for 6 months at 40°C as a function of relative humidity function of relative humidity 110 Also, drug X tablets swell above 50% RH as described in Appendix F (see Figure 96 and Figure 99). Drug X tablets are formulated with a hygroscopic swellable material (croscarmellose sodium (CAS)). Tablets stored in the range of 50-65% RH at 40°C have the greatest hardness value as shown in Figure 60, and water in tablets may be bound directly to polymer units. While tablets stored in the range of 75-90% RH at 40°C have the smallest hardness value, they contain much more water that may be used for hydrogen bonding (water-water and water-polymer). Therefore, they may be crosslinked much more than tablets stored in the range of 50-65% RH. However, they can also swell much more than tablets stored in the range of 50-65% RH. The swelling may counteract crosslinking among excipients. Therefore, it may offset intermolecular forces in tablets stored at 75-90% RH. If excipients in the tablet are crosslinked with each other, intermolecular forces among excipients may increase, then tablets are hard to disintegrate into the medium. However, when CAS in the tablet swells, intermolecular forces among excipients may decrease, finally tablets disintegrate readily into the medium. It may be that the dissolution of tablets stored at 40°C/65% RH decreased most rapidly as a function of storage time because excipients were crosslinked but they did not swell much (1.5% swelling). On the other hand, the dissolution of tablets stored at 40°C/90% RH decreased less even if tablets may be crosslinked much more than those stored at 40°C/65% RH because they swelled a lot (by 4.2% of the thickness of tablets). 111 CHAPTER 5 PACKAGE DESIGN Based on the open dish study, it was found that the dissolution of drug X, both :oated and coated tablets, was very sensitive to temperature and moisture. The solution of both uncoated and coated tablets at the 30 minute stirring time did not mge at all at 25°C at 0, 50, 65, 75, and 90% RH for 6 months, but it declined at 40°C 50, 65, 75, and 90% RH for 6 months. The dissolution of both coated and uncoated )lets was not reduced when stored at 40°C, 0% RH for 6 months. Uncoated tablets in the HDPE bottle containing 0.5 g silica gel did not reach .tial equilibrium RH for 3 months, and the dissolution was not reduced below the initial uilibrium RH (34.23%) (see Figure 59). Even though there is no 6 month dissolution ta from the open dish study between 0% RH and initial RH (34.23%), it is assumed that ’dissolution of drug X uncoated tablets stored below initial conditions does not change ‘5 months at 40°C in this study. So, a zero value of the dissolution retardation rate is flied to calculate the dissolution of tablets between 0% RH and the initial equilibrium 1 (3 4% RH). The dissolution of tablets in open dishes stored at 25°C at 0, 50, 65, 75, and 90% H did not change significantly for 6 months, so dissolution retardation rates could not >e determined. The 6 month accelerated testing is used as an indication of the 24 month ong~terrn testing. Assume a company wants to select a package for NDA registration stability testing. They want drug X tablets to be safe for 6 months at accelerated testing (40°Ci2°C/75% RH:5%) and 24 months at long-term testing (25°Ci2°C/60% RHi5°/o). 112 available packages are Aclar blister, and 50 mL HDPE bottles, with 0.5 g, l g, or 2 g L gel canisters. \clar blister (PVC/2 mil PIE/0.6 mil Aclar, P = 0.00058404 g/day-cavity-ps at 40°C) The permeability of this Aclar blister was obtained from previous work at the 001 of Packaging. The first example assumes that one tablet (W, = 250 mg) is :rted into one blister cavity. For the blister package, it is impossible to use silica gel siccant, so the relative humidity of Aclar blister headspace will increase from the initial ,uilibrium relative humidity as shown in Figure 62. The tablet reaches equilibrium with te environmental condition (40°C/75%) in 180 days based on the moisture prediction 'TOgl‘atn. The relative humidity inside the package is changed from initial to equilibrium {H as a function of storage time. Dissolution at each relative humidity between initial and equilibrium RH is calculated by the dissolution prediction program using 1 day time interval iterations. The tablet is predicted to reach the specification limit 75% dissolution in 50 days. Therefore, the Aclar blister is predicted to not be a suitable package for drug X tablets. 113 100% —. -* , 75% ’ ’ RH of package HS Dissolution 50% 4 25% Dissolution or RH of package headspace 0% . T . 4 o 50 100 150 200 Storage time (days) Figure 62 RH of Aclar blister headspace calculated by the moisture prediction program and 30 minute dissolution calculated by the dissolution prediction program as a function of storage time. 2. HDPE bottle (50 mL, P = 0.0016 g/day-pkg-ps at 40°C) First, assume that 50 tablets (W, = 12.5 g) are inserted into the HDPE bottle without desiccant. The relative humidity of the package headspace reaches 52.7% equilibrium RH in 6 months based on the moisture prediction program. Dissolution behavior at various moisture contents is calculated by the dissolution prediction program using 1 daytime interval iterations. The prediction is that dissolution significantly changes for 6 months (see Figure 63), so the HDPE bottle without any amount of desiccant is not a suitable package for drug X tablets. Second, it is assumed that 0.5 g silica gel is inserted into HDPE bottles containing 50 tablets (W, = 12.5 g). The RH of the package headspace reaches 41.30% at 6 months 114 based on the moisture prediction program, and the dissolution reaches 79.54% at 6 months based on the dissolution prediction program (see Figure 63). Based on the above trials, the package for drug X tablets can be designed. If a 0.5 g silica gel canister is inserted into HDPE bottle containing 50 tablets, tablets are predicted to be safe in terms of dissolution at the accelerated testing condition (40°C/75%) for 6 months. ‘K 3 8 (1);. U i a. : " 3 E 75% : O . = 2 g \ (2) 8 4: .3 50% - . - %- """" ()1 o ‘ . ‘ a "' . : fi . (3) r: i " ‘ - - r ' =3 25% , . - -‘ 2 l. ' p O l‘ ‘ .3 . O i 0% . . . i o 50 100 150 200 Storage time (days) Curves (1) and (2) represent the 30 minute dissolution: (1) 12.5g tablets in HDPE bottle with 0.5 g silica gel (2) 12.5g tablets in HDPE bottle without silica gel Curves (3) and (4) represent the RH of the package headspace: (3) 12.5g tablets in HDPE bottle with 0.5 g silica gel (4) 12.5g tablets in HDPE bottle without silica gel Figure 63 RH of the HDPE bottle headspace calculated by the moisture prediction program and 30 minute dissolution calculated by the dissolution prediction program as a function of storage time 115 't. Permeability calculation The package permeability required to maintain dissolution above the 75% specification for drug X tablets stored for 6 months at 40°C/75% RH can be determined. To do so, calculate the required permeability by trial and error using the moisture and dissolution prediction programs. Parameters used to calculate thejpermeability usigmoisture and dissolution prediction pro grams . Solids 0 Dry weight: 12.5 g (tablets) 0 Initial moisture content: 1,9312% (tablets) o Sorption isotherm equations: GAB constants (Wm: 0.013392, Cg: 1 13.2096, K: 0.933012) for tablets . Package 0 Volume: 0.05 L . Storage condition 0 Temperature at packaging line: 25°C Relative humidity at packaging line: 40% Temperature at storage: 40°C ‘ Relative humidity at storage: 75% Storage time: 180 days 0000 If a package permeability of 0.0004 g/day-pkg-pS is used for drug X tablets, the package can maintain the dissolution of tablets above 75% for 6 months at 40°C/75% RH. Figure 64 shows the dissolution and relative humidity of the package headspace change for 6 months. 116 1 00% 8 \ a 3' Dissolution 3 75% o .c: o 8’ x o a ..‘f 50% o g ......................... o P i I - 8 R“ of package HS =3 25% 2 o a a E 0% I I I i 0 50 100 150 200 Storage time (days) Figure 64 RH of a package (P=0.0004 g/day-pkg-ps) headspace calculated by the moisture prediction program and 30 minute dissolution calculated by the dissolution prediction program as a function of storage time The calculated package permeation (0.0004 g/day-pkg-ps) required is about four times lower than 50 mL HDPE bottle permeability (0.0016 g/day-pkg-ps). This barrier package may be very costly, so it may be not a good choice to package drug X tablets. In this case, HDPE bottle with 0.5 g silica gel may be a better choice. 117 CHAPTER 6 CONCLUSIONS AND FUTURE WORK By using an open dish study in this experiment, it was found that coated and incoated tablets dissolve differently as a function of storage RH. Dissolution of coated and uncoated tablets stored at 40°C/90% and 0% RH is still high at 6 months storage time because tablets swell at 90% RH and there may be no physical interactions at 0% RH. However, dissolution of coated and uncoated tablets stored at 40°C at 75%, 65%, and 50% RH decreases rapidly during 6 months of storage time because they may be degraded physically such as crosslinking among excipients. Also, the dissolution variability from six dissolution values of uncoated tablets stored at 40°C at 90% and 0% RH is small, but the dissolution variability at 40°C at 75%, 65%, and 50% RH is very large (see Table 16 on page 78). Apparently, high temperature dissolution behavior can be grouped in two different patterns. One group (40°C at 7 5%, 65% and 50% RH) has rapid dissolution change during a 6 month period, so these are not good conditions for storage of tablets. The other group (40°C at 90% and 0%) can maintain tablets at a high dissolution value for 6 months but tablets stored at 90% RH are failed with hardness. Uncoated tablets stored below the initial RH at 40°C show no dissolution change for 3 months (see Figure 59 on page 107). Therefore, it can be concluded that drug X coated and uncoated tablets would best be maintained below the initial RH at the 40°C storage condition. The dissolution of drug X coated tablets stored in open dishes at 40°C behaved very differently in comparison with that of drug X uncoated tablets. The coated tablets 118 did not follow the dissolution theory (S-shaped dissolution change as a function of stirring time). Aged coated tablets did not disintegrate rapidly. They took some longer time to start to disintegrate. They swelled without any disintegration. The coating material was observed to behave like a plastic film. This means the coating material may be degraded either chemically or physically. When aged coated tablets started to disintegrate, the coating material broke open suddenly. After that, aged coated tablets disintegrated rapidly. Therefore, the dissolution of coated tablets at the 30 minute stirring time did not change regularly as a function of storage time. By using the open dish study in this experiment, the relationships between RH (or moisture) and tablets’ physical properties such as dissolution and hardness were determined more quickly than doing stability testing. It was found that the dissolution of drug X tablets was dependent on temperature, moisture content, and storage time. In order to determine the relationship between moisture and dissolution, Nakabayashi’s method was tried, but his model did not work well for drug X tablets because of dissolution variability. A different approach was deve10ped by using the dissolution retardation rate (R). The 30 minute dissolution was plotted as a function of storage time at each relative humidity. Based on empirical data fitting using a first order kinetic method, dissolution retardation rates were determined at each relative humidity. Dissolution retardation rates were plotted with RH, and then a dissolution prediction model (Equation 20) was developed based on that relationship. The dissolution can be calculated simply at any RH and storage time by using Equation 20. The relative humidity of the package headspace changes during the unsteady state, so the dissolution of tablets stored at that condition is 119 ard to calculate. Therefore, the dissolution prediction computer program was developed .sing the Visual Basic program language. Dissolution retardation rates for drug X coated tablets could not be determined in his study because they did not behave according to the dissolution theory. Dissolution results from the dissolution prediction program were compared with the experimental results to verify the program. There is fairly good agreement between experimental and predicted dissolution. However, the dissolution prediction program still needs more verification with other products. As a necessary tool for the dissolution prediction program, a mathematical model calculating the time required to reach final moisture content was also developed. The model was deve10ped using piecewise linear equations, which could work for any number of components in a package. And, the simple approach calculating the moisture content of components (any number of components) as a function of storage time was developed. Based on the new mathematical models, moisture and shelf life prediction computer programs were developed using the Visual Basic program language (see Appendix B). The moisture content and the time required to reach final moisture content of drug X tablets were predicted by using the moisture and shelf life prediction programs. These programs were verified based on the experimental data. The prediction programs worked well for both one component and two components in packages such as LDPE bags and HDPE bottles, and they should work for even more than two components in a package. . In this study, a small amount of tablets (15 tablets, 3.75g) was used to verify the moisture and shelf life prediction programs. In the future, it should be verified for bulk 120 packages (e. g., 100,000 tablets, 25kg) too. The moisture and shelf life prediction programs should work for bulk packages but the bulk package must be represented by some assumptions (see Appendix B for several major assumptions). The equilibrium between moisture and the solid component inside the package should be reached quickly. In other words, there should be no gradient of water vapor in the solid component. If this assumption is satisfied, the moisture and shelf life prediction programs can be used for bulk package too. By using the moisture and dissolution prediction programs, a package for NDA stability testing can be designed as explained in Chapter 5. Package design. An open dish study was done for 6 months to determine the relationship between dissolution and moisture content of tablets, and it was used to design a package to make drug X tablets survive at 40°C/75% RH for 6 months. It seems this is not a useful method because 6 months time was spent to design a package for 6 months accelerated testing. However, this still can be very useful to select a package without any trial and error approach for stability testing, and also many situations can be simulated using different permeabilities and storage conditions. Until now, there were no good models to select a package for the registration stability testing in terms of dissolution. Now, the correct barrier package can be selected with greater confidence. The prediction programs cannot be an absolute tool yet, but they can be useful when further refined to determine a package prior to the registration stability testing. It is recommended that the open dish study work be done during drug development and well before the time when stability tests must be started. Then the calculation of required barrier can be made in a timely manner. Furthermore, if the open 121 dish data are available when a change in packaging is required for marketing, the choice of package barrier can be done quickly. In the future, if a protocol for open dish study is established for every new product, a barrier package can be selected confidently based on parameters already established during product development. Also, if the mechanism of tablet aging as a function of RH and storage time is explained, it will be very helpful in understanding the relationship between the dissolution retardation rate (R) and RH. The mechanism by which the disintegration time is increased as a function of storage time must be explained based on the physical interaction between moisture and ingredients (drug and excipients). In order to develop that mechanism, the following research is suggested. 1. The properties of each ingredient should be understood as a function of temperature, RH, moisture sorption rate, and storage time. 2. The physical structure change inside tablets should be explained as a function of temperature, RH, moisture sorption rate, and storage time. 3. If the dissolution testing is improved to have good reproducibility, a better relationship between dissolution and moisture content of tablets can be made. This can result in better dissolution prediction results. 122 Appendix A Background and Literature Review (Moisture and Shelf life Prediction Models) 123 The moisture content of solid oral dosage forms such as tablets and capsules in a package has been the subject of research for a long time because it plays an important role in properties such as dissolution and hardness of solid dosage forms. Before the 19905, the moisture content of product in a package was predicted using a simple linear relationship between initial and final points of the moisture sorption isotherm. Van Den Berg and Bruin (1981) stressed the advantages of using the GAB equation obtained from Guggenheim-Anderson-De Boer. This is a nonlinear equation for moisture sorption isotherms (Bizot, 1983). Since then, nonlinear equations have been applied to develop shelf life and moisture prediction models for one component in a package and for two components in a package. Three concepts (moisture content equations, psychrometric equations, moisture sorption isotherm equations) together are necessary to develop moisture and shelf life prediction programs. 1. Moisture content equations Models predicting the shelf life and moisture content of solids are normally calculated based on the dry weight. When solids change weight during moisture sorption and desorption, an equation that can be used to calculate the dry-weight-based moisture content using initial and final wet weight is needed. Equation 23 is the simplest such equation available. It is used in the PKG 815 Shelf Life class at the School of Packaging, Michigan State University. The following discussion shows how Equation 23 is derived from basic principles. Equations 21-31 are regularly used in shelf life calculations. 124 Equations 32 and 33 are added as clarifying equation developing steps to improve understanding. The moisture content [M(%)] based on the dry weight of solids can be calculated by Equation 21: me M(%) = W d x100 (21) where m. = the mass of moisture at equilibrium, W; = the dry weight of solid The moisture content based on the wet weight of solids can be calculated by Equation 22. me 100 22 W x ( ) M,(%) = If solids absorb or desorb moisture as a function of relative humidity, the moisture content can be determined by Equation 23. W,-(M,+1) l M(%) =[ —1:|x 100 (23) Equation 23 is derived from Equation 21. Equation 21 looks simple, but me and Wd need to be calculated. So, the following shows how to derive Equation 23 from Equation 21. There are two parts. One is to calculate the numerator (me) and the other is to calculate the denominator (Wd) in Equation 21. (1) Calculation of me, the mass of moisture at equilibrium Equation 24 can be used to calculate the mass of moisture at equilibrium (me). me = m, + moisture gain/ loss = m, + (W ,— — WI) (24) 125 Sui To calculate the mass of moisture at initial time (m,-) using the initial weight of product (W,-) and initial moisture content (Mm) based on the wet weight of product, Equation 25 can be used. m, = M m. x W, (25) If the initial moisture content is calculated based on the dry weight of product, m M. = ——' 26 . Wd ( ) Then, Mm, the initial moisture content based on the wet weight of product, can be represented as Equation 27. m . M .. = —-'— = m‘ (27) ”/1 Wd + ml From Equation 26 and Equation 27, I =Wd+m, =fl+1=_1_+1 Mm mi m: l Therefore, M. M m. = ’ 28 1 + M . ( ) Substitute Equation 28 into Equation 25. M m, = ’ x W. 29 1 + M , ( ) Substitute Equation 29 into Equation 24. Ml m = xW.+(W,—W,) (30) c 1+M. 126 (2) Calculation of Wd, the dry weight of solid Equation 31 can be used to calculate the dry weight of product (Wd). W. = W, -— m. (31) Substitute Equation 29 into Equation 31, M. W =W.- ' W 32 d l 1+Mix l ( ) Now, me (Equation 30) and W; (Equation 32) are derived, so substitute them into Equation 21. M(%): ' M x100 (33) W.— ' xW. 1+M, By simplifying the Equation 33, Equation 23 is obtained. 2. Psychrometric equations The psychrometric equations and chart are a very useful tool to determine the relationship between air and the moisture it contains. ASAE (American Society of Agricultural Engineers) publishes equations of saturation vapor pressure, vapor pressure, and absolute humidity. They were used to develop the moisture simulation computer program. Below are three useful psychrometric equations: (1) Saturation vapor pressure (p,, Pascal) At a given temperature T, saturation vapor pressure (p,) can be calculated by Equation 34 which is designed for the unit “pascal” value. 127 A+BT+CT2 +DT3 +ET‘ FT SGT} (273.16 S T S 533.16) (34) In(ps/R) = where, R = 22,105,649.25 A = -27,405.526 B = 97.5413 C = -O.146244 D = 0.12558x10‘3 E = -0.48502x10'7 F = 4.34903 G = 0.39381x10’2 T = the absolute temperature (°K = °C + 273.16) (2) Vapor pressure (p) At a given relative humidity [RH (%)], vapor pressure (p) can be calculated by Equation 35. _ x RH(%) 100 (35) (3) Absolute humidity (g H20/g dry air) (AH) At a given water vapor pressure (p) and atmospheric pressure (pom), absolute humidity (AH) (or water vapor concentration) can be calculated by Equation 36. AH is given in grams of water per gram of dry air. _ 0.6219p patm _p AH (255.38 3 T s 533.16, p < p0,," ) (36) Another Equation 37 for the saturation vapor pressure was published by ASHRAE (American Society of Heating, Refrigeration and Air Conditioning Engineers). It is designed for the unit “psia” value. ln(ps) =_(’.7:f_+C, +C3T+C4TZ +C5T3 +C6 In(T)(32°F S T s 392°F) (37) where C I = -1.044039E+04 C 2 = -1.1294650E+01 C 3 = -2.7022355E-02 C4 = 1.289036OE-05 C5 = -2.4780681E-09 C6 = 6.5459673 T = the absolute temperature, °R = °F + 459.67 128 Also, the saturation vapor pressure (p3) can be calculated by using Equation 38 which is used in calculations developed by Downes (1989) at the School of Packaging, Michigan State University. -5269 p, (mmHg) = 11325 70000 * e T (33) where T = the absolute temperature (°K = °C + 273.16) He obtained the constants (-5269 and 1132570000) used in Equation 38 from an empirical fit to the known data based on the theoretical model 39. This is an Arrhenius type of expression. Acuvamm [Energy P, = A _e Temperature (39) where A = a constant The simple Equation 38 was used to develop the moisture simulation computer program. The equations (saturation vapor pressure Equations 34, 37, 38 and absolute humidity Equation 36) given above yield results that agree closely with existing psychrometric charts. 3. Moisture sorption isotherm equations A moisture sorption isotherm is a tool for describing the relationship between equilibrium moisture content (M) and the moisture in the air surrounding a product (aw), which is necessary to develop the shelf life and moisture prediction programs. It can be 129 determined by storing the products at several humidities over the range 5-95 percent. In order to represent that relationship mathematically, linear and non-linear equations can be used. In this study, 9919991 point ofanisothenn is defined as the intersection of the initial moisture content and initial equilibrium a,,. on the sorption isotherm curve, and the final point of an isotherm is defined as the intersection of the final moisture content and final equilibrium aw on the sorption isotherm curve. The final equilibrium a... can be chosen to be equal to or below the external ambient condition. It will never be higher than ambient. Figure 65 shows a graphical representation of linear and nonlinear relationships between M and aw. The slope (,6) shows the linear relationship and the sorption isotherm curve itself shows the nonlinear relationship. M ‘ A M(final) [3 (Linear) M(initial) Nonlinear T aw(initial) aw(final) aw Figure 65 Graphical representation of linear and nonlinear relationships between M and aw 130 (1) Linear equation The sorption relationship between the initial and final points on the sorption isotherm curve sometimes can be simplified with a linear equation as shown in Equation 40. When the curvature of the isotherm is small, the linear equation can be a useful approximation. In this relationship, moisture content is a variable dependent upon water activity (aw). aw is used interchangeably with equilibrium relative humidity [RH(%)/100] or relative vapor pressure (p/ps). M = ,6 - aw + C (40) M(final) " M ( mmal ) where ,B = aw( final ) - aw( mural ) (2) Nonlinear equations In order to represent the real path between the initial and final points on the sorption isotherm curve, nonlinear equations such as GAB and Langmuir equations can be used (Bell, 2000 and Bizot, 1983). (a) GAB equation The GAB equation can be used to describe the relationship between the moisture content of solids (e.g. tablets) and a... as shown in Equation 41. The GAB equation often fits sigmoid-shaped moisture isotherm data very well over the range of relative humidities between 10% and 90% (Bizot, 1983). M— Wm;Cg-K-aw _ '[I—K-a,]x[1-K-a,+CgK-fl (41) where Wm, C 3, K = GAB constants 131 Equation 41 can be solved for the constants by rearranging it into a polynomial form of the GAB equation: £22.". —I——1a“:+il-i a,+ ’ (42) M Wm Cg Wm Cg Wm KCg W . . . . a So, If the morsture sorption or desorption data are plotted as M— vs aw , the plot can be represented by a polynomial equation. Then the GAB constants can be calculated from the polynomial constants: Q -—‘1-=A-aj+B°aw+C (43) where A=—K— —l——1, Bz—I— I-i, C: 1 Wm Cg Wm Cg WMKCg Rearranging and substituting into the above polynomial constants, one ultimately arrives at the following solutions for the GAB constants: 2— _— KzJB 4AC B Cg: B +2 W..= 1 2C C-K C-K-Cg (44) (b) Langmuir equation The Langmuir equation can also be used to describe the relationship between moisture content of solids (e.g. desiccant) and aw as shown in Equation 45 (Zografi, 1988). The Langmuir equation often fits hyperbolic-shaped moisture isotherm data very well over the range of relative humidities between 10% and 90%. 132 _ Wm .CL .aw 1+C1. -aw (45) where Wm" and C L = Langmuir constants. Equation 45 can be solved for the constants by rearranging it into a polynomial form of the Langmuir equation: M Wm W 'CL aw So, if the moisture sorption or desorption data are plotted as 11? vs —1— , the plot can be W represented by a linear equation. Then the Langmuir constants can be calculated from the polynomial constants: —-——=B.——+C 47 M ( ) where B: , C:— W . Rearranging and substituting into the above polynomial constants, one ultimately arrives at the following solutions for the Langmuir constants: C1. = — W = —‘ (48) The GAB and Langmuir constants also can be determined by computer fitting the isotherm data to the GAB or Langmuir equations with a statistical program such as the h W," is the moisture content of the monolayer. Wm used in GAB and Langmuir equations is the same concept 133 pad Ant the 1 P00 nonlinear regression Solver function in Microsoft Excel. The solver algorithm used in Microsoft Excel is not available to see, so a simple algorithm to help the reader understand how Solver works is explained in detail in Appendix B Moisture and Shelf Life Prediction Programming, and Verification. 4. Shelf life prediction models Shelf life prediction models have been developed by various researchers using the linear equation for one or two solids in a package and using the GAB non-linear equation for one solid in a package. The basic equations (Equations 49 and 50) for moisture transfer through a permeable package were derived from Fick’s law in combination with Henry’s law (Labuza et al., 1972). Either one can be used to develop the shelf life prediction models. fl=P.A-Ps[aw —a . 1 (49) dt I (out) W(m) OI' dM P- A "”3 ... WNW-Pm) - - <50) Equation 49 and Equation 50 provide the same information in terms convenient for different uses. If the focus is on the mass of moisture change permeating into the package (dw) in developing the shelf life prediction model, Equation 49 can be used. And, if the focus is on the mo_i§tgefontent change of a component (dM) in developing the shelf life prediction model, Equation 50 can be used. When Downes et al. (1989) and Pocas (1995) developed shelf life prediction models using the linear equation, Equation 134 49 was used. And, when Diosady (1996) developed the shelf life prediction model using the GAB non-linear equation, Equation 50 was used. By using Equation 49 and 50, the time required to reach the final moisture content from the initial moisture content can be ----n.w,m..m ~u‘uuirfluq‘.w Ww~rm3~.g¢rn 9" calculated based on the unsteady state vapor pressure difference between the outside and inside of the package. The outside vapor pressure is assumed to be constant, so the inside vapor pressure should be determined as a function of storage time. Linear and non-linear equations can be used to calculate the vapor pressure of the package headspace. (1) Linear equation Downes et al. (1989) at the School of Packaging in Michigan State University developed a DOS based shelf life prediction program using the linear Equation 51 to determine the inside air water activity values (awn-,0) used in Equation 49. Equation 51 provides water activity values for known moisture contents. In order to calculate the water activity of air inside the package (W(m)) simply, aw moves to the y-axis and M moves to the x-axis in contrast to Equation 40 that represents a typical relationship between M and aw, with M as the dependent variable. aw(m)=C+,B-M (51) a —a . . . where fl = W(fi’m’) W(mmal) M (final) " M (initial) Substitute Equation 51 into Equation 49. dw_P-A-ps :1;- _ E [aW(0ut) _ C _ fl ' M] (52) 135 Assume the contents in a package absorb the permeated moisture immediately. Then: M = _W_ Wd Differentiate Equation 53. 1 dM = ——dw W (1 Divide by d! on both sides, then rearrange. 62-141 d1 dt " Substitute Equation 55 into Equation 52. p. . flwd=_’4_& d! 8 [aW(out) _ C _ '6 ' M] Rearrange equation 56 to integrate. dM _P-A-psdt —C—,B~M [-Wd aW(out) Integrating fi'om M,- to M] (t = 0 to t = t). M f dM P-Ap,’ = dt —C—,6~M €-Wd 0 M,‘ aw(0u’) For integration, let u = aw)” ) - C — flM du = -,6 dM dM = —Ldu fl 136 (53) (54) (55) (56) (57) (58) M, at u = lawmw —aw(m)Jat tzme = 0 a at time =t Wm} M, atu=[a W(nut) _ Substitute u into Equation 58. iaW(out) “’W(in) L, , _i i 51‘: =____.P'A'ps Id: (59) [a u ['Wd 0 W(out) —aW(in) =0 Integrate Equation 59. _ i1“ (aW(out) — aW(in))t=t = P - A - pst (60) )3 (“19(0)“) ‘ aw(in))t=0 g ' W at Solving 60 for t yields the shelf life equation 61 using the linear equation. I = — Wd ' g In (aW(0ut) — aW(jn))l=t (61) fl.P-Aops (aW(0ut) _aW(in))t=O If the numerator and denominator in the logarithm are switched, the minus sign can be removed: (62) f: Wd -Z In (aW(0ut) ‘ aw(,°n))t=0 (aW(0ut) — aWUn) )t=t Equation 61 or Equation 62 can be used to calculate the shelf life of one component in a package by using a simple linear relationship between M and aw. Pocas (1995) developed a mathematical model to predict the shelf life of two solids in a package by using linear sorption isotherms. She said that when two solids A and B are packaged together, the total amount of moisture dw permeating through the package is equal to the moisture change in solid A plus the moisture change in solid B: 137 dszdAdMA+WdBdMB (63) Substitute Equation 63 into Equation 49, then rearrange: P-A-ps[ WdAdMA + WdBdMB = aww) — awm) ]dt (64) The moisture sorption isotherms of the solids can be represented by linear equations: dM MA=CA+flA'0w (“A =flA] (65) dM MB=CB+flB°aw [d 8:133] (66) aw where C A, ,6," C B, ,8” are the coefficients of each linear equation. Then, dMA can be expressed as a fimction of dMg and vice versa: dMA = dMB £1. (67) .313 dMB = dMA 38— (68) .3/1 Substitute Equation 68 into Equation 64, then rearrange: t3 P - A l- p dMA(WdA +WdBfl—j = ——€—s—[aw(0w) —aw(m)}1t (69) Rearrange Equation 69 for dt. 2 dM dz=——(W6A+de ”3): A 1 (70) P . A ' p3 flA [aW(0ut) _ aW(in)J 138 Integrate Equation 70. M MAi aw(0ut) _ aw(in) The analytical integration of Equation 71 gives Equation 72 (see Equations 58-60 for more information about integrating). E t=———W W l P-A-ps( dAflA’r dBflB)n[ (aW(0u[) — 0190'") )t=0 ] (72) aW(0ut) " Old/(in) )t=t Equation 72 will be used to calculate the shelf life of two solid contents (e.g., tablets and desiccant) in a package by using a simple linear relationship between M and aw. (2) Nonlinear equation When the linear equation is too simple to represent real relationships, the use of a nonlinear equation needs to be considered. Diosady (1996) incorporated the nonlinear GAB equation into the basic equation for the rate of moisture transfer into a permeable package, thus obtaining a shelf life prediction model. Equations 75-83, 85, and 89 are rearranged from Diosady’s (1996) paper, and Equations 73, 74, 84, 86, 87, and 88 are added by this author as clarifying intermediate steps to improve understanding. Equation 43 is rearranged as shown in Equation 73. A-M~aj+(B-M—1)aw+C~M=0 (73) Equation 73 is modified to the following equation by the quadratic formula: a _ -(B-M—1)—\/(B-M-1)2 -4-A~C-M2 " 2-A~M (74) 139 The polynomial constants A, B, and C are substituted into Equation 74: 2+(Wm/M—I)-Cg—J[2+(Wm/M—1)-Cg]2—4+4-Cg (75) a = "’ Z-K-(I—Cg) From awn) = fl and am”) = p ""’ in combination with 75: _ 2+(Wm/M—1)-Cg-\[[2+(Wm/M-I)-Cg]2—4+4Cg (76 pan—p3 2‘K'(1—Cg) ) and _ 2+(Wm/Mc—1)-Cg—\/[2+(Wm/Me—I).Cg]2—4+4Cg (77 pout _ps 2'K°(I—Cg) ) where M, = the equilibrium moisture content of solids exposed to the package outside RH (g HzO/g dry weight of solids) Substitute 76 and 77 into 50: dM P. A. _= p, {(Wm/Me)'Cg dt Wd -£-(2).K-(1-—Cg) -fi2+(W,,,/M,).Cg -Cg]2-4+4Cg —(W,,,/A/0-Cg (78) +\/[2+(W,,,/w-Cg -Cg]2 —4+4Cg} Assuming constant temperature and external relative humidity, let P ° A - p. ‘ = constant = (D (79) Wd-€o(2)-K-(1-Cg) and 140 (Wm/M, ) . Cg — \[[2 + (Wm/M, ) - Cg - Cg ]2 — 4 + 4C8 = constant = 17 (80) Substitute 79 and 80 into 78, and integrate from t = 0 tot = t and M, to M]: Mf dM I =01 (81) Min—(Wm/M-Cg +J12+1Wm/A0-cg-cg]2 _4+4cg Expanding the square in the denominator and simplifying: Mf 61M 1 M, H-(Wm/M-Cg +\/1/M(4W,,,Cg - 2WmC§ )+(W,,,/1w2 cg +C§ as: (82) Diosady (1996) said that Equation 82 can be integrated only by numerical methods. However, if Cg is large so that 4WmCg << 2Wng2, or Cg >> 2i then Equation 82 can be written as: Mf dM 11,17 —(W,,,/M)-Cg + f1/M(—2W,,,ng ) +(W,,,/1w2 .ng +ng = $1 (83) In order to simplify the denominator, multiply numerator and denominator by M. Then, rearrange. W M -dM l = <15: (84) 14,1714 -W,,,Cg +CgJM2 -2W,,,M+W,,2, But M" —2W,,M+W,f =(M—Wm)2 Therefore, Equation 84 simplifies to i Diosady wrote Cg >> 2 at that statement but he wrote C8 >> 20 in text. If C, is much greater than 2, 4WmC8 << 2W,,,C,,2 can be obtained. 50, 2 is correct. 141 M f M-dM Mi M(17+Cg)-2Wm -Cg (85) For integration, Let 5: M(]7+Cg)-2W,,,Cg d§=dM(/7+Cg) +2WC M=—-4—€——, M=§___"'__K (17+Cg) (174-Cg) Mfat §=Mj(]7+Cg)-2Wng at time = t M, at 4==M,(17+Cg)-2 Wng at time = 0 Substitute 5 into Equation 85. Mf(”+Cg)’2WmC8(§+ 2Wng )/(17+Cg) d6 C :0): (86) M;(I7+Cg)—2Wng 5 (17+ 8) Rearrange, and split. 1 2 mcg 001 = j ———-—-2-d§ + j 2 d5 (87) M,-(17+Cg)—2W,,,Cg (”+Cg) M,-(I7+Cg)—2Wng (”+Cg) 4‘ Integrate Equation 87. Mf(17+Cg )-2Wng a” _ Mi(fl+Cg)—2Wng _ 1 . le(fl+Cg)—2Wng 2W C (88) (17+Cg)2 Mi(fl+Cg )-2Wng Therefore, a shelf life equation using the GAB non-linear equation can be derived as shown in Equation 89. 142 1 2Wng In (174-Cg )Mf —2W,,,C ._ _ , 8 (_(H+Cg)¢ Mf M, J (89) +— (17+Cg) (17+Cg)M,--2Wng Equation 89 was used by Diosady to calculate the time to reach the final moisture content from the initial moisture content in a package at a given storage condition by using the non-linear GAB sorption equation. He said this model is limited to Cg values greater than about 2 and it can be applied to only one component in a package as shown. It is very complicated to develop a shelf life prediction model analytically using the GAB nonlinear equation. If one more component is added into the package to develop the shelf life prediction model, it will be very complicated, or it might be impossible to develop a shelf life prediction model using the nonlinear equations. 5. Moisture prediction models Zografi et al. (1988) developed a mathematical model to predict the final relative water vapor pressure in a closed system for a multicomponent mixture of solids knowing the initial water content for each component. The mathematical model for a closed system is useful for calculating the initial equilibrium water vapor pressure of components that have different water vapor pressures. Zografi et a1. put micro crystalline cellulose (MCC) and corn starch in a glass bottle and they assumed that the bottle was closed completely, there was no moisture permeation through the bottle. The packaging line was conditioned at 23 °C/65% RH, so the initial relative humidity of the package headspace was 65% RH. Before MCC and corn starch were inserted into the bottle, their initial moisture contents were measured as shown in Table 27. 143 f Table 27 Initial moisture content of MCC and corn starch | I M,- (%) | Equilibrium RH (%) | I MCC I 18.1% I 96% RH based on Moisture Desorption lsotherm I ICom Starch I 0 [0% RH based on Moisture Sorption lsotherrn I MCC has a higher equilibrium vapor pressure than the package head space and corn starch has a lower one, so water in the MCC will be desorbed into the package headspace and the corn starch will absorb water from the package head space. Therefore, the moisture desorption isotherm of MCC and the moisture sorption isotherm of corn starch must be used'to predict the final RH of the package headspace. Figures 66 and 67 help to explain Zografi et al.’s model more clearly. A 4 0 5 Corn starch (sorption) 1‘ 3 0 ~ ? I I 2 o l J I M, (%) of MCC ' 1 0 MCC (desorption) 8 0 1 0 0 M,- (%) of corn starch RH (%) Figure 66 Graphical representation of changes in moisture during equilibration between MCC and corn starch As shown in Figure 66, MCC will lose some moisture and corn starch will gain some moisture to reach equilibrium (somewhere between 0% and 96%). The equilibrium point between MCC and corn starch is dependent on the relative amOunts of each component. I44 There are three different equilibrium vapor pressures in the bottle at the time t=0 when it is closed, as shown in Figure 67-(a). The system is not at equilibrium at this time (F0). 0 Package head space : 23°C/65% RH (13.71 mmHg) 0 MCC : 23°C/96% RH (20.25 mmHg) 0 Corn Starch : 23°C/0% RH (0 mmHg) Headspace Headspace (65% RH) (88% RH) r: “20 ‘1 | I MCC Corn starch MCC Corn starch (96% RH) (~0% RH) (88% RH) (88% RH) (a) at storage time t = 0 (b) at equilibrium Figure 67 Graphical representation of moisture transfer and moisture equilibrium in the closed system Moisture will be transferred from MCC to corn starch until equilibrium is reached as shown in Figure 67-(b). At equilibrium the head space, MCC, and corn starch have the same vapor pressure, but they each have a different moisture content. The water in the MCC and the water in the corn starch both have the same thermodynamic state as defined by the chemical potential (Bell, 1990). Kontny et al. (1992) developed a mathematical model to predict the moisture content of components in a permeable package using a sorption-desorption moisture transfer (SDMT) model. They address the situation where an aspirin and desiccant, each 145 with an initial moisture content, are stored together in a permeable container at a given temperature, initial headspace humidity, and headspace volume. A method is shown in which the amount of moisture permeating into the container over the storage time can be determined. Then it is shown how the distribution of the moisture between the aspirin, desiccant, and headspace can be determined using sorption-desorption moisture transfer models. Kontny’s description 5 reported in the following paragraphs. The amount of moisture in the package at time t = 0 (mm a, ,,-,,,e=0) can be determined by Equation 90. mT, at time=0 = WdA MA + WdBMB + mh (90) Once the amount of moisture permeating into the package is calculated for a time interval j, this mass of water can be added to mm, mm, to obtain mm, my , the amount of water inside the container at the end of this time increment. After time interval j, the total moisture in the system (mm, mm] ) can be expressed by: ’"T, at time: j = "77‘, at time=0 + W (91) The sorption-desorption moisture transfer (SDMT) model also can be utilized to obtain the relative vapor pressure (p/p,),~,, inside the package at a time equal to time interval j. This method can then be iterated to obtain @425)»: at each time interval through the total storage time, where the time associated with a calculated (p/p,),-,, is obtained by summing the time interval j. In order to calculate the vapor pressure (p/ps)", inside the package, the relationship of each component’s moisture content with RH must be known and defined I46 mathematically. The GAB and Langmuir equations provide a good fit with moisture sorption isotherm data. Referring to Equation 90, the mass of moisture (mA) in component A can be calculated with the GAB or Langmuir equation: ”’14 = WdA x MA(GAB) (or MA(Langmuir)) (92) where MMGAB) (or MA(Langmuir)) = the moisture content associated with component A as given by the GAB (or Langmuir) equation for component A at any relative humidity The ideal gas law is used to calculate the mass of moisture in the headspace volume (mh) for the total head space volume. -V-( / )x18 where R = gas constant, 0.08205 Latmlmol-K, T= absolute temperature (°K) In order to get p,, a psychrometric chart or look-up table can be used. Also, p, can be calculated by using the saturation vapor pressure Equations 34, 37, and 38. Equation 38 was used to develop the computer program. When the temperature changes, the saturation vapor pressure at the new temperature is calculated easily by use of Equations 38. Kontny used the GAB equation for aspirin and the Langmuir equation for desiccant, so Equation 90 written in its entirety takes the form: 147 m . :0 : T,atttme WdA{[1_KA(p/ps)]xIl—KA(p/ps)+CgAKA(p/Ps)] +Wd B{ WmBCLB(p/ps)}+ P3 'V'(p/ps)x18 [1+CLB(P/Ps)] R-T WmACgAKA(P/ps) I (94) where, WM, C8,), KA - the GAB constants of component A ng, C [,3 the Langmuir constants of component B The permeated mass of moisture (w) into a package for a time interval j can be calculated by Equation 95. w=Px1x[(p/p,)0,.412/12.)th (95) where j = time interval Therefore, Equation 91 written in its entirety takes the form: mT, at time=j = mT, at time=0 + {P x J. x [(P / P3 )out _ 0” P5 )in I} (96) where (p/ps)”, is the relative water vapor pressure in the equilibrated system at each time interval j. Rearrange Equation 94 and set (p/pj equalto x to obtain a fifth order polynomial equation, Equation 97. x5 +C,x" +C2x3 +C3x2+C,x-C, =0 (97) C 1, C 2, C3, C4, and C 5 are constants. See Appendix I in the paper “Prediction of moisture transfer in mixtures of solids: transfer via the vapor phase.” (Zografi et al., 1988) for more information about the constant terms. To solve Equation 97, the real root between (p/p,) = 0 and (p/p,) = 1 must be found. Zografi et al. used Newton’s method which is one of approximation techniques. If one more component is added in the moisture 148 transfer process, Equation 97 will be very complicated even though it is mathematically possible to calculate the constant values for a high-order system. See Appendix B. Moisture and Shelf Life Prediction Programming. and Verification for a simple method to determine (p/ps). 149 Appendix B Moisture and Shelf Life Prediction Programming, and Verification 150 represent the sorption function between the initial and final points of the isotherm, and the model using the nonlinear GAB equation has a limitation that it Cannot be applied for more than one component in a package. Therefore, a model without any limitation, that represents the real relationship between the initial and final points of the isotherm and that can be applied for any number of components in a package needs to be developed. A model using piecewise linear equations can be integrated analytically and can be applied for any number of components in a package, and is close to the real relationship. The nonlinear section between the initial and final points is divided into sections, and then each section is represented by the linear equation. Figure 68 shows a hypothetical graphical representation of piecewise linear relationships between M and aw. There are two sorption isotherm curves. One is for hypothetical component A and the other is for hypothetical component B. MA 1 denotes the initial equilibrium moisture content of component A, MB, denotes the initial equilibrium moisture content of component B. M,m+1 ) denotes the final moisture content of component A, and M3041) denotes the final moisture content of component B. aw; is the equilibrium water activity at the initial equilibrium moisture content (MA 1 or MB 1), and awn-+1) is the equilibrium water activity at the final moisture content (MM-+1) or Man-+1)). The nonlinear sorption isotherm between the initial and final points is divided into as many as i or pieces, then linear equations are applied to each divided section. As can be seen in Figure 68, linear slopes 66,) 1, fig A“) for component A and linear slopes (fig), fig) fig.) for component B can be achieved. Those linear slopes are used to make a close to real relationship between M and a, (p/p, or RH(%)/100). 152 The moisture prediction computer program consists of two parts. One is the shelf life prediction program and the other is the moisture prediction program. The shelf life prediction program is useful for calculating the time required to reach some specific moisture content from the initial moisture content of components in a package at a given storage condition. It was developed using piecewise relationships between the initial and final moisture contents. And, the moisture prediction program is useful for calculating the moisture content of components in a package and relative humidity of the package headspace as a function of storage time. The following are major assumptions for the models used in the moisture prediction program; a. Initial concentrations of water in the solids (e.g. tablets, capsules and desiccant) and headspace reach equilibrium rapidly. b. The equilibration of moisture with the solid components inside the container is rapid relative to the permeation of moisture into the container. c. There is no gradient of water vapor in the headspace surrounding the solids. 1. Shelf life prediction program A linear sorption isotherm equation can be used to develop the shelf life prediction models for one and two components in a package, and the nonlinear GAB sorption isotherm equation can be used to develop the shelf life prediction model for one component in a package with a limitation that it needs to be integrated (see Appendix A, Equation 82-84 on page 141). The linear equation may be too simple to adequately 151 represent the sorption function between the initial and final points of the isotherm, and the model using the nonlinear GAB equation has a limitation that it cannot be applied for more than one component in a package. Therefore, a model without any limitation, that represents the real relationship between the initial and final points of the isotherm and that can be applied for any number of components in a package needs to be developed. A model using piecewise linear equations can be integrated analytically and can be applied for any number of components in a package, and is close to the real relationship. The nonlinear section between the initial and final points is divided into sections, and then each section is represented by the linear equation. Figure 68 shows a hypothetical graphical representation of piecewise linear relationships between M and aw. There are two sorption isotherm curves. One is for hypothetical component A and the other is for hypothetical component B. M,“ denotes the initial equilibrium moisture content of component A, M3, denotes the initial equilibrium moisture content of component B. MM+ 1) denotes the final moisture content of component A, and Man-+1) denotes the final moisture content of component B. aw, is the equilibrium water activity at the initial equilibrium moisture content (MA, or M3 1), and awn-+1) is the equilibrium water activity at the final moisture content (MAM 1) or Man-+1)). The nonlinear sorption isotherm between the initial and final points is divided into as many as i or pieces, then linear equations are applied to each divided section. As can be seen in Figure 68, linear slopes 66,1 1, ,6,” ,BA,) for component A and linear slopes (fig), ,632 flm) for component B can be achieved. Those linear slopes are used to make a close to real relationship between M and a,, (p/p, or RH(%)/100). 152 MB(i+l) . Bat : MBi : M A i i A 3 B83 . 5 M33 g i 1 [5132 M32 MA(i+l) " i Bl MBI B : MM 0... 3 / fl [3 BM ...... ‘ BAI A2 ._ -.--.l._.--.._..__-.___.._--.-- ”mL-“--- . aw] awz aw3 .......... awi aw( i+ I ) aw Figure 68 Hypothetical graphic representation of piecewise linear equations for two sorption isotherms for components A and B Equation 98 shows the piecewise linear relationship between M and aw. Mc(n+l) = flcm ' aw(,,+1) + Ccm (O S n S i, I S m S i) (98) M — M where .ch = c(n+l) C(n) , c = the component (e.g., A, B, Z) “W(Ml) _ “W(H) 153 When components are packaged together, the amount of moisture change overall (dw) is equal to the moisture change in all components (A + B ....+ Z). dszdAdMA +WdBdMB + ......... +WdszZ (99) Substitute Equation 99 into Equation 49 in Appendix A, then rearrange it. Equation 100 represents that the moisture change in all components can be calculated by using package permeability, package thickness and area, and the water vapor partial pressure difference between the inside and the outside of the package. P- A - p WdAdMA +WdBdMB + ...... +WfldMZ =—7-—s-[aw(0w) —aw(in)}it (100) The moisture sorption isotherms of the components are represented by piecewise linear equations: . . dM MAUI-H) =CAm +flAm -aw(,,+l) (OSnSl,1SmSl)[ daA =flA] (101) W . . dM MB(n+l) = CBm + flBm °aw(n+l) (0 -<— n 51:15 m S 1) (_a—B = ’68) (102) w . . dM M201“)=CZm+flZm-aw(n+l)(OSnSz,1_<_m.<_z)[d Z =52] (103) aw where CA," , flAm , C3,", flBm , ........ ’CZm , '62," are the coefficients of each linear equation. Then, dMA, dMB, sz can be expressed as a function of dMB: 154 dMA =dMggi (104) B dMB =dMA-—- ’35- (105) A4 sz =dMAfl—Z (106) flA Substitute Equation 105 and Equation 106 into Equation 100, then rearrange: ,33 fl_z) P'A ' P ]d dMA (WdA +Wd3 fi+ ...... + Wdz (12.3/1) =——é——S[aw(ow) —aw(in) t (107) Solve for dt. dt=—£——(WdA+WdBE£+ ...... +WdZ ’62 ’ am" (108) P . A ' pS flA flA laW(0u()_ aW(in)] Integrate Equation 108. MA] t=—-[——[WdA+WdB—’—’1+ ...... +Wdz flz] “W" (109) P-A ° [)3 flA flflA MAi aw(out) “W(in) Analytical integration and applying piecewise linear equations for Equation 109 gives Equation 110. See Equations 58-60 in Appendix A for more information about integrating. i (a —a ' )=' ——Z (WM/3A...+WdBflBm~-+Wdzflz,.)ln “0“” “’“"’ ’ ’ (110) m1: (“W(out) — “W(m) )t=i+l =-PAp———S 155 MA(n+l) - M A(n) M B(n+l) '- M301) where 16A = 9flB = 9 flZ m aw(n+l) ' aw(n) m aw(n+l) — aw(n) m aw(n+l) - (Mn) _ M Z(n+1) - M202) (0 _< n _< i) Equation 110 can be used to calculate the shelf life of any number of components in a package by using the piecewise linear relationship between M and aw. 2. Moisture prediction model In Appendix 1 of the paper “Prediction of moisture transfer in mixtures of solids: transfer via the vapor phase”, Zografi and coworkers (1988) showed that the polynomial constants C1, C2, C 3, C4, and C 5 in Equation 97 are very complex even though only two components were considered. If one more component is added in the moisture transfer process, an increase of two additional roots results in Equation 97 in Appendix A. It makes finding the real root of the equation between (p/p,) = O and (p/ps) = 1 much more complex. The “Solver” function is a statistical program in Microsofi Excel that uses nonlinear regression. If it is used to determine the @/p,),,, at each time interval j, the complex polynomial Equation 97 does not need to be developed. The Solver algorithm used in Excel is not available for inspection. The simple algorithm in Figure 69 describes how Solver works. Equation 111 and Equation 112 can be extended to consider any number of components in a package, and (1)/me can be determined easily by using the “Solver” function. mT,attime=O=Wd4MA+WdBMB+ ...... +WdZMZ+mh (11]) 156 WmACgAKA(p/ps) } m . = =W T,atume o dA{[1_KA(p/ps)]x[l—KA(p/ps)+CgAKA(P/Ps)] +Wd B{WmBCLB(p/p5)}+ ...... +WdZGABZ(0r Langmuirz) (112) [1+CLB(p/ps)] +ps-V-(p/ps)><18 R-T n = 0 j = time interval 1 = Increment v 09409:». ry = (0 < MUM 01) mT=Wd-M, (Component A)+Wd -M (Component B)+m,,+w WMCM K ....(p/p) W‘“ [I-K (p/p)lxl1-K

fll — K(p/p.) +C,K

au\8.b._.aoo:=an. c.5585. _ 8 988.08. ... .... oE=.o> gas: .85 m 35. Ease: ... .... 5. 8 ".5 u... 8 .. 3:: 8588.02. :. Go. 2322.52. . ".8. =3 8 288.88 .u. 88. 9. N E 8.8988 526.323 :32 ... 258 . F. M ._ m x W ----.-.... .. 1 iii-......- ai-..ii. ...- -.i-... in..- ... - so - .....ui 162 The package volume, temperature and relative humidity at the packaging line are used to calculate the amount of initial moisture in the package. If temperatures at the packaging line and storage are different, another sorption isotherm at the temperature of the packaging line is needed to calculate the amount of initial moisture in the package. However, as explained in Chapter 3.2.(2)(a) Moisture sorption isotherms of drug X tablets, the moisture sorption isotherms do not vary much over the range of 20-50°C. Therefore, for the purpose of simplifying computer programming, the moisture sorption isotherm obtained at the storage temperature (40°C) was used to calculate the amount of initial moisture in tablets packaged at 25°C. If two different sets of GAB constants are used, the program will be much larger. 163 8880:. 8.8an om: 8.3m 05 EB... 305.88% 0.9538. 8.. 958E 3.8% an an 5E8 " 7.3% $2 3 a 89 3238»... .o .225: o... m. ".... E .235 "d 83 "Gassssgsahstsxm. 888.8 a. $80 ".3295...€38.53. $82. "3 SD ...Eisszgi . 823 a... .23 as. 2 ”2:23:25 .... E n .88 ,n.8us_§_..m _lna am: ".822 mm “2.:3.9.2....59.22532: .. .2 8m; "8:; s .2 $3 "8:... 2.383 22:; .....a z :x .-...-._ I ...o w h. w ... o o $828.8 8: :88... I U 4 wwmvmwr3'w 164 To verify the moisture and shelf life prediction models, moisture content of tablets in LDPE bags and HDPE bottles was determined experimentally over time, and compared to moisture content calculated by the moisture prediction part in the moisture simulation program (see Figures 74-79). Each bag and bottle had different weights of tablets and silica gel, so the moisture prediction program was run 7 times using each weight of tablets and silica gel, and a different storage time. Moisture content was calculated for a given storage time using 1 day time intervals. The results, initial equilibrium and final moisture content, obtained from the moisture prediction program were inserted into the shelf life prediction program, and then the shelf life was calculated at given storage conditions. The results were compared with the actual storage time to verify the shelf life program (see Tables 28-33). They show good agreement between the actual storage time and the shelf life calculated from the shelf life prediction program. The sorption isotherm curve between the initial and final points was divided into just 100 piecewise calculations to save program rumiing time. It was very close to the shelf life result using 1000 piecewise calculations. Based on the example below, shelf life calculated using 100 piecewise calculations was 39.77 days, and shelf life calculated using 1000 piecewise calculations was 39.78 days. So, it is almost the same as the shelf life result would be using infinite piecewise calculations. Appendix D shows all moisture raw data used to calculate moisture content of solids and shelf life. 165 (1) Tablets in LDPE bags without silica gel and with silica gel (0.5 g, 1 g, and 2 g) in LDPE bags Each bag had a slightly different weight of tablets and silica gel, so the moisture prediction program was run 7 times using actual weights of tablets and silica gel at each storage time. Figure 74 and Table 28 show good agreement between the moisture content of tablets in LDPE bags without desiccant measured experimentally and calculated by the moisture prediction program in the moisture simulation program. M(%) a.» - «A . ~ — e 7 a 3 6 . 1 5 0 I 4 r 3 2t 1 1 o r . T . o 20 4o 60 Storage time (days) 100 O M(%) of tablets measured experimentally I M(%) of tablets calculated by the moisture prediction program Figure 74 Comparison between experimental and calculated moisture content of tablets stored in LDPE bags without silica gel Table 28 Comparison between experimental and calculated moisture content, and between actual storage time and calculated shelf life of tablets stored in LDPE bags without desiccant Storage time M(%) of tablets measured M(%) of tablets calculated Shelf life (days) calculated (days) experimentally by moistugprediction program by SL prediction program 7 3.91% 3.62% 7.5 14 4.58% 4.50% 14.7 28 5.23% 5.57% 28.9 35 5.90% 5.95% 36 44 6.46% 6.33% 45 58 6.74% 6.77% 59 82 7.17% 7.29% 83.5 166 Figure 75 and Table 29 show the moisture content of tablets stored in LDPE bags containing 0.5 g silica gel measured experimentally and calculated by the moisture prediction program. The M (%) of silica gel at 58 and 82 days storage time had differences of 1.63 and 2.35%, respectively, between the experimental and calculated values. The moisture gain of tablets was measured easily, but the “experimental” moisture gain of the silica gel was calculated by difference (see Chapter 2.2.(5)(c) Verification of moisture simulation program). In this case, only 0.5 g silica gel was used. The M (%) of silica gel is changed greatly by even a small amount of moisture change (e.g., 2% M (%) difference results from 0.01 g moisture change). Therefore, 1.63 and 2.35% M (%) differences at 58 and 82 days storage time are not bad. . O 35 , r- t i s 30 4 25 a £5 20 E 15 10 g 5 5 4' at“ J 0 . . O 20 40 60 80 100 Storage time (days) 0 M(%) of tablets measured experimentally I M(%) of tablets calculated by the moisture prediction program A M(%) of silica gel by difference 9 M(%) of silica gel calculated by the moisture prediction program Figure 75 Comparison between experimental and calculated moisture content of tablets and silica gel (0.5 g) stored in LDPE bags 167 Table 29 Comparison between experimental and calculated moisture content of tablets and 0.5 g silica gel stored in LDPE bag, and between actual storage time and calculated shelf life. Storage time M(%) measured M(%) calculated by the moisture Shelf life (days) (days) experimentally predictiorgrogram calculated by SL Tablets Silica gel Tablets Siliflel prediction program 7 2.55% 24.69% 2.25% 23.78% 7 14 3.49% 30.76% 3.18% 29.95% 14.5 28 4.72% 34.08% 4.57% 33.80% 28.8 35 5.24% 35.31% 5.08% 34.60% 35 44 5.50% 35.34% 5.59% 35.23% 45 58 6.45% 34.21% 6.19% 35.84% 59 82 7.01% 34.03% 6.88% 36.38% 83.4 Figure 76 and Table 30 show the moisture content of tablets stored in LDPE bags containing 1 g silica gel measured experimentally and calculated by the moisture prediction program. The M (%) of silica gel measured experimentally are 1.49-3.45% higher than the M(%) calculated by the moisture prediction program. 40 . 35 - . . 30 25 20 15 10 5 3 r ? i O l l l l T j‘ 0' “I ‘D M(%) O D Storage time (days) 9 M(%) of tablets measured experimentally I M(%) of tablets calculated by the moisture prediction program A M(%) of silica gel by difference 0 M(%) of silica gel calculated by the moisture prediction program Figure 76 Comparison between experimental and calculated moisture content of tablets and silica gel (1 g) stored in LDPE bags 168 Table 30 Comparison between experimental and calculated moisture content of tablets and 1 g silica gel stored in LDPE bag, and between actual storage time and calculated shelf life. Storage time M(%) measured M(%) calculated by the Shelf life (days) (days) experimentally moisture prediction program calculated by SL Tablets Silica gel Tablets Silica gel prediction program 7 1.82% 18.51% 1.74% 16.30% 7 14 2.62% 26.94% 2.33% 24.51% 14 28 3.81% 33.68% 3.47% 31.06% 28.6 35 4.39% 34.69% 4.02% 32.66% 35.7 44 5.00% 37.54% 4.75% 34.10% 44.9 58 5.54% 38.60% 5.52% 35.15% 59 82 6.08% 37.37% 6.36% 35.98% 83 169 Figure 77 and Table 31 show the same situation as shown in Figure 76 and Table 30. The M (%) of silica gel measured experimentally is 1.37-6.50% higher than the M (%) calculated by moisture prediction program. The 6.50% difference is large, but the trend of silica gel moisture content is predicted well, as shown in Figure 77. The M (%) of tablets measured experimentally and calculated by the moisture prediction program are very close. 35 A i 30 ‘ ‘ 25 20 15 10 5 f 3 0 f T T I I l 20 40 60 80 1 00 di 11 M(%) Storage time (days) 0 M(%) of tablets measured experimentally I M(%) of tablets calculated by the moisture prediction program A M(%) of silica gel by difference 0 M(%) of silica gel calculated by the moisture prediction program Figure 77 Comparison between experimental and calculated moisture content of tablets and silica gel (2 g) stored in LDPE bags Table 31 Comparison between experimental and calculated moisture content of tablets and 2 g silica gel stored in LDPE bag, and between actual storage time and calculated shelf life. Storage time M(%) measured M(%) calculated by the Shelf life (days) (days) experimentally moisture prediction program calculated by SL Tablets Silica fl Tablets Silica gel prediction program 7 1.42% 12.21% 1.51% 10.84% 7 14 1.84% 23.02% 1.76% 16.65% 14 28 2.24% 30.59% 2.37% 24.91% 28 35 2.72% 34.37% 2.77% 27.87% 35 44 3.33% 34.72% 3.30% 30.43% 44.6 58 4.44% 36.51% 4.05% 32.71% 59 82 5.17% 39.09% 5.24% 34.81% 83 170 (2) Tablets in HDPE bottles without silica gel and with 0.5 g Silica gel in HDPE bottles Each bottle had a slightly different weight of tablets and silica gel, so the moisture prediction program was rim 7 times using actual weights of tablets and silica gel at each storage time. AS shown in Figure 78 and Table 32, there is good agreement between the moisture content measured experimentally and calculated by the moisture prediction program. M(%) 5 . 4 .. a l . t 3 s 6 . 3 1 2 ’ i 1 i l l 0 T Y T fl 0 50 100 150 Storage time (days) 200 O M(%) of tablets measured experimentally l M(%) of tablets calculated by the moisture prediction program Figure 78 Comparison between experimental and calculated moisture content of tablets stored in HDPE bottles without silica gel Table 32 Comparison between experimental and calculated moisture content of tablets stored in HDPE bottle without Silica gel, and between actual storage time and calculated shelf life. Storage time M(%) of tablets measured M(%) of tablets calculated by the Shelf life (days) calculated (days) experimentally moisture flediction program by SL prediction program 14 2.21% 2.22% 13.8 35 2.60% 2.60% 34.5 58 2.81% 2.93% 57 83 2.91% 3.18% 82 103 3.35% 3.46% 102 135 3.65% 3.77% 133.8 160 3.86% 3.98% 158.8 171 Figure 79 and Table 33 Show good agreement between the moisture content measured experimentally and calculated by the moisture prediction program. The M (%) of silica gel at 160 days storage time had difference of 2.59% between the experimental and calculated values. The moisture gain of tablets was measured easily, but the “experimental” moisture gain of the Silica gel was calculated by difference. As explained before, 2.59% M (%) difference at 160 days storage time is not bad. M(%) 25 20 15 10 ii. CD .A.. —_‘.H . 150 Storage time (days) 200 O M(%) of tablets measured experimentally I M(%) of tablets calculated by the moisture prediction program A M(%) of silica gel by difference 0 M(%) of silica gel calculated by the moisture prediction program Figure 79 Comparison between experimental and calculated moisture content of tablets and Silica gel (0.5 g) in HDPE bottles Table 33 Comparison between experimental and calculated moisture content of tablets and 0.5 g Silica gel in HDPE bottle, and between actual storage time and calculated Shelf life. Storage time M(%) measured M(%) calculated by moisture Shelf life (days) (days) experimentally prediction program calculated by SL Tablets Silica 5i Tablets Silica El prediction program 14 1.36% 10.27% 1.48% 9.96% 13.9 35 1.43% 13.96% 1.63% 13.76% 34.9 58 1.69% 18.93% 1.79% 17.30% 57.8 83 1.77% 20.80% 1.98% 20.44% 82.6 103 2.07% 21.62% 2.14% 22.56% 102.4 135 2.23% 23.36% 2.40% 25.23% 134.3 160 2.47% 24.29% 2.62% 26.88% 159.2 172 Appendix C Tablet Formulation, Manufacturing, and Interaction 173 1. Formulation Table 34 Shows the drug X tablet formulation. Table 34 Drug X tablet formulation ”L “/o Functions Characteristics Wet Granulation Active pharmaceutical Sensitive to moisture and light, ‘ Drug X 20.40 8.16 Medient (API) Poorly soluble in water Non-hygroscopic (up to ~75%), Mannitol (granular) 157.72 63.09 diluent soluble in water Enhance dissolution of poorly soluble binder, dissolution aid, drugs, very hygroscopic, soluble in Povidone 10.00 4.00 disintegrant acids and water Croscarmellose Insoluble, high absorption, Sodium 3.75 1.50 superdisintegrant high swelling (4~8 times) Microcrystalline Hygroscopic, insoluble in water and Cellulose (MCC) 25.00 10.00 binder, disinfigrant dilute acids Extragranulation Croscannellose Sodium 1 .25 0.50 swerdisintegrant Microcrystalline Cellulose (MCC) 20.00 8.00 binder, disintegrant Promote the flow of powder, ‘ Magnesium Stearate 1.88 0.75 lubricant insoluble in water, hydrophobic Coating Color Mixture Yellow 10.00 4.00 Soluble in water Camauba Trace Natural wax Total 250.00 100.00 Drug X, mannitol, povidone, and portions of the croscarmellose sodium and microcrystalline cellulose were screened (10 mesh) into the high shear granulator. The powders were then dry mixed for 5 minutes to make a uniform blend prior to granulation (main blade: 200rpm, chopper blade: 1800rpm). Purified water was then used to granulate the powder mix in the high shear granulator for about 4 minutes (wet granulation). The granulation was dried using a fluid bed drying process. The milled granulation was then placed into an appropriately Sized tumble bin. The appropriate quantities of croscarmellose sodium (20 mesh), microcrystalline cellulose (20 mesh), and magnesium stearate (30 mesh) were sieved and added to the 174 tumble bin. The mixture was blended for 5 minutes, then compressed on a rotary tablet presser. The color mixture yellow was mixed with purified water to form the coating suspension. The core tablets were placed into a side vented, perforated coating pan. The tablets were then spray coated with the suspension until an approximate 4.0% weight gain was achieved. Figure 80 shows the graphical representation of the manufacturing of drug X tablets. 175 3635 x m5 mo mew—38358 05 .3 8385882 363380 cm 9.qu ”swammaaamwms 33333on “fig «5.3953 002 30 Ill, I Allll Allll @520 9:2an oo .96 .885on 2332 .x was From the extra granulation process, the granules were surrounded by croscarmellose sodium, microcrystalline cellulose, and magnesium stearate. The magnesium stearate is a lubricant and is hydrophobic, so the tablet dissolution rate decreases as the time of blending increases, but magnesium stearate increases tablet friability (Bolhuis, 1981 and Chowan, 1986). Blending times with magnesium stearate should thus be carefully controlled. Croscarmellose sodium and microcrystalline cellulose are hygroscopic, especially croscarmellose sodium absorbs moisture quickly, then it swells to 4-8 times its original volume (Kibbe, 2000). With the swelling of croscarmellose sodium, the boundary strength among granules becomes weak. It makes the tablet disintegrate quickly. The general characteristics of excipients used for drug X tablets were reviewed based on the USP monograph, Handbook of Pharmaceutical Excipients (Kibbe, 2000), and Modern Pharmaceutics (Marshall et al., 1989). (1) Drug X (API, Active Pharmaceutical Ingredient) Drug X is sensitive to moisture and light, and it is poorly soluble in water. (2) Mannitol Mannitol can be used as a sweetening agent, diluent, or binder in tablets, and occurs as white, odorless, crystalline, or free-flowing granules. Figure 81 shows the structural formula of mannitol. Manniol is not hygroscopic, so it may be used with moisture sensitive active ingredients. Mannitol resists moisture sorption, even at high relative humidity as Shown in Figure 82. Granulations containing mannitol have the 177 advantage of being dried easily. Granular mannitol flows well and imparts improved flow properties to other materials. Suitable binders for preparing granulations of powdered mannitol are gelatin, methylcellulose 400, starch paste, povidone, and sorbitol. Usually, 3-6 times as much magnesium stearate or 1.5-3 times as much calcium stearate is needed for lubrication of mannitol granulations than as needed for other excipients. 12 O 10 r CH2 H l i 8 ~ HO—C—H g I 5 1- HO — C -— H I 4 r- H -— C -—- OH | 2 . H —— (I: — 0H - CH20H o‘233393525737715100 ' Behave hum (st) 0 sorption I desorption Figure 81 Structural formula of Figure 82 Moisture sorption-desorption mannitol isotherm of mannitol (Kibbe, 2000) (3) Povidone Povidone can be used as a disintegrant, dissolution aid, and tablet binder. It is a fine, white to creamy-white colored, odorless or almost odorless, hygroscopic powder. Figure 83 Shows the structural formula of povidone and Figure 84 Shows that significant amounts of moisture can be absorbed at low relative humidity. In tableting, povidone solutions are used as binders in wet-granulation processes. Povidone is also added to powder blends in dry form and granulated in situ by the addition of water, alcohol, or hydroalcoholic solutions. Povidone is used as a disintegrant and has been shown to enhance dissolution of poorly soluble drugs from solid—dosage forms. The solubility of a 178 number of poorly soluble active drugs may be increased by mixing with povidone. Povidone is freely soluble in acids, chloroform, ethanol, ketones, methanol, and water. It is practically insoluble in ether, hydrocarbons, and mineral oil. 50 § i L O mmuas-cm 8 8 _ _ .... r -l L CH CH2 .. a 101- -l l- 4 nib—{o 33 4b East? To ail—tibiae autoimmune) Figure 83 Structural formula of Figure 84 Moisture sorption isotherm of povidone povidone (Kibbe, 2000) (4) Croscarmellose sodium Croscarmellose sodium can be used as a tablet super disintegrant due to its high swelling property. When croscarmellose sodium is used in wet granulations, it is best added in both the wet and dry stages of the process (intra and extragranularly) so that the wicking and swelling ability of the disintegrant is best utilized. It is insoluble, although croscarmellose sodium rapidly swells to 4-8 times its original volume on contact with water. Thibert and Hancock (1996) observed directly the hydration behavior of croscarmellose sodium particles by using ESEM (Environmental Scanning Electron Microscopy). At 40% RH, the croscarmellose sodium particles comprised twisted fibers. Upon exposure to 80% RH the particles experienced considerable additional twisting and 179 expansion. After the RH was reduced to 40% the particles did not regain their original shape. This may be linked to the hysteresis observed in the water vapor sorption isotherm for croscarmellose sodium. (5) Microcrystalline cellulose Microcrystalline cellulose (MCC) is a purified, partially depolymerized cellulose that occurs as a white, odorless, tasteless, crystalline powder composed of porous particles. MCC can be used as a diluent, binder, or disintegrant in tablets. It is " hygroscopic and slightly soluble in 5% w/v sodium hydroxide solution, and practically insoluble in water, dilute acids, and most organic solvents. MCC has been shown to be highly porous, with strong “wicking” tendencies, so it is a good disintegrant. Also, MCC can enhance poor compression characteristics of starch (Banker and Rhodes, 1989). However, Thibert and Hancock observed that there were no changes in the particle morphology nor was there any swelling of the MCC particles after prolonged exposure to 80% RH. These results are consistent with the limited disintegrant properties of MCC and its low level of water vapor sorption. Figure 85 shows the structural formula of microcrystalline cellulose (MCC). H OH ‘ cnzorp H OH anon H H H H H OH H H 0 OH H H ‘ OH H 0- OH H H H o- OH H H H 0 H CHZOH , H on CH,0H H on J ‘- 0' II Figure 85 Structural formula of microcrystalline cellulose (MCC) 180 (6) Magnesium stearate Magnesium stearate is a fine, white, precipitated or milled, impalpable powder of low bulk density, having a faint odor of stearic acid and a characteristic taste. It can be used as a lubricant in tablets. It is practically insoluble in ethanol, ethanol (95%), ether and water, and slightly soluble in warm benzene and warm ethanol (95%). Magnesium stearate is hydrophobic and may retard the dissolution of a drug from a solid dosage form, so the lowest possible concentration should be used. Tablet dissolution rate and crushing strength decrease as the time of blending increases (Chowan, 1986). It may also increase tablet friability. Blending time with magnesium stearate should thus be carefully controlled. The structural formula is [CH3(CH2)16COO]2Mg. (7) Coating material Many tablets are now coated because this can minimize the unpleasant taste of certain medicaments, protect the ingredients against decomposition, improve the manufacturing process (no dust), and enhance the appearance. The coating material must be soluble in water. 2. Manufacturing — wet granulation The components of the formulation are mixed with a granulating liquid such as water to produce granules which will readily compress to give tablets. The wet granulated tablets are more robust than those produced by direct compression, so the content uniformity is better than with direct compression. The general purpose of wet granulation is (1) to enlarge the particle size, (2) to improve the particle Shape and make 181 it fairly spherical, (3) to make the surface of the particles and the tablet hydrophilic (to promote wetting, and consequently disintegration and dissolution), and (4) to promote compressibility (Carstensen, 1993). The disintegration of the tablet must be followed by granular disintegration in order to promote rapid dissolution and hence absorption (Banker and Rhodes, 1989). 182 Appendix D Summary Tables of Permeability, Moisture Sorption Isotherms, and Moisture Content Verification 183 1. Permeability Table 35 Moisture gain (g) of LDPE bag's using CaClyg at 40°C Leaking Days 0 7 l4 16 18 30 37 57 Test l 11.3793 11.6928 11.8640 11.9128 11.9580 12.2448 12.3765 12.8089 Pass 2 10.9961 11.2880 11.4496 11.5225 11.5463 11.8114 11.9720 12.4051 Pass 3 11.7248 12.0478 12.1979 12.2482 12.3484 12.6051 12.7953 13.2500 Pass 4 11.8688 12.2805 12.5254 12.6198 12.7951 13.3334 13.6869 14.6863 Fail 5 11.6610 12.0170 12.1322 12.1802 12.2300 12.4880 12.6593 13.0937 Pass Net Moisture Gain (g) 1 0 0.3035 0.4747 0.5235 0.5687 0.8555 0.9872 1.4196 2 0 0.2819 0.4435 0.5164 0.5402 0.8053 0.9659 1.3990 3 0 0.3130 0.4631 0.5134 0.6136 0.8703 1.0605 1.5152 4 0 0.4017 0.6466 0.7410 0.9163 1.4546 1.8081 2.8075 5 0 0.3460 0.4612 0.5092 0.5590 0.8170 0.9883 1.4227 Table 36 Moisture gain (g) of HDPE bottles using CaClz at 40°C Days 0 7 21 28 46 Leaking Test 1 45.9352 45.9550 45.9720 45.9805 46.0033 Pass 2 45.5874 45.6076 45.6245 45.6332 45.6559 Pass 3 45.6107 45.6307 45.6481 45.6567 45.6792 Pass 4 45.7392 45.7598 45.7760 45.7841 45.8062 Pass 5 45.9762 45.9962 46.0132 46.0214 46.0437 Pass Net Moisture Gain (g) 1 0 0.0072 0.02355 0.03175 0.05375 2 0 0.0076 0.02385 0.03225 0.05415 3 0 0.0074 0.02415 0.03245 0.05415 4 0 0.0080 0.02355 0.03135 0.05265 5 0 0.0074 0.02375 0.03165 0.05315 Table 37 Moisture gain (g) of HDPE bottle blanks at 40°C Days I 0 7 21 28 46 160 I Leaking Test 1 | 75.6306I 75.6430] 75.6437] 75.6440] 75.6445 | 75.6516] Pass 2 | 75.8447I 75.8575 | 75.8581 | 75.8584I 75.8595] 75.8662I Pass Net Moisture Gain (g) 7 l I 0] 0.0124] 0.0131 | 0.0134] 0.0139] 0.0210] 2 | 0| 0.0128I 0.0134] 0.0137] 0.0148] 0.0215] . Average | 0| 0.0126] 0.0132] 0.0136] 0.0143] 0.0213 I 184 2. Moisture Sorption Isotherms Table 38 Moisture sorption isotherm data of uncoated tablets at 25°C EMC (%) IMC (%) RH (%) Pi (g) Pf (g) EMC (%) using GAB equation 1 2.1 199 0.00 251.060 0 0 2 4.95 251.060 248.694 1.1574 1.1587 3 9.87 251.060 249.071 1.31 1 1 1.3713 4 14.89 251.060 249.494 1.4829 1.5100 5 19.93 251.060 249.880 1.6401 1.6326 6 25.02 251.060 250.254 1.7922 1.7561 7 29.86 251.060 250.573 1.9217 1.8805 8 35.07 251.060 250.903 2.0562 2.0275 9 40.01 251.060 251.247 2.1961 2.1837 10 44.92 251.060 251.660 2.3640 2.3608 1 1 50.13 251.060 252.317 2.6313 2.5788 12 55.14 251.060 252.996 2.9073 2.8269 13 60.06 251.060 253.788 3.2295 3.1 193 14 64.87 251.060 254.612 3.5648 3.4671 15 69.85 251.060 255.595 3.9644 3.9170 16 74.86 251.060 256.787 4.4494 4.5023 17 80.31 251.060 258.537 5.1611 5.3715 18 85.07 251.060 261.103 6.2050 6.4552 19 89.99 251.060 266.394 8.3570 8.1570 Table 39 Moisture sorption isotherm data of coated tablets at 25°C EMC (%) IMC (%) RH (%) Pi (g) Pr (g) EMC (%) using GAB equation 1 2.3410 0.00 261.593 0 0 2 5.01 261.593 259.118 1.3727 1.4217 3 10.19 261.593 259.399 1.4826 1.5500 4 14.92 261 .593 259.873 1.6678 1.6458 5 19.91 261.593 260.201 1.7963 1.7482 6 24.97 261.593 260.562 1.9376 1.8600 7 30.05 261.593 260.919 2.0773 1.9842 8 34.97 261.593 261.251 2.2073 2.1 192 9 40.02 261.593 261.584 2.3374 2.2767 10 45.04 261.593 262.010 2.5039 2.4573 1 1 49.91 261.593 262.614 2.7403 2.6611 12 55.04 261.593 263.263 2.9943 2.9147 13 59.89 261.593 264.002 3 .2833 3.2026 14 64.94 261.593 264.819 3.6030 3.5695 15 70.01 261.593 265.895 4.0241 4.0321 16 74.88 261.593 267.064 4.4813 4.6050 17 80.03 261.593 268.874 5.1895 5.4166 18 85.01 261.593 271.618 6.2628 6.5301 19 89.95 261.593 277.21 I 8.451 1 8.2021 185 Table 40 Moisture sorption isotherm data of uncoated tablets at 40°C EMC (%) IMC (%) RH (%) Pi (g) Pf (g) EMC (%) using GAB equation 1 1.9312 0.00 O 0 2 4.80 248.612 246.730 1.1597 1.1797 3 9.72 248.612 247.048 1.2902 1.3528 4 14.94 248.612 247.444 1.4526 1.4756 5 19.85 248.612 247.775 1.5880 1.5821 6 24.88 248.612 248.113 1.7267 1.6944 7 29.99 248.612 248.457 1.8680 1.8181 8 34.88 248.612 248.800 2.0083 1.9497 9 39.97 248.612 249.198 2.1717 2.1042 10 44.93 248.612 249.667 2.3641 2.2780 11 49.91 248.612 250.184 2.5758 2.4812 12 54.85 248.612 250.805 2.8304 2.7198 13 59.87 248.612 251.506 3.1177 3.0126 14 64.92 248.612 252.290 3.4392 3.3773 15 69.89 248.612 253.205 3.8145 3.8311 16 74.91 248.612 254.436 4.3191 4.4310 17 79.87 248.612 256.087 4.9962 5.2404 18 84.86 248.612 259.070 6.2189 6.4155 19 90.00 248.612 264.708 8.5305 8.3418 Table 41 Moisture sorption isotherm data of coated tablets at 40°C EMC (%) IMC (%) RH (%) Pi (g) Pr(g) EMC (%) using GAB equation 1 2.3086 0.00 0 O 2 4.94 260.046 257.524 1.3167 1.3873 3 9.82 260.046 257.896 1.4630 1.5033 4 14.78 260.046 258.276 1.6126 1.6005 5 19.95 260.046 258.630 1.7515 1.7037 6 24.98 260.046 258.972 1.8863 1.81 19 7 29.86 260.046 259.306 2.0177 1.9283 8 34.99 260.046 259.684 2.1663 2.0660 9 39.91 260.046 260.085 2.3240 2.2164 10 45.13 260.046 260.566 2.5132 2.4005 1 1 49.86 260.046 261.085 2.7177 2.5957 12 54.85 260.046 261.71 1 2.9637 2.8380 13 60.04 260.046 262.394 3.2325 3.1420 14 64.94 260.046 263.080 3.5023 3.4954 15 70.00 260.046 263.990 3.8606 3.9538 16 74.96 260.046 265.204 4.3382 4.5366 17 79.71 260.046 267.064 5.0698 5.2816 13 85.08 260.046 269.998 6.2240 6.4843 19 90.03 260.046 275.693 8.4645 8.2053 186 Table 42 Moisture sorption isotherm data of silica gel at 25°C IMC RH Pt Pr EMC EMC (%) EMC (%) (%) (%) (g) (g) (%) using Langmuir equ. using GAB equ. 1 3.031 0.00 22.04 0 0.0000 0.0000 2 5.14 22.04 22.653 5.8966 3.6003 3 .6006 3 10.12 22.04 23.183 8.3742 6.9210 6.9215 4 15.08 22.04 23.645 10.5339 10.0759 10.0764 5 20.13 22.04 24.139 12.8433 13.1423 13.1427 6 25.1 22.04 24.613 15.0591 16.0262 16.0265 7 29.97 22.04 25.132 17.4853 18.7314 18.7315 8 35.16 22.04 25.693 20.1078 21.4913 21.4912 9 39.92 22.04 26.271 22.8098 23.9178 23.9176 10 45.15 22.04 26.909 25.7922 26.4756 26.4752 1 1 49.88 22.04 27.531 28.6999 28.6968 28.6962 12 54.95 22.04 28.148 31.5842 30.9863 30.9857 13 60.02 22.04 28.719 34.2535 33.1867 33.1861 14 65.1 22.04 29.205 36.5254 35.3073 35.3067 15 69.94 22.04 29.639 38.5543 37.2536 37.2531 16 75.1 1 22.04 29.987 40.181 1 39.2571 39.2567 17 79.94 22.04 30.302 41.6536 41.0621 41.0620 13 85.16 22.04 30.598 43 .0373 42.9442 42.9445 19 90.18 22.04 30.807 44.0143 44.6904 44.691 1 20 95.25 22.04 30.921 44.5473 46.3939 46.3952 Table 43 Moisture sorption isotherm data of silica gel at 40°C IMC RH Pi Pf EMC EMC (%) EMC (%) (%) (%) (g) (g) (%) using Langmuir equ. using GAB equ. 1 0 0.00 1 10.059 0 0.0000 0.0000 2 5.28 110.059 114.359 3.9071 3.8156 3.8158 3 10.02 110.059 1 17.074 6.3734 6.9486 6.9488 4 14.85 1 10.059 1 19.634 8.6995 9.8907 9.8909 5 20.10 110.059 122.383 11.1975 12.8427 12.8427 6 25.10 110.059 125.211 13.7671 15.4362 15.4361 7 29.91 110.059 128.130 16.4188 17.7518 17.7515 8 35.08 1 10.059 131.116 19.1318 20.0687 20.0683 9 40.06 1 10.059 134.246 21.9761 22.1492 22.1486 10 45.04 1 10.059 137.269 24.7226 24.0899 24.0893 1 1 50.04 110.059 140.100 27.2948 25.9182 25.9176 12 55.05 1 10.059 142.61 1 29.5768 27.6402 27.6396 13 60.08 1 10.059 144.615 31.3973 29.2634 29.2629 14 65.16 1 10.059 146.053 32.7042 30.8067 30.8062 15 69.92 110.059 146.986 33.5516 32.1737 32.1734 16 75.02 1 10.059 147.694 34.1949 33.5600 33.5599 17 79.63 1 10.059 148.203 34.6571 34.7473 34.7475 13 84.90 110.059 148.751 35.1553 36.0360 36.0365 19 89.99 110.059 149.282 35.6378 37.2131 37.2139 20 95.38 1 10.059 149.774 36.0845 38.3987 38.4000 187 3. Verification Table 44 Moisture content of tablets in LDPE bags without silica gel as a function of storage time lnitial Afier Storage Package Product Product Total Storage time Total Product Leaking (g) (g) dry weight (g) (g) (DaYS) (g) (g) Test 1 1.1010 3.7609 3.6896 4.8619 7 3.8340 Pass 2 1.1728 3.7666 3 .6952 4.9394 14 3.8646 Pass 3 1.0943 3.7749 3 .7034 4.8692 28 3 .8970 Pass 4 1.1 199 3.7658 3.6945 4.8857 35 3.9124 Pass 5 1.1239 3.7668 3.6954 4.8907 44 3.9342 Pass 6 1.1532 3.7673 3.6959 4.9205 58 3.9450 Pass 7 1.2387 3.7752 3.7037 5.0139 82 3.9692 Pass Table 45 Moisture content of tablets and 0.5 g silica gel in LDPE bags as a function of storage time Initial Package Product Product Silica gel Silica gel (g) (g) dry weight (g) (g) dry weight (g) Total (g) 1 1.1690 3.7642 3.6929 0.5010 0.4863 5.4342 2 1.1062 3.7665 3.6951 0.5043 0.4895 5.3770 3 1.1428 3.7751 3 .7036 0.5051 0.4902 5.4230 4 1.0884 3.7569 3.6857 0.5031 0.4883 5.3484 5 1.1603 3.7672 3.6958 0.5038 0.4890 5.4313 6 1.2139 3.7800 3.7084 0.5009 0.4862 5.4948 7 1.1861 3.7698 3.6984 0.5095 0.4945 5.4654 Afier Storage Storage time Total Package Product Silica gel Leaking (DayS) (g) (g) (g) (g) Test 7 5.5825 1.1890 3.7872 0.6063 Pass 14 5.5904 1.1262 3.8242 0.6400 Pass 28 5.6985 1.1628 3.8784 0.6573 Pass 35 5.6481 1.1084 3.8790 0.6607 Pass 44 5.7413 1.1803 3.8992 0.6618 Pass 58 5.8338 1.2339 3 .9474 0.6525 Pass 82 5.8265 1.2061 3.9576 0.6628 Pass 188 Table 46 Moisture content of tablets and 1 g silica gel in LDPE bags as a function of storage time Initial Package Product Product Silica gel Silica gel _ (g) (g) dry weight (g) (g) dtxweight (g) Total (g) 1 1.1528 3.7754 3 .7039 1.0709 1.0394 5.9991 2 1.1497 3 .7707 3.6993 1.0060 0.9764 5.9264 3 1.2255 3.7788 3.7072 1.0714 1.0399 6.0757 4 1.1396 3.7715 3.7000 1.0763 1.0446 5.9874 5 1.1655 3.7666 3.6952 1.0148 0.9849 5.9469 6 1.1501 3.7645 3 .6932 1.0063 0.9767 5.9209 7 1.1657 3.7585 3 .6873 1.0533 1.0223 5.9775 Afier Storage Storage time Total Package Product Silica gel Leaking (daYS) (g) (g) (g) (g) Test 7 6.1758 1.1728 3.7712 1.2318 Pass 14 6.2051 1.1697 3 .7960 1.2394 Pass 28 6.4842 1.2455 3.8486 1.3901 Pass 35 6.4292 1 .1 596 3 .8626 1 .4070 Pass 44 6.4203 1.1855 3.8801 1.3547 Pass 58 6.4217 1.1701 3.8979 1.3537 Pass 82 6.5015 1.1857 3.9114 1.4044 Pass Table 47 Moisture content of tablets and 2 g silica gel in LDPE bags as a function of storage time Initial Package Product Product Silica gel Silica gel __ (g) (g) dry weight (Q (g) dry weiflgr) Total (g) 1 1.1897 3.7747 3.7032 2.0570 1.9965 7.0214 2 1.1550 3.7793 3.7077 2.0225 1.9630 6.9568 3 1.2203 3.7801 3 .7085 2.0346 1.9747 7.0350 4 1.1423 3.7632 3.6919 2.0053 1.9463 6.9108 5 1.1456 3.7806 3 .7090 2.0020 1.9431 6.9282 6 1.1847 3.7551 3.6840 2.0490 1.9887 6.9888 7 1.1772 3.7747 3 .7032 2.0174 1.9581 6.9693 After Storage Storage time Total Package Product Silica gel Leaking (days) (g) (g) (g) (g) Test 7 7.2059 1.2097 3.7559 2.2403 Pass 14 7.3658 1.1750 3.7760 2.4148 Pass 28 7.6107 1.2403 3.7915 2.5789 Pass 35 7.5700 1.1623 3.7925 2.6152 Pass 44 7.6159 1.1656 3.8325 2.6178 Pass 58 7.7670 1.2047 3 .8475 2.7148 Pass 82 7.8152 1.1972 3.8945 2.7235 Pass 189 Table 48 Moisture content of tablets only in HDPE bottles as a function of storage time Initial After Storage Package Product Product Total Storage time Total Product Leaking __ (g) (g) dry weight (g) (g) (days) (g) (g) Test 1 13.8743 3.7781 3.7065 17.6524 14 3.7885 Pass 2 13.9523 3.7743 3.7028 17.7266 35 3.7989 Pass 3 13.9853 3.7759 3.7044 17.7612 58 3.8085 Pass 4 13.9199 4.0327 3.9563 17.9526 83 4.0716 Pass 5 13.8608 3.7972 3.7253 17.6580 103 3.8501 Pass 6 13.9392 3.7796 3.7080 17.7188 135 3.8432 Pass 7 13.9496 3.7759 3 .7044 17.7255 160 3.8472 Pass Table 49 Moisture content of tablets and 0.5 g Silica gel in HDPE bottles as a function of storage time Initial Package Product Product Silica gel Silica gel _ (g) (g) dngeight (g) (g) dry weight (g) Total (g) 1 13.9370 3.7643 3.6930 0.5032 0.4884 18.2045 2 13.9006 3.7762 3.7047 0.5004 0.4857 18.1772 3 13.8637 3.7689 3.6975 0.5010 0.4863 18.1336 4 13.9122 3.7789 3.7073 0.5040 0.4892 18.1951 5 13.9266 3 .7700 3.6986 0.5038 0.4890 18.2004 6 13.8595 3.7863 3.7146 0.5038 0.4890 18.1496 7 13.8869 3.7761 3.7046 0.5022 0.4874 18.1652 After Storage Storage time Total Package Product Silica gel (days) (5) (g) (g) (g) Leaking Test 14 18.2315 13.9498 3.7431 0.5386 Pass 35 18.2260 13.9147 3.7578 0.5535 Pass 58 18.2176 13.8792 3.7601 0.5783 Pass 83 18.2931 13.9292 3.7730 0.5909 Pass 103 18.3146 13.9448 3.7751 0.5947 Pass 135 18.2801 13.8796 3.7973 0.6032 Pass 160 18.3105 13.9085 3.7962 0.6058 Pass 190 Appendix E Dissolution Raw Data and Dissolution Profiles at 25°C 191 1. Dissolution raw data Table 50 Initial dissolution raw data of uncoated tablets Stirring time Number of trial (minuteS) 1 I 2 ] 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.4065] 0.4846] 0.5200] 0.5287] 0.5019] 0.4597 20 0.5595] 0.5688] 0.5657I 0.5707] 0.5587I 0.5676 30 0.5724] 0.5753] 0.5715] 0.5783] 0.5684] 0.5772 % Dissolved 10 68.23] 81.38] 87.34] 88.79] 84.28] 77.18 81.20 7.603 20 93.71] 95.39] 94.94] 95.79] 93.75] 95.16 94.79 0.868 30 95.85I 96.46] 95.90] 97.05] 95.34] 96.74 96.23 0.635 Table 51 Initial dissolution raw data of coated tablets Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 7 7 10 0.3677I 0.3754] 0.1924] 0.3538] 0.4342 I 0.0965 20 0.5705] 0.5785I 0.5791] 0.5700] 0.5762] 0.5577 30 0.5768] 0.5807] 0.5361] 0.5782I 0.5830] 0.5864 % Dissolved 10 61.71] 63.00I 32.22] 59.37] 72.90] 16.09 50.88 21.82 20 95.48I 96.83] 96.63] 95.38] 96.55] 92.90 95.63 1.470 30 96.52] 97.19] 89.53I 96.74] 97.67] 97.63 95.88 3.144 Table 52 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/90% Stirring time Number of trial (minuteS) 1| 2] 3] 4] 5| 6 Average SD 7 7 . Absorbance 10 0.4697] 0.5088 | 0.5177] 0.5096] 0.5096] 0.5165 20 0.5478] 0.5707] 0.5686] 0.5578] 0.56721 0.5729 30 0.5737] 0.5837] 0.5760I 0.5739] 0.5734] 0.5848 7 I % Dissolved I 10 78.87I 85.45 | 86.94] 85.59] 85.58] 86.74 84.86 3.004 20 91.88] 95.75] 95.42] 93.62] 95.18] 96.13 94.66 1.614 30 96.15] 97.90] 96.64] 96.27I 96.20I 98.10 96.88 0.888 Table 53 Dissolution raw data of coated tablets stored for 1 month at 40°C/90% Stirring time Number of trial (minuteS) 1 | 2 | 3 I 4 I 5 I 6 Average SD Absorbance 10 0.3739] 0.4833] 0.414] 0.5039] 0.4767] 0.4907 20 0.5545] 0.5441] 0.5595] 0.5660] 0.5551] 0.5545 30 0.5858I 0.5602I 0.5822I 0.5781I 0.5722] 0.5709 1 % Dissolved 10 62.75] 81.15] 69.50] 84.62] 80.04I 82.40 76.74 8.633 20 92.83] 91.29] 93.72] 94.97] 93.10] 93.03 93.16 1.204 30 98.00] 93.94] 97.47] 96.97] 95.92] 95.73 96.34 1.463 192 Table 54 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/75% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD 7 7 Absorbance 10 0.1146] 0.1131] 0.2890] 0.2109] 0.2359] 0.1463 20 0.4007] 0.4257] 0.5018I 0.4862] 0.5013] 0.4423 30 0.5020] 0.5047] 0.5343] 0.5189] 0.5500] 0.5106 1 % DiSSolved 7 10 19.13] 18.88] 48.47I 35.33] 39.54] 24.46 30.97 12.062 20 66.78] 70.93] 83.90] 81.18I 83.74] 73.76 76.72 7.236 30 83.48I 83.96I 89.27] 86.57] 91.77] 85.02 86.68 3.255 Table 55 Dissolution raw data of coated tablets stored for 1 month at 40°C/75% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.0609 I 0.0241] 0.0435 I 0.0285] 0.0194] 0.0255 20 0.3616] 0.0652I 0.3154] 0.3655I 0.2450] 0.1655 30 0.4913] 0.3483I 0.4857I 0.5075] 0.4425 I 0.4588 % Dissolved 10 10.10] 3.90] 7.17] 4.64] 3.11] 4.15 5.51 2.638 20 60.17] 10.74] 52.45] 60.77] 40.69I 27.46 42.05 19.910 30 81.57] 57.42] 80.53] 84.18I 73.25] 75.81 75.46 9.689 Table 56 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/65% Stirring time Number Of 17181 (minutes) 1 | 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 7 10 0.2179] 0.1698] 0.2293] 0.2457] 0.1708] 0.2030 20 0.4913] 0.4690] 0.5011] 0.4999] 0.4934] 0.4873 30 0.5326] 0.5242] 0.5456] 0.5438I 0.5269] 0.5237 % Dissolved 10 36.50] 28.4II 38.42] 41.18] 28.59I 34.00 34.52 5.220 20 82.04I 78.25] 83.70] 83.52I 82.32] 81.35 81.86 1.984 30 88.85] 87.35] 91.02] 90.75] 87.84I 87.35 88.86 1.666 Table 57 Dissolution raw data of coated tablets stored for 1 month at 40°C/65% Stirring time Number of trial (1111110185) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.0157] 0.0200] 0.0317] 0.0384] 0.0176I 0.0182 20 0.1068] 0.2162] 0.1604] 0.2604] 0.0483I 0.0395 30 0.3701] 0.3948] 0.4399] 0.4699] 0.3193] 0.0745 % Dissolved 10 2.49] 3.21] 5.18] 6.30] 2.81] 2.91 3.82 1.549 20 17.66I 35.90] 26.62] 43.29] 7.92] 6.45 22.97 14.973 30 61.07] 65.33] 72.70] 77.82] 52.60] 12.22 56.96 23.622 193 Table 58 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/50% Stin'ing time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 7 10 0.3926] 0.3456] 0.4145] 0.4895] 0.3730] 0.3206 20 0.5509] 0.5342] 0.5532] 0.5550] 0.5578] 0.5378 30 0.5685] 0.5498] 0.5665] 0.5687] 0.5732] 0.5589 % Dissolved 10 65.90] 57.98] 69.57] 82.20] 62.60I 53.79 65.34 9.976 20 92.27] 89.41] 92.68] 93.11] 93.39] 89.96 91.80 1.694 30 95.16] 91.97] 94.88] 95.37] 95.92] 93.43 94.46 1.476 Table 59 Dissolution raw data of coated tablets stored for 1 month at 40°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.0236] 0.0354] 0.0227] 0.0238] 0.0209] 0.0352 20 0.1808] 0.1956] 0.0670] 0.1729] 0.1151] 0.2843 30 0.4506] 0.4846] 0.3995] 0.4704] 0.4417] 0.4590 1 % Dissolved 10 3.82] 5.81] 3.66] 3.85] 3.37] 5.77 4.38 1.105 20 29.99] 32.48] 11.05] 28.69I 19.06] 47.26 28.09 12.351 30 74.48] 80.14] 65.87I 77.73] 72.90] 76.07 74.53 4.934 Table 60 Dissolution raw data of uncoated tablets stored for 1 month at 40°C/0% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.3537] 0.3793] 0.3809] 0.4063] 0.4440] 0.3652 20 0.5557] 0.5670] 0.5693] 0.5708I 0.5734] 0.5786 30 0.5729] 0.5757] 0.5745] 0.5809] 0.5807] 0.5869 % Dissolved 7 10 59.35] 63.65] 63.93] 68.20] 74.58] 61.29 65.17 5.487 20 92.99] 94.92] 95.30] 95.61] 96.10] 96.83 95.29 1.307 30 95.83] 96.36] 96.16] 97.27] 97.31] 98.20 96.86 0.890 Table 61 Dissolution raw data of coated tablets stored for 1 month at 40°C/0% Stirring time Number of trial (minuteS) 1 ] 2 | 3 I 4 I 5 I 6 Avergge SD ' Absorbance 10 0.3537] 0.2786] 0.3278I 0.3102] 0.1825] 0.2527 20 0.5561] 0.5674] 0.5624] 0.5716] 0.5652] 0.5750 30 0.5754] 0.5808] 0.5712] 0.5779] 0.5763] 0.5831 % Dissolved 10 59.36] 46.72] 54.99] 52.04] 30.55] 42.36 47.67 10.311 20 93.07] 94.82] 94.08] 95.57] 94.29] 96.04 94.64 1.073 30 96.25] 97.03] 95.51] 96.61] 96.13] 97.38 96.48 0.670 194 Table 62 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/90% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Avera e SD 7 Absorbance 10 0.5340] 0.5316] 0.5475] 0.5392 I 0.5469] 0.5258 20 0.5635] 0.5588I 0.5736I 0.5661] 0.5708] 0.5550 30 0.5728] 0.5673] 0.5833I 0.5767I 0.5757] 0.5612 7 % Dissolved 10 89.69] 89.28] 91.96] 90.55] 91.86] 88.30 90.3 1.462 20 94.6] 93.8] 96.3I 95.0] 95.8I 93.2 94.8 1.191 30 96.1] 95.2] 97.9] 96.8] 96.6] 94.2 96.1 1.294 Table 63 Dissolution raw data of coated tablets stored for 1 month at 25°C/90% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Averae SD Absorbance 10 0.5528 I 0.5540] 0.5498] 0.5608] 0.5625] 0.5556 20 0.5686] 0.5728] 0.5704] 0.5762] 0.5744] 0.5782 30 0.5733] 0.5789] 0.5726I 0.5824] 0.5787I 0.5822 1 % Dissolved 10 92.86] 93.06] 92.35] 94.20] 94.49] 93.33 93.4 0.817 20 95.5] 96.2] 95.8] 96.8] 96.5] 97.1 96.3 0.601 30 96.3] 97.2] 96.1] 97.8] 97.2] 97.7 97.0 0.707 Table 64 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/75% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.5598] 0.5500] 0.5634] 0.5594] 0.5572] 0.5470 20 0.5806] 0.5721] 0.5737 I 0.5723] 0.5678I 0.5620 30 0.5872] 0.5780] 0.5770] 0.5770] 0.5728] 0.5650 , %Dissolved 7 7 10 94.03] 92.38] 94.64] 93.95] 93.58] 91.88 93.4 1.062 20 97.5] 96.1] 96.4] 96.1] 95.4] 94.4 96.0 1.042 30 98.6] 97.0] 96.9] 96.9] 96.2] 94.9 96.8 1.191 Table 65 Dissolution raw data of coated tablets stored for 1 month at 25°C/75% Stirring time Number of trial (minutes) 1 I 2 | 3 I 4 I 5 I 6 Avera e SD Absorbance 7 10 0.5018] 0.4577] 0.4737] 0.2351] 0.5411] 0.5636 20 0.5661] 0.5875] 0.5819] 0.5794] 0.5709] 0.5718 30 0.5710] 0.5931] 0.5879] 0.5860] 0.5734] 0.5762 % Dissolved 7 7 10 84.27I 76.84] 79.55] 39.40] 90.88] 94.67 77.6 19.880 20 95.0] 98.5] 97.6] 96.7] 95.8] 96.0 96.6 1.261 30 95.8I 99.4] 98.5I 97.8] 96.3I 96.8 97.4 1.399 195 Table 66 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 10 0.5458] 0.5527] 0.5463] 0.5460] 0.5509] 0.5422 20 0.5767] 0.5709] 0.5778 1 0.5679] 0.5708] 0.5818 30 0.5811] 0.5760] 0.5849] 0.5767] 0.5780] 0.5853 %Dissolved 7 10 91.67] 92.84] 91.76] 91.70] 92.54] 91.06 91.9 0.647 20 96.8] 95.9] 97.0] 95.4] 95.8] 97.7 96.4 0.875 30 97.5] 96.7] 98.2] 96.8I 97.0] 98.2 97.4 0.687 Table 67 Dissolution raw data of coated tablets stored for 1 month at 25°C/65% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 7 10 0.5259] 0.3704] 0.4167I 0.4045] 0.2629I 0.0729 20 0.5453] 0.5665] 0.5703] 0.5776] 0.5805] 0.5558 30 0.5681] 0.5847] 0.5739] 0.5855] 0.5863] 0.5775 1 % Dissolved I 10 88.32] 62.17] 69.95] 67.91] 44.07] 12.12 57.4 26.363 20 91.6] 94.8I 95.5] 96.7] 97.0] 92.5 94.7 2.214 30 95.3] 97.8I 96.1] 98.0] 97.9] 96.1 96.9 1.176 Table 68 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/50% Stirring time Number Of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 10 0.5214] 0.5364] 0.5581] 0.5328I 0.5333] 0.5445 20 0.5690] 0.5653] 0.5759] 0.5750] 0.5749] 0.5697 30 0.5775] 0.5730] 0.5809] 0.5789] 0.5770] 0.5749 7 %Dissolved 7 77 10 87.57] 90.10] 93.73] 89.48] 89.58] 91.46 90.3 2.088 20 95.5] 94.9] 96.7] 96.5] 96.5] 95.6 96.0 0.723 30 96.9] 96.2] 97.5] 97.2I 96.8I 96.5 96.9 0.477 Table 69 Dissolution raw data of coated tablets stored for 1 month at 25°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.3319] 0.0929] 0.2139] 0.2264] 0.4708] 0.1924 20 0.5702] 0.5410] 0.5890] 0.5836] 0.5638] 0.5593 30 0.5873 I 0.5679I 0.5949] 0.5983] 0.5715] 0.5735 %Dissolved 10 55.69] 15.47] 35.83] 37.94] 79.06] 32.22 42.7 21.964 20 95.4] 90.1] 98.3] 97.4] 94.5] 93.3 94.8 2.958 30 98.2] 94.5] 99.3] 99.8] 95.8] 95.7 97.2 2.177 196 Table 70 Dissolution raw data of uncoated tablets stored for 1 month at 25°C/0% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.3577] 0.4806] 0.4195] 0.3970] 0.3735] 0.3481 20 0.5619] 0.5717] 0.5819I 0.5774] 0.5757] 0.5774 30 0.5825] 0.5779] 0.5892] 0.5828] 0.5796I 0.5824 7 * %DisSolved 10 60.02] 80.70I 70.42] 66.64] 62.69] 58.41 66.5 8.233 20 94.0] 95.9] 97.5] 96.7] 96.4] 96.6 96.2 1.169 30 97.4] 96.9] 98.7I 97.6] 97.0] 97.4 97.5 0.635 Table 71 Dissolution raw data of coated tablets stored for 1 month at 25°C/0% Stirring time Number of trial (minutes) 1 I 2 ] 3 ’I 4 I 5 I 6 Averagg SD Absorbance 10 0.2047] 0.3557] 0.2964] 0.1247] 0.1951] 0.3762 20 0.5836] 0.5686] 0.5721] 0.5640I 0.5832] 0.5636 30 0.5968] 0.5711] 0.5789] 0.5729] 0.5923] 0.5678 %Dissolved ' 10 34.28I 59.69] 49.71] 20.83I 32.68I 63.13 43.4 16.745 20 97.4] 95.2] 95.6] 94.0] 97.3] 94.3 95.6 1.449 30 99.6] 95.6] 96.8] 95.5] 98.8I 95.0 96.9 1.900 Table 72 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/90% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.3798] 0.3650I 0.4209] 0.4650] 0.4404] 0.4672 20 0.5169] 0.5022] 0.5194] 0.5330] 0.5244] 0.5421 30 0.5517] 0.5330] 0.5439] 0.5463] 0.5470] 0.5495 %Dissolved 10 63.74I 61.25] 70.67I 78.08] 73.94] 78.44 71.02 7.239 20 86.59] 84.11] 87.06] 89.40I 87.93], 90.92 87.67 2.361 30 92.32] 89.19] 91.11] 91.59] 91.65] 92.15 91.33 1.135 Table 73 Dissolution raw data of coated tablets stored for 2 months at 40°C/90% Stirring time Number of trial (MINES) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.4153] 0.2295] 0.3584] 0.3664I 0.4144] 0.3978 20 0.5165] 0.4744] 0.5142] 0.5011] 0.5213 @5183 30 0.5438] 0.5277] 0.5460 L0.5301| 0.5476] 0.5464 1 % Dissolved 10 69.71] 38.46] 60.14] 61.49] 69.56] 66.78 61.02 11.761 20 86.58] 79.24] 86.10] 83.93] 87.38I 86.85 85.01 3.067 30 91.07] 88.03] 91.33] 88.71] 91.70] 91.47 90.39 1.588 197 Table 74 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/75% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 10 0.1058] 0.0765] 0.0851] 0.1028] 0.0937] 0.1401 20 0.3867] 0.3843I 0.4105] 0.3607I 0.3696] 0.4363 30 0.4895] 0.4700] 0.4894] 0.4673] 0.4650] 0.5016 %Dissolved I 10 17.64] 12.73] 14.17] 17.14] 15.61] 23.43 16.78 3.732 20 64.44] 63.99I 68.36] 60.10I 61.56] 72.76 65.20 4.655 30 81.39] 78.12I 81.38I 77.68] 77.29] 83.52 79.89 2.546 Table 75 Dissolution raw data of coated tablets stored for 2 months at 40°C/75% Stirring time Number of trial (minutes) 1 I 2 | 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.0171] 0.0028I 0.0048] 0.0225] 0.0157] 0.0036 20 0.1354] 0.0164] 0.0657] 0.2832] 0.0220] 0.2446 30 0.4002] 0.2451] 0.4185] 0.4273] 0.2977] 0.4034 1 %Dissolved , I 10 2.73] 0.32] 0.65] 3.64] 2.49] 0.46 1.71 1.413 20 22.42] 2.59] 10.79] 47.06] 3.54] 40.59 21.16 19.040 30 66.08] 40.28] 68.96] 70.82] 48.99] 66.77 60.32 12.566 Table 76 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 7 10 0.0947] 0.1070] 0.1044] 0.1334] 0.0885] 0.0937 20 0.3008] 0.3278] 0.3879] 0.4350] 0.2179] 0.2755 30 0.4469I 0.4251] 0.4663] 0.4936] 0.3731] 0.3414 7 %Dissolved 10 15.77]. 17.84] 17.40] 22.29] 14.73] 15.62 17.28 2.720 20 50.10] 54.63] 64.63] 72.53] 36.28] 45.90 54.01 13.050 30 74.20] 70.67I 77.56] 82.19] 61.88] 56.75 70.54 9.629 Table 77 Dissolution raw data of coated tablets stored for 2 months at 40°C/65% Stirring time Number of trial (1111110165) 1 I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 7 10 0.0296 U.0256I 0.0215] 0.0201] 0.0229] 0.0192 20 0.0396] 0.0430] 0.0805I 0.0389] 0.1309] 0.2603 30 0.2632] 0.2145] 0.3239] 0.2169] 0.3539] 0.4435 %Dissolved 10 4.83] 4.15] 3.47] 3.23] 3.70] 3.08 3.74 0.654 20 6.49] 7.05] 13.30] 6.36] 21.69] 43.24 16.35 14.451 30 43.37] 35.33] 53.42] 35.71] 58.46] 73.44 49.96 14.808 198 Table 78 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 7 10 0.1244] 0.1731] 0.2085] 0.2121] 0.1852] 0.1728 20 0.4073] 0.4503] 0.4529 I 0.4534] 0.4389I 0.4467 30 0.4509] 0.4836] 0.4994] 0.4847I 0.4850] 0.4862 %Dissolved 7 10 20.77] 28.97] 34.93] 35.53] 31.01] 28.93 30.02 5.354 20 67.89] 75.13] 75.62] 75.71] 73.26] 74.53 73.69 2.981 30 75.08] 80.62I 83.30I 80.89] 80.86I 81.05 80.30 2.741 Table 79 Dissolution raw data of coated tablets stored for 2 months at 40°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.0085] 0.0124] 0.0052] 0.0091] 0.0113] 0.0118 20 0.1757] 0.1560] 0.4489] 0.0543] 0.1866I 0.2139 30 0.4034] 0.3699] 0.5322] 0.4364] 0.3799] 0.3737 % Dissolved I 10 1.28] 1.94] 0.72] 1.38] 1.75] 1.83 1.48 0.455 20 29.12] 25.85] 74.63] 8.90I 30.95] 35.49 34.16 21.827 30 66.66I 61.12] 88.35] 71.91] 62.81I 61.84 68.78 10.391 Table 80 Dissolution raw data of uncoated tablets stored for 2 months at 40°C/0% Stirring time Number of trial (minUtes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.3132] 0.3224] 0.3405] 0.3263I 0.3568] 0.3523 20 0.5359] 0.5325] 0.5407] 0.5316I 0.5414] 0.5289 30 0.5455] 0.5428] 0.5434] 0.5384I 0.5422] 0.5304 %Dissolved I 10 52.54] 54.08] 57.13] 54.74] 59.87] 59.11 56.25 2.927 20 89.63] 89.08] 90.48] 88.94I 90.63 I 88.53 89.55 0.856 30 91.22 F9079] 90.93] 90.06] 90.76] 88.78 90.42 0.888 Table 81 Dissolution raw data of coated tablets stored for 2 months at 40°C/0% Stirring time Number of trial (minutes) 1 I 2 ] 3 I 4 | 5 I 6 Average SD 7 Absorbance 10 0.2389] 0.2300] 0.1606] 0.1198] 0.0988] 0.2447 20 0.5421] 0.5412] 0.5311] 0.5523] 0.5336] 0.5442 30 0.5493] 0.5546] 0.5384] 0.5676] 0.5532] 0.5554 1 %Dissolved , 10 40.04] 38.55] 26.87] 20.00] 16.46] 41.01 30.49 10.832 20 90.55 F 90.37] 88.57] 92.03] 88.89I 90.90 90.22 1.292 30 91.72] 92.59] 89.78] 94.56I 92.11] 92.75 92.25 1.555 199 Table 82 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/90% Stirring time Number of trial (minutes) 1 I 2 I 3 ] 4 I 5 I 6 Averagg SD Absorbance 10 0.5353] 0.5472] 0.5389] 0.5515] 0.5467] 0.5488 20 0.5666] 0.5661] 0.5655] 0.5683I 0.5636I 0.5669 30 0.5782I 0.5709] 0.5750] 0.5728I 0.5679I 0.5718 7 %Dissolved I 10 89.91I 91.90] 90.51] 92.62] 91.83I 92.17 91.49 1.048 20 95.11] 95.05] 94.93] 95.44] 94.63] 95.20 95.06 0.271 30 97.03] 95.85] 96.50] 96.17] 95.35] 96.00 96.15 0.575 Table 83 Dissolution raw data of coated tablets stored for 2 months at 25°C/90% Stirring time Number Of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Avegg: SD Absorbance 10 0.5427] 0.5438] 0.5531] 0.5494] 0.5701] 0.5558 20 0.5669] 0.5596] 0.5759] 0.5731] 0.5754] 0.5767 30 0.5700] 0.5683] 0.5816] 0.5723] 0.5788I 0.5822 % Dissolved , 10 91.15] 91.33] 92.90] 92.27] 95.76] 93.35 92.79 1.687 20 95.18] 93.97] 96.70] 96.22I 96.65] 96.84 95.93 1.136 30 95.68] 95.40] 97.64] 96.09] 97.21] 97.74 96.63 1.027 Table 84 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/75% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Averaje SD 7 Absorbance 10 0.5446] 0.5480] 0.5544] 0.5565] 0.5502 I 0.5556 20 0.5750] 0.5685] 0.5701] 0.5698] 0.5710] 0.5700 30 0.5781 I 0.5714] 0.5740] 0.5729] 0.5754] 0.5760 1 %Dissolved 10 91.47] 92.05] 93.12] 93.47] 92.41] 93.33 92.64 0.796 20 96.54] 95.46] 95.74] 95.69] 95.88] 95.71 95.84 0.368 30 97.05] 95.94] 96.38] 96.19] 96.60] 96.71 96.48 0.394 Table 85 Dissolution raw data of coated tablets stored for 2 months at 25°C/75% Stirring time Number of trial (minutes) 1 I 2 ] 3 I 4 I 5 I 6 Average SD Absorbance 10 0.3726] 0.4290] 0.4652] 0.5070] 0.4862I 0.5384 20 0.5747] 0.5477] 0.5661] 0.5616] 0.5673] 0.5662 30 0.5803I 0.5799] 0.5744] 0.5679J 0.5801] 0.5741 7 %Dissolved I 10 62.53I 72.03] 78.10] 85.15] 81.64] 90.43 78.31 9.934 20 96.20] 91.79] 94.91] 94.24] 95.15] 95.05 94.56 1.496 30 97.12] 97.10] 96.29] 95.28I 97.26] 96.36 96.57 0.754 200 Table 86 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/65% Stirring time Number of trial (minutes) 1 I 2 J 3 I 4 I 5 I 6 Average so Absorbance 7 10 0.4999] 0.5131] 0.5053] 0.5137] 0.5174] 0.4799 20 0.5346] 0.5398] 0.5446] 0.5334] 0.5279] 0.5331 30 0.5330] 0.5386] 0.5477] 0.5351] 0.5341] 0.5434 7 %Dissolved 10 83.95] 86.18] 84.86] 86.28] 86.89] 80.58 84.79 2.322 20 89.72] 90.61] 91.41] 89.55] 88.64] 89.45 89.90 0.974 30 89.46] 90.42] 91.92] 89.84] 89.67] 91.14 90.41 0.958 Table 87 Dissolution raw data of coated tablets stored for 2 months at 25°C/65% Stirring time Number Of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 10 0.1695] 0.0159] 0.3646] 0.2401] 0.4130] 0.0441 20 0.5382] 0.5417] 0.5384] 0.5497] 0.5340] 0.5446 30 0.5508] 0.5480] 0.5441] 0.5555] 0.5413] 0.5584 %Dissolved 10 28.37] 2.53] 61.18] 40.24] 69.33] 7.27 34.82 27.419 20 89.77] 90.09] 90.13] 91.80] 89.48] 90.62 90.31 0.823 30 91.85] 91.13] 91.07] 92.77] 90.69] 92.90 91.74 0.931 Table 88 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/50% Stirring time Number Of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 7 Absorbance 10 0.5306] 0.5694] 0.5699] 0.5500] 0.5599] 0.5207 20 0.5700 F 0.5808] 0.5735] 0.5751] 0.5711] 0.5590 30 0.5760] 0.5853] 0.5800] 0.5821] 0.5777] 0.5708 7 I %Dissolved 7 10 89.11] 95.65] 95.73] 92.38] 94.04] 87.45 92.39 3.453 20 95.68] 97.54] 96.32] 96.56] 95.91] 93.83 95.97 1.234 30 96.66] 98.28] 97.39] 97.71] 96.99] 95.77 97.14 0.873 Table 89 Dissolution raw data of coated tablets stored for 2 months at 25°C/50% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 10 0.3814] 0.2371] 0.3502] 0.1131] 0.3438] 0.4319 20 0.5668] 0.5778] 0.5702] 0.5086] 0.5752] 0.5739 30 0.5724] 0.5796] 0.5751] 0.5408] 0.5874] 0.5841 %Dissolved 10 64.01] 39.74] 58.77] 18.87] 57.69] 72.50 51.93 19.446 20 94.88] 96.49] 95.40] 84.74] 96.23] 96.15 93.98 4.566 30 95.82] 96.78] 96.21] 90.06] 98.24] 97.84 95.82 2.972 201 Table 90 Dissolution raw data of uncoated tablets stored for 2 months at 25°C/0% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Averae so 7 Absorbance 10 0.3957] 0.3955] 0.4178] 0.4242] 0.3904] 0.3841 20 0.5706] 0.5718] 0.5746] 0.5685] 0.5786] 0.5710 30 0.5807] 0.5793] 0.5784] 0.5757] 0.5877] 0.5828 7 %Dissolved 10 66.41] 66.39] 70.14] 71.21] 65.52] 64.47 67.36 2.689 20 95.54] 95.74] 96.25] 95.24] 96.87] 95.60 95.88 0.587 30 97.21] 96.98] 96.87] 96.44] 98.38] 97.53 97.24 0.667 Table 91 Dissolution raw data of coated tablets stored for 2 months at 25°C/0% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.2369] 0.3447] 0.2596] 0.3483] 0.1093] 0.1025 20 0.5694] 0.5748] 0.5954] 0.5746] 0.5691] 0.5441 30 0.5726] 0.5820] 0.5893] 0.5798] 0.5805] 0.5865 7 %Dissolved 10 39.70] 57.83] 43.51] 58.45] 18.24] 17.08 39.14 18.249 20 95.08] 96.16] 99.45] 96.14] 94.82] 90.65 95.38 2.847 30 95.61] 97.35] 98.45] 96.99] 96.70] 97.64 97.12 0.954 Table 92 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/90% Stirring time Number Of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance ' 10 0.4412] 0.4009] 0.4099] 0.3733] 0.3793] 0.4480 20 0.5310] 0.5083] 0.5210] 0.4998] 0.4887] 0.5281 30 0.5598] 0.5453 I 0.5536] 0.5382] 0.5334] 0.5481 7 %Dissolved 7 10 74.07] 67.30] 68.81] 62.65] 63.67] 75.22 68.62 5.201 20 89.02] 85.17] 87.31] 83.73] 81.88] 88.56 85.95 2.836 30 93.77] 91.28] 92.68] 90.04] 89.26] 91.85 91.48 1.666 Table 93 Dissolution raw data of coated tablets stored for 3 months at 40°C/90% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.3580] 0.2260] 0.3109] 0.0543] 0.3575] 0.2876 20 0.5105] 0.4494] 0.5194] 0.3896] 0.4899] 0.4889 30 0.5532] 0.5241] 0.5682] 0.5054] 0.5357] 0.5400 %Dissolved 10 60.08] 37.87] 52.15] 8.99] 59.99] 48.24 44.55 19.288 20 85.47] 75.09] 86.87] 64.83] 82.04] 81.76 79.34 8.197 30 92.51] 87.39] 94.92] 83.91] 89.59] 90.19 89.75 3.853 202 Table 94 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/75% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 7 10 0.0692] 0.1048] 0.1007] 0.1608] 0.1286] 0.1242 20 0.2379] 0.3960] 0.3972] 0.4445] 0.3923] 0.3778 30 0.4401] 0.4935] 0.4964] 0.5249] 0.4860] 0.4776 % Dissolved 10 11.49] 17.48] 16.78] 26.90] 21.48] 20.74 19.15 5.199 20 39.58] 65.93] 66.17] 74.15] 65.40] 62.97 62.37 11.786 30 72.93] 82.06] 82.53] 87.41] 80.85] 79.44 80.87 4.733 Table 95 Dissolution raw data of coated tablets stored for 3 months at 40°C/75% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.0438] 0.0178] 0.0487] 0.0276] 0.0167] 0.0169 20 0.0982] 0.0374] 0.4051] 0.2999] 0.0373] 0.0309 30 0.4201] 0.2803] 0.4965] 0.4488] 0.2755] 0.2891 7 %Dissolved 7 10 7.22] 2.84] 8.04] 4.49] 2.66I 2.68 4.65 2.416 20 16.27] 6.10] 67.40] 49.85] 6.10] 5.02 25.12 26.850 30 69.34] 46.16] 82.47] 74.40] 45.36] 47.59 60.89 16.460 Table 96 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/65% Stirring time Number of trial (minutes) 1 I 2 L 3 I 4 I 5 I 6 Avera e so 7 7 Absorbance 10 0.0707] 0.0634] 0.0784] 0.0725] 0.0739] 0.0692 20 0.3165] 0.1977] 0.2880] 0.3364] 0.3456] 0.1376 30 0.4215] 0.3283] 0.3756] 0.4540] 0.4275 I 0.1922 %Dissolved 10 11.75] 10.51] 13.04] 12.04] 12.28] 11.49 11.85 0.847 20 52.68] 32.89] 47.95] 56.00] 57.53] 22.87 44.99 14.014 30 69.99] 54.41] 62.39] 75.38] 71.03] 31.89 60.85 16.005 Table 97 Dissolution raw data of coated tablets stored for 3 months at 40°C/65% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.0139] 0.0163] 0.0211] 0.0164] 0.0178] 0.0231 20 0.0326] 0.0359] 0.0441] 0.0364] 0.0434] 0.1951 30 0.2732] 0.2262 I 0.3344] 0.2721] 0.0735] 0.4013 %Dissolved 10 2.18] 2.59] 3.40] 2.60] 2.84] 3.74 2.89 0.575 20 5.31] 5.86] 7.23] 5.94] 7.11] 32.38 10.64 10.678 30 44.97] 37.24] 55.10] 44.80] 12.07] 66.39 43.43 18.379 203 Table 98 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/50% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.1669] 0.1313] 0.0921] 0.1088] 0.0947] 0.2359 20 0.4216] 0.3408] 0.2946] 0.4058] 0.1774] 0.4595 30 0.4888] 0.4440] 0.3655] 0.4826] 0.2148] 0.5043 7 "/6 Dissolved 7 10 27.92] 21.93] 15.35] 18.16] 15.78] 39.54 23.11 9.305 20 70.35] 56.82] 49.06] 67.61 I 29.56] 76.78 58.37 17.245 30 81.42] 73.85] 60.76] 80.28I 35.72] 84.16 69.36 18.488 Table 99 Dissolution raw data of coated tablets stored for 3 months at 40°C/50% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 10 0.0250] 0.0213] 0.0319] 0.0177] 0.0522] 0.0263 20 0.2823] 0.1861] 0.1384] 0.0425] 0.2148] 0.2607 30 0.4489] 0.3064] 0.3792] 0.2883] 0.3929] 0.4406 7 "/6 Dissolved 10 4.06] 3.43] 5.21] 2.83] 8.62] 4.27 4.74 2.066 20 46.91] 30.88] 22.95] 6.96] 35.71] 43.31 31.12 14.625 30 74.38] 50.71 I 62.65] 47.49] 65.08] 72.98 62.21 11.149 Table 100 Dissolution raw data of uncoated tablets stored for 3 months at 40°C/0% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 7 10 0.3255] 0.4356] 0.4508] 0.3949] 0.4168] 0.4218 20 0.5625 I 0.5698] 0.5733] 0.5725] 0.5727] 0.5654 30 0.5800] 0.5755] 0.5790] 0.5808] 0.5807] 0.5772 7 7 %Dissolved 7 10 54.60] 73.13] 75.68] 66.2fl 69.97] 70.82 68.42 7.464 20 94.09] 95.49] 96.10] 95.87] 95.93] 94.73 95.37 0.794 30 96.97] 96.42] 97.04] 97.24] 97.25] 96.68 96.93 0.328 Table 101 Dissolution raw data of coated tablets stored for 3 months at 40°C/0% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.1588] 0.1404] 0.1819] 0.1098] 0.0811] 0.1220 20 0.5394] 0.5572] 0.5506] 0.5513] 0.4910] 0.5411 30 0.5554] 0.5585] 0.5647] 0.5590] 0.5366] 0.5691 %Dissolved I 10 26.57] 23.47] 30.45] 18.31] 13.50] 20.38 22.11 6.048 20 89.96] 92.90] 91.85] 91.85] 81.76] 90.18 89.75 4.069 30 92.60] 93.10] 94.18] 93.12] 89.28] 94.79 92.84 1.920 204 Table 102 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/90% Stin'ing time Number of trial (minutes) I I 2 I 3 I 4 j 5 I 6 Average SD Absorbance 7 10 0.5300] 0.5364] 0.5118] 0.5354] 0.5277] 0.5415 20 0.5718]0.5683] 0.5608 I 0.5616] 0.5586] 0.5757 30 0.5809] 0.5776] 0.5693] 0.5686] 0.571tfl 0.5823 7 %Dissolved 10 89.02] 90.09] 85.95 I 89.92] 88.62] 90.95 89.09 1.743 20 95.97] 95.41] 94.11] 94.28] 93.78] 96.64 95.03 1.150 30 97.48] 96.94] 95.51] 95.44] 95.81 r9773 96.49 1.024 Table 103 Dissolution raw data of coated tablets stored for 3 months at 25°C/90% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD A Absorbance ' 10 0.5295] 0.5665] 0.5494] 0.5497] 0.5426] 0.5437 20 0.5698] 0.5749] 0.5784] 0.5777] 0.5696] 0.5724 30 0.5763] 0.5842] 0.5853] 0.5845] 0.5747 I 0.5799 %Dissolved 7 10 88.93] 95.16] 92.28] 92.33] 91.13] 91.32 91.86 2.034 20 95.64] 96.55] 97.10] 96.99] 95.62] 96.09 96.33 0.650 30 96.71] 98.08] 98.24] 98.12] 96.48] 97.34 97.49 0.769 Table 104 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/75% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.5591] 0.5586] 0.5550] 0.5483] 0.5559] 0.5454 20 0.5779] 0.5747] 0.5686] 0.5637] 0.5696 I 0.5668 30 0.5848] 0.5801] 0.5789] 0.5708] 0.5755] 0.5732 % Dissolved 7 _ 10 93.92] 93.83] 93.22] 92.08] 93.37] 91.61 93.01 0.948 20' 97.04] 96.51] 95.48] 94.66] 95.64] 95.17 95.75 0.879 30 98.17] 97.40] 97.18] 95.82] 96.63] 96.22 96.90 0.853 Table 105 Dissolution raw data of coated tablets stored for 3 months at 25°C/75% Stin'ing time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Averagg so Absorbance 7 10 0.4896] 0.3429] 0.5264] 0.4363] 0.4643] 0.4495 20 0.5662] 0.5574] 0.5650] 0.5793] 0.5736 I 0.5725 30 0.5806] 0.5787] 0.5692] 0.5847] 0.5825] 0.5801 %Dissolved 7 10 82.22] 57.54] 88.40] 73.24] 77.97] 75.46 75.81 10.438 20 94.98] 93.26] 94.83] 97.06] 96.16] 95.96 95.38 1.321 30 97.35] 96.77] 95.53] 97.96] 97.63 I 97.21 97.08 0.856 205 Table 106 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/65% Stirring time Number of trial (minutes) 1 I 2 ] 3 I 4 I 5 I 6 Average so 7 Absorbance 7 10 0.5396] 0.5449] 0.5227] 0.5558] 0.5315] 0.5419 20 0.5653] 0.5726] 0.5706] 0.5732 I 0.5696] 0.5700 30 0.5695] 0.5749] 0.5776] 0.5732 I 0.5775] 0.5752 %Dissolved 10 90.62] 91.52] 87.79] 93.36] 89.26] 91.01 90.59 1.915 20 94.90] 96.14] 95.76] 96.25] 95.61] 95.69 95.73 0.478 30 95.60] 96.52] 96.92] 96.25] 96.91] 96.56 96.46 0.495 Table 107 Dissolution raw data of coated tablets stored for 3 months at 25°C/65% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.1445] 0.0923] 0.3389] 0.1542] 0.1771] 0.1875 20 0.5371] 0.5633] 0.5793] 0.5574] 0.5654] 0.5722 30 0.5766] 0.5804] 0.5871] 0.5712] 0.5793] 0.5820 7 %DissOlved 10 24.16] 15.38] 56.87] 25.79] 29.63] 31.38 30.54 14.055 20 89.55] 93.82] 96.91] 92.95] 94.32] 95.46 93.84 2.510 30 96.06] 96.65] 98.20] 95.21] 96.60] 97.07 96.63 0.999 Table 108 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 7 10 0.5486] 0.5325] 0.5362] 0.5408] 0.4899] 0.5682 20 0.5641] 0.5745] 0.5726] 0.5735] 0.5777] 0.5782 30 0.5713] 0.5790 L0.5723I 0.5788] 0.5846] 0.5847 7 %Dissolved I 10 92.14] 89.43] 90.05] 90.83] 82.26] 95.43 90.02 4.357 20 94.72] 96.42] 96.12] 96.27 I 96.88] 97.11 96.25 0.841 30 95.91] 97.18] 96.07] 97.15] 98.02] 98.18 97.08 0.950 Table 109 Dissolution raw data of coated tablets stored for 3 months at 25°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.1335] 0.5076] 0.4506] 0.5087] 0.2102] 0.1359 20 0.5482] 0.5743] 0.5750] 0.5760] 0.5758] 0.5608 30 0.5823] 0.5825] 0.5810] 0.5835] 0.5846] 0.5832 7 %Dissolved 7 10 22.30] 85.24] 75.66] 85.43] 35.22] 22.71 54.43 30.883 20 91.37] 96.36] 96.38] 96.63] 96.11] 93.47 95.05 2.150 30 97.00] 97.71] 97.36] 97.88] 97.56] 97.17 97.45 0.333 206 Table 110 Dissolution raw data of uncoated tablets stored for 3 months at 25°C/0% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 10 0.4340] 0.3970] 0.3927] 0.3733] 0.4039] 0.4364 20 0.5749] 0.5802] 0.5752] 0.5754] 0.5664] 0.5757 30 0.5850] 0.5888] 0.5859] 0.5929] 0.5776] 0.5805 * %Dissolved 7 10 72.86] 66.63] 65.92] 62.65] 67.79] 73.27 68.19 4.147 20 96.33] 97.14] 96.31] 96.31] 94.86] 96.46 96.24 0.748 30 97.99] 98.56] 98.07] 99.20] 96.71] 97.26 97.97 0.892 Table 111 Dissolution raw data of coated tablets stored for 3 months at 25°C/0% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 10 0.2546] 0.2923] 0.3037] 0.2249 I 0.2307] 0.3025 20 0.5666] 0.5787] 0.5782] 0.5772] 0.5766] 0.5646 30 0.5762] 0.5850] 0.5854] 0.5924] 0.5878] 0.5649 A %Dissolved * 10 42.68] 49.03] 50.94] 37.68] 38.66 I 50.74 44.95 6.061 20 94.64] 96.73] 96.67] 96.37] 96.27] 94.39 95.84 1.046 30 96.24] 97.76] 97.84] 98.87] 98.11] 94.44 97.21 1.607 Table 112 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/90% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 7 10 0.3775] 0.3485] 0.3986] 0.3914] 0.4305] 0.4366 20 0.4950] 0.4906] 0.5085 L0.48I8I 0.5216] 0.5271 30 0.5356] 0.5378] 0.5432 I 0.5192] 0.5490] 0.5534 7 7 %Dissolved . ' 10 63.36] 58.48] 66.90 I 65.70] 72.28] 73.30 66.67 5.558 20 82.93] 82.15] 85.22] 80.76] 87.44] 88.37 84.48 3.036 30 89.63] 89.92] 90.94] 86.92] 91.96] 92.71 90.35 2.046 Table 113 Dissolution raw data of coated tablets stored for 4 months at 40°C/90% Stirring time Number of trial (minUtCS) 1 I 2 T 3 I 4 I 5 I 6 Average so Absorbance 10 0.2658] 0.2279] 0.3542] 0.2056] 0.2249] 0.2131 20 0.4569] 0.4355] 0.5024] 0.4292] 0.4105] 0.4383 30 0.5234] 0.5025] 0.5416] 0.5111] 0.4948] 0.5147 %Dissolved _ A 10 44.57] 38.19] 59.44] 34.44] 37.68] 35.70 41.67 9.380 20 76.40] 72.76] 84.11] 71.67] 68.60] 73.20 74.46 5.357 30 87.36] 83.81] 90.58] 85.19] 82.49] 85.81 85.87 2.847 207 Table 114 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/75% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.1247] 0.0694] 0.0693] 0.0701] 0.1099] 0.0895 20 0.4232] 0.2989] 0.1965] 0.1772] 0.4012] 0.4055 30 0.5248] 0.4625] 0.4465] 0.4269] 0.5114] 0.4969 %Dissolved 10 20.82] 11.53] 11.50] 11.65] 18.33] 14.91 14.79 4.007 20 70.54] 49.76] 32.70] 29.48] 66.86] 67.54 52.81 18.366 30 87.29] 76.72] 73.90] 70.64] 85.02] 82.60 79.36 6.606 Table 115 Dissolution raw data of coated tablets stored for 4 months at 40°C/75% Stirring time Number Of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.0104] 0.0380] 0.0235] 0.0240] 0.0572] 0.0752 20 0.1876] 0.2375] 0.2912] 0.1197] 0.3812] 0.3739 30 0.3855] 0.4263] 0.4850 I 0.3708] 0.5001] 0.4961 %Dissolved 10 1.59] 6.25] 3.80] 3.89] 9.47] 12.50 6.25 4.066 20 31.11] 39.48] 48.39] 19.83] 63.44] 62.26 44.08 17.327 30 63.74] 70.59] 80.34] 61.23] 83.05] 82.40 73.56 9.710 Table 116 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/65% Stin'ing time Number of trial (minutes) 1 I 2 I 3 I 4 ] 5 I 6 Averae so Absorbance 10 0.0531] 0.0594] 0.0675] 0.0561] 0.0633] 0.0752 20 0.1111] 0.1296] 0.2545] 0.1162] 0.2821] 0.1357 30 0.1990] 0.2107] 0.3651] 0.1720] 0.3718] 0.1857 7 %Dissolved , 10 8.78] 9.83] 11.21] 9.29] 10.50] 12.51 10.35 1.360 20 18.44] 21.54] 42.36] 19.30] 46.94] 22.57 28.52 12.662 30 32.93] 34.91] 60.59] 28.49] 61.73] 30.82 41.58 15.322 Table 117 Dissolution raw data of coated tablets stored for 4 months at 40°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 10 0.0244] 0.0166] 0.0203] 0.0226] 0.0227] 0.0306 20 0.0972] 0.0355] 0.0384] 0.0442] 0.0466] 0.1764 30 0.3606] 0.1741] 0.2843] 0.2938] 0.3925] 0.3579 7 %Dissolved 10 3.95] 2.65] 3.25] 3.65] 3.67] 5.00 3.70 0.783 20 16.08] 5.79] 6.28] 7.24] 7.65] 29.29 12.05 9.254 30 59.51] 28.64] 46.82] 48.40] 64.67] 59.21 51.21 13.043 208 Table 118 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 7 7 10 0.1374] 0.1380] 0.0988] 0.1134] 0.1065] 0.1435 20 0.3190] 0.3706] 0.4066] 0.4219] 0.3409] 0.3284 30 0.3705] 0.4270] 0.4674] 0.4770] 0.4501] 0.3976 7 %Dissolved 10 22.97] 23.07] 16.48] 18.92] 17.76] 23.99 20.53 3.195 20 53.21 I 61.81 | 67.73 | 70.30] 56.81 | 54.78 60.77 7.057 30 61.70] 71.11] 77.77] 79.39] 74.80] 66.19 71.83 6.872 Table 119 Dissolution raw data of coated tablets stored for 4 months at 40°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.0227] 0.0474] 0.0231] 0.0245 I 0.1167 I— 0.0237 20 0.0391] 0.3745] 0.2525] 0.1210] 0.4187] 0.0561 30 0.2851] 0.5097] 0.4277] 0.3555] 0.5123] 0.3241 7 %Dissolved 10 3.67] 7.83] 3.74] 3.97] 19.48] 3.84 7.09 6.282 20 6.41] 62.30] 41.94] 20.05] 69.78] 9.23 34.95 27.235 30 46.96] 84.59] 70.83] 58.71 I 85.21] 53.42 66.62 16.186 Table 120 Dissolution raw data of uncoated tablets stored for 4 months at 40°C/0% Stirring time Number of trial (MINES) l I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.3988] 0.3950] 0.4526] 0.3313] 0.3723] 0.3421 20 0.5571] 0.5743] 0.5743] 0.5743] 0.5738] 0.5701 30 0.5764] 0.5820] 0.5820] 0.5889] 0.5859] 0.5816 %Dissolved * 10 66.94] 66.30] 76.00] 55.59] 62.48] 57.41 64.12 7.406 20 93.30] 96.16] 96.27] 96.06] 96.04] 95.37 95.53 1.138 30 96.49] 97.43] 97.54] 98.46] 98.04] 97.26 97.54 0.676 Table 121 Dissolution raw data of coated tablets stored for 4 months at 40°C/0% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 ‘ 10 0.1449] 0.0443] 0.0279] 0.2971] 0.1719] 0.1092 20 0.5576] 0.5158] 0.4608 I 0.5654] 0.5676] 0.5656 30 0.5764] 0.5877] 0.5708] 0.5813] 0.5818] 0.5738 7 % Dissolved 10 24.22] 7.30] 4.54] 49.83] 28.77] 18.22 22.15 16.495 20 92.97] 85.83 I 76.64] 94.52] 94.67] 94.24 89.81 7.276 30 96.05] 97.68] 94.78] 97.13] 97.02] 95.59 96.38 1.093 209 Table 122 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/90% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.5149] 0.5177] 0.5218] 0.5142] 0.5151] 0.5234 20 0.5522] 0.5593] 0.5589] 0.5489] 0.5410] 0.5663 30 0.5620] 0.5732] 0.5760] 0.5659] 0.5565] 0.5753 % Dissolved I 10 86.47] 86.94] 87.63] 86.35] 86.51] 87.91 86.97 0.657 20 92.68] 93.87] 93.82] 92.13] 90.82] 95.05 93.06 1.497 30 94.30] 96.16] 96.64] 94.94] 93.37] 96.53 95.32 1.335 Table 123 Dissolution raw data of coated tablets stored for 4 months at 25°C/90% Stirring time Number of trial (minutes) i I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.5436] 0.5362] 0.5487] 0.5375] 0.5333] 0.5317 20 0.5669] 0.5708] 0.5798] 0.5686] 0.5661] 0.5704 30 0.5789] 0.5775] 0.5906] 0.5762] 0.5742] 0.5758 7 %Dissolved 10 91.29] 90.06] 92.15] 90.27] 89.56] 89.31 90.44 1.085 20 95.18] 95.82] 97.34] 95.46] 95.04] 95.75 95.77 0.832 30 97.16] 96.93] 99.12] 96.71] 96.36] 96.63 97.15 1.000 Table 124 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/75% Stirring time Number of trial (minutes) I I 2 I 3 L 4 I 5 I 6 Avera e SD Absorbance 10 0.5550] 0.5700] 0.5444] 0.5488] 0.5419] 0.5532 20 0.5820] 0.5812] 0.5722] 0.5856] 0.5667] 0.5803 30 0.5891] 0.5901] 0.5787] 0.5909] 0.5738] 0.5855 %Dissolved I 10 93.23] 95.75] 91.43] 92.18] 91.02] 92.92 92.75 1.690 20 97.72] 97.61] 96.06] 98.31] 95.14] 97.44 97.05 1.194 30 98.88] 99.07] 97.15] 99.18] 96.32] 98.29 98.15 1.169 Table 125 Dissolution raw data of coated tablets stored for 4 months at 25°C/75% Stirring time Number Of trial (minutes) 1 I 2 I 3 I 4 J 5 I 6 Average SD Absorbance 7 10 0.5483] 0.1944] 0.4424] 0.4404] 0.4579] 0.1451 20 0.5741] 0.5717] 0.5644] 0.5758] 0.5776] 0.5496 30 0.5861 I 0.5845 I 0.5751 | 0.5790] 0.5834] 0.5721 %Dissolved 10 92.09] 32.56] 74.28] 73.93] 76.88] 24.26 62.33 27.240 20 96.39] 95.40] 94.60] 96.49] 96.82] 91.63 95.22 1.942 30 98.37] 97.51] 96.35] 97.02] 97.78] 95.35 97.06 1.084 210 Table 126 Dissolution raw data of uncoated tablets stored for 4 months at 25 °C/65% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.4958] 0.5500] 0.5069] 0.5148] 0.5260] 0.5409 20 0.5726] 0.5759] 0.5697] 0.5783] 0.5741] 0.5686 30 0.5791] 0.5809] 0.5729] 0.5854] 0.5796] 0.5759 %Dissolved 10 83.25] 92.38] 85.13] 86.46] 88.33] 90.84 87.73 3.466 20 96.04] 96.68] 95.59] 97.03] 96.35] 95.46 96.19 0.615 30 97.12] 97.51] 96.11] 98.20] 97.26] 96.66 97.14 0.716 Table 127 Dissolution raw data of coated tablets stored for 4 months at 25°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.2172] 0.0854] 0.1228] 0.3418] 0.0636] 0.0363 20 0.5628] 0.5462] 0.5731] 0.5825] 0.5258] 0.5284 30 0.5875] 0.5928] 0.5828] 0.5879] 0.5842] 0.5774 7 %Dissolved 10 36.38] 14.21] 20.51] 57.36] 10.54] 5.96 24.16 19.392 20 93.95] 90.96] 95.51] 97.44] 87.53] 87.92 92.22 4.077 30 98.02] 98.64] 97.11] 98.33] 97.16] 96.00 97.54 0.975 Table 128 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/50% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.5392] 0.5510] 0.5574] 0.5676] 0.4996] 0.5521 20 0.5680] 0.5706] 0.5722] 0.5772] 0.5782] 0.5722 30 0.5744] 0.5763] 0.5798] 0.5773] 0.5871] 0.5797 %Dissolved 10 90.56] 92.55] 93.62] 95.33] 83.90] 92.73 91.45 4.010 20 95.36] 95.82] 96.09] 96.94] 96.99] 96.08 96.21 0.641 30 96.42] 96.75] 97.34] 96.95] 98.46] 97.32 97.21 0.705 Table 129 Dissolution raw data of coated tablets stored for 4 months at 25°C/50% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 10 0.3728] 0.2678] 0.2065] 0.1076] 0.3896] 0.2662 20 0.5624] 0.5489] 0.5470] 0.5784] 0.5569] 0.5605 30 0.5746] 0.5754] 0.5681] 0.5945] 0.5709] 0.5823 %Dissolved 10 62.57] 44.89] 34.60] 17.94] 65.40] 44.63 45.01 17.694 20 94.15] 91.72] 91.31] 96.37] 93.26] 93.65 93.41 1.825 30 96.15] 96.09] 94.78] 99.03] 95.57] 97.24 96.48 1.484 211 Table 130 Dissolution raw data of uncoated tablets stored for 4 months at 25°C/0% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.3704] 0.3879] 0.4135] 0.4275] 0.4181] 0.4519 20 0.5825] 0.5736] 0.5601] 0.5765] 0.5670] 0.5743 30 0.5968] 0.5816] 0.5687] 0.5827] 0.5726] 0.5813 %Dissolved 7 10 62.16] 65.11] 69.42] 71.78] 70.19] 75.88 69.09 4.867 20 97.49] 96.04] 93.83] 96.58] 94.98] 96.27 95.87 1.286 30 99.84] 97.35] 95.25] 97.62] 95.92] 97.42 97.23 1.591 Table 131 Dissolution raw data of coated tablets stored for 4 months at 25°C/0% Stin'ing time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Avera e SD Absorbance 10 0.1605] 0.3679] 0.3295] 0.3720] 0.3859] 0.1001 20 0.5688] 0.5797] 0.5714] 0.5740] 0.5650] 0.5644 30 0.5894] 0.5893] 0.5816] 0.5802] 0.5746] 0.5890 %Dissolved 10 26.85] 61.75] 55.28] 62.43] 64.76] 16.69 47.96 20.779 20 94.86] 97.02] 95.58] 96.07] 94.60] 94.02 95.36 1.087 30 98.26] 98.60] 97.25] 97.10] 96.19] 98.08 97.58 0.897 Table 132 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/90% Stirring time Number of trial (minutes) 1 ] 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.3259] 0.3722] 0.3023] 0.3313] 0.3587] 0.3939 20 0.4624] 0.4777] 0.4499] 0.4553] 0.4713] 0.5016 30 0.5129] 0.5217] 0.4987] 0.5057] 0.5176] 0.5362 %Dissolved 10 54.68 62.47 50.71 55.59 60.19 66.12 58.29 5.661 20 77.41 80.04 75.29 76.23 78.95 84.05 78.66 3.158 30 85.74 87.29 83.33 84.54 86.58 89.76 86.21 2.244 60 (200 rpm) 95.64 94.77 94.95 95.49 96.32 96.32 95.58 0.658 Table I33 Dissolution raw data of coated tablets stored for 5 months at 40°C/90% Stirring time Number of trial (minutes) I J 2 I 3 I 4 I 5 I 6 Average SD 7 Absorbance 7 10 0.0278] 0.0555] 0.1077] 0.0712 I 0.0671] 0.0360 20 0.1550] 0.1838] 0.3106] 0.2361] 0.2700] 0.1451 30 0.3110] 0.2871] 0.4133] 0.3456] 0.3843] 0.2615 %Dissolved 10 4.53 9.18 17.97 11.82 11.13 5.90 10.09 4.806 20 25.71 30.56 51.76 39.29 44.93 24.08 36.06 11.105 30 51.43 47.58 68.69 57.34 63.78 43.26 55.35 9.747 60(200 rpm) 91.54 89.90 94.22 89.64 91.63 91.32 91.38 1.638 212 Table I34 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/75% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.0673] 0.0697] 0.0760] 0.0576] 0.0825] 0.0895 20 0.3141] 0.2534] 0.3355 LO.I645I 0.3472] 0.2987 30 0.4669] 0.4248] 0.4780] 0.3188] 0.4749] 0.3906 % Dissolved 10 11.16 11.58 12.63 9.54 13.73 14.91 12.26 1.917 20 52.27 42.17 55.85 27.34 57.82 49.74 47.53 11.302 30 77.47 70.42 79.35 52.78 78.87 64.89 70.63 10.414 60 (200 rpm) 95.58 96.27 97.35 96.26 96.73 96.03 96.37 0.608 Table I35 Dissolution raw data of coated tablets stored for 5 months at 40°C/75% Stirring time Number of trial (minutes) I I 2 I 3 I 4 r 5 I 6 Average SD Absorbance 10 0.0198] 0.0333] 0.0314] 0.0460] 0.0206] 0.0282 20 0.0352] 0.0622] 0.3075] 0.2490] 0.0898] 0.2093 30 0.3396] 0.3062] 0.4875] 0.4359] 0.3585] 0.4510 % Dissolved I 10 3.18 5.45 5.13 7.59 3.32 4.59 4.88 1.622 20 5.75 10.26 51.11 41.39 14.85 34.76 26.35 18.579 30 55.93 50.49 80.79 72.21 59.14 74.61 65.53 11.993 60 (200 rpm) 96.53 95.86 96.98 96.85 94.83 98.21 96.54 1.137 Table I36 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 7 Absorbance 10 0.0544] 0.0361] 0.0448] 0.0343] 0.0487] 0.0535 20 0.1267 I 0.0829] 0.0911] 0.0798] 0.1593] 0.1078 30 0.1815] 0.2162] 0.1349] 0.1465] 0.2442 L0.1572 %Dissolved 10 9.00 5.93 7.38 5.62 8.03 8.85 7.47 1.442 20 21.05 13.72 15.09 13.19 26.46 17.90 17.90 5.115 30 30.07 35.69 22.32 24.20 40.46 26.03 29.79 7.069 60 (200 rpm) 92.78 93.78 82.61 90.88 93.82 83.77 89.61 5.096 Table I37 Dissolution raw data of coated tablets stored for 5 months at 40°C/65% Stirring time Number of trial ' (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.0211 I 0.0282] 0.0324] 0.0269] 0.0237] 0.0112 20 0.0499] 0.1233] 0.1764] 0.1031] 0.0515] 0.0346 30 0.3496] 0.3614] 0.4286] 0.3249] 0.2828] 0.1780 % Dissolved 7 10 3.40 4.59 5.30 4.38 3.83 1.73 3.87 1.236 20 8.19 20.44 29.29 17.06 8.46 5.63 14.84 9.108 30 57.61 59.69 70.86 53.63 46.60 29.27 52.94 14.068 60 (200 rpm) 96.18 95.69 96.56 96.94 98.06 97.41 ' 96.81 0.856 213 Table I38 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.1214] 0.0843] 0.0635] 0.0993] 0.0944] 0.1030 20 0.2520] 0.2510] 0.1112] 0.1494] 0.3383] 0.1496 30 0.3812 0.3192] 0.1383] 0.1799] 0.4028I 0.1741 %Dissolved 10 20.27 14.03 10.52 16.56 15.72] 17.18 15.71 3.266 20 42.02 41.79 18.47 24.90 56.35] 24.94 34.75 14.333 30 63.33 53.04 22.94 29.92 66.99[ 28.98 44.20] 19.240 60 (200 rpm) 86.04 90.28 86.71 86.54 92.49] 86.62 88.11] 2.641 Table I39 Dissolution raw data of coated tablets stored for 5 months at 40°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 7 10 0.0393] 0.0452] 0.036II 0.0295] 0.0322] 0.0245 20 0.0529] 0.0840] 0.0744] 0.0703] 0.0894] 0.0580 30 0.2300] 0.2899] 0.3953] 0.2483] 0.2583] 0.1112 %Dissolved 10 6.46 7.45 5.92 4.81 5.27 3.97 5.65 1.237 20 8.72 13.92 12.31 11.61 14.79 9.55 11.82 2.375 30 37.92 47.87 65.21 40.95 42.64 18.32 42.15 15.178 60 (200 rpm) 97.02 99.64 99.32 98.54 97.89 99.79 98.70 1.094 Table I40 Dissolution raw data of uncoated tablets stored for 5 months at 40°C/0% Stirring time Number of trial (minutCS) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.3704] 0.4120] 0.3998 I 0.3524] 0.3567] 0.3207 20 0.5617]0.5622| 0.5717] 0.5765] 0.5700] 0.5653 30 0.5757] 0.5750] 0.5817] 0.5875] 0.5760] 0.5788 % Dissolved 10 62.16 69.16 67.11 59.14 59.86 53.81 61.87 5.608 20 94.03 94.18 95.74 96.46 95.39 94.55 95.06 0.962 30 96.34 96.29 97.39 98.27 96.38 96.76 96.90 0.786 60 L200 rpm) 96.92 96.18 97.04 99.32 96.75 97.65 97.31 1.090 Table l4l Dissolution raw data of coated tablets stored for 5 months at 40°C/0% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 10 0.0576] 0.0829] O.l888I 0.0593] 0.2550] 0.0938 20 0.5348] 0.5340] 0.5647] 0.5251] 0.5591] 0.5552 30 0.5796] 0.5751] 0.5780] 0.5691] 0.5755] 0.5816 %Dissolved I 10 9.54 13.80 31.61 9.82 42.75 15.62 20.52 13.575 20 89.02 88.93 94.22 87.41 93.40 92.48 90.91 2.802 30 96.41 95.71 96.41 94.66 96.10 96.83 96.02 0.762 60@0 rpm) 97.19 96.66 96.74 97.63 96.18 97.58 97.00 0.571 214 Table I42 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/90% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.5101] 0.5197] 0.5165] 0.4886] 0.5009] 0.5059 20 0.5618] 0.5640] 0.5615] 0.5582] 0.5510] 0.5534 30 0.5740] 0.5758] 0.5751L0.5744I 0.5656] 0.5666 %Dissolved 10 85.67 87.28 86.74 82.05 84.12 84.96 85.14 1.902 20 94.28 94.65 94.24 93.65 92.46 92.87 93.69 0.868 30 96.29 96.61 96.48 96.31 94.87 95.05 95.94 0.766 60 (200 rpm) 96.13 97.48 97.38 97.52 96.84 95.85 96.87 0.726 Table I43 Dissolution raw data of coated tablets stored for 5 months at 25°C/90% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 7 10 0.5307] 0.5225] 0.5117] 0.5214] 0.5168] 0.5138 20 0.5643] 0.5724] 0.5655] 0.5580] 0.5692] 0.5533 30 0.5729] 0.5847] 0.5765] 0.5668] 0.5808] 0.5603 7 %Dissolved 10 89.13 87.75 85.93 87.56 86.80 86.29 87.24 1.161 20 94.73 96.06 94.89 93.66 95.52 92.86 94.62 1.181 30 96.15 98.08 96.71 95.12 97.43 94.02 96.25 1.501 60 (200 rpm) 96.46 98.30 96.76 96.53 97.56 94.99 96.77 1.122 Table I44 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/75% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 10 0.5409] 0.5637] 0.5453] 0.5514] 0.5397] 0.5491 20 0.5749] 0.5716] 0.5700] 0.5687] 0.5794] 0.5750 30 0.5829] 0.5684] 0.5690 I 0.5659 I 0.5743] 0.5684 7 %Dissolved 10 90.84 94.68 91.58 92.61 90.65 92.23 92.10 1.475 20 96.50 96.00 95.71 95.49 97.25 96.54 96.25 0.646 30 97.83 95.47 95.53 95.03 96.42 95.45 95.96 1.027 60 (200 rpm) 96.24 95.39 95.38 95.05 96.67 95.61 95.72 0.611 Table I45 Dissolution raw data of coated tablets stored for 5 months at 25°C/75% Stirring time Number of trial _ (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 10 0.4591] 0.3310] 0.4533] 0.3914] 0.1946] 0.0563 20 0.5739] 0.5699] 0.5715 I 0.5673] 0.5719] 0.5378 30 0.5887] 0.5809] 0.5831] 0.5814] 0.5864] 0.5846 %Dissolved 10 77.08 55.54 76.10 65.69 32.58 9.32 52.72 26.852 20 96.21 95.32 95.80 94.99 95.43 89.52 94.55 2.499 30 98.65 97.13 97.71 97.31 97.82 97.23 97.64 0.564 60(200 rpm) 98.35 97.53 98.13 97.44 98.25 98.99 98.12 0.573 215 Table I46 Dis Stirring time (minutes) 10 20 30 7 60 (200 mm Table I47 Dis Stirring timt (minutes) I] IIIH IO / / Stirring tlm ‘50 (200 n Stirring tin minmes) T [[Hs/ //" l0 /./ IO 20 30 W 5‘ A [O O O Table I46 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/65% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 7 10 0.4490 I 0.4452] 0.5333] 0.4894] 0.5205] 0.5255 20 0.5691] 0.5635] 0.5635] 0.5594] 0.5652] 0.5658 30 0.5754] 0.5727] 0.5703] 0.5709] 0.5685] 0.5793 %Dissolved 10 75.39 74.75 89.57 82.18 87.42 88.26 82.93 6.589 20 95.38 94.46 94.60 93.85 94.86 94.96 94.68 0.520 30 96.42 95.97 95.72 95.74 95.40 97.20 96.07 0.646 60 (200 rpm) 96.94 96.50 95.61 96.08 95.74 97.43 96.38 0.711 Table I47 Dissolution raw data of coated tablets stored for 5 months at 25°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 7 10 0.2864] 0.1793] 0.0278] 0.0340] 0.0300] 0.0921 20 0.5634] 0.5573] 0.5209] 0.5370] 0.4480] 0.5393 30 0.5753] 0.5730] 0.5773] 0.5693] 0.5241 I 0.5676 7 I %Dissolved 10 48.04 30.01 4.52 5.56 4.89 15.34 18.06 17.673 20 94.16 92.96 86.65 89.28 74.52 89.82 87.90 7.087 30 96.13 95.56 95.95 94.67 87.06 94.48 93.98 3.454 60 (200 rpm) 97.26 96.26 97.18 95.88 96.79 95.99 96.56 0.602 Table I48 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 10 0.5194] 0.5244] 0.5374] 0.5074] 0.4729] 0.5422 20 0.5613] 0.5613] 0.5732] 0.5697] 0.5702] 0.5718 30 0.5716] 0.5651] 0.5767] 0.5699] 0.5801] 0.5752 %Dissolved 10 87.23 88.07 90.27 85.21 79.41 91.06 86.87 4.221 20 94.22 94.21 96.22 95.59 95.62 795.99 95.31 0.879 30 95.90 94.84 96.80 95.62 97.25 96.55 96.16 0.878 60 (200 rpm) 96.53 94.78 96.00 95.46 96.85 96.61 96.04 0.791 Table I49 Dissolution raw data of coated tablets stored for 5 months at 25°C/50% Stirring time Number of trial (minutes) I ] 2 j 3 I 4 I 5 I 6 Average SD 7 7 Absorbance 10 0.2944] 0.2183] 0.2581] 0.1673] 0.4324] 0.0596 20 0.5717] 0.5559] 0.5637] 0.5172] 0.5619] 0.5527 30 0.5839] 0.5697] 0.5922] 0.5470] 0.5737] 0.5778 %Dissolved I 7 10 49.37 36.58 43.27 27.99 72.59 9.87 39.95 21.092 20 95.56 92.80 94.18 86.28 94.16 92.01 92.50 3.286 30 97.57 95.08 98.86 91.19 96.11 96.14 95.82 2.626 60 (200 rpm) 96.98 95.45 98.38 97.38 95.70 97.34 96.87 1.109 216 Table 150 Dissolution raw data of uncoated tablets stored for 5 months at 25°C/0% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 10 0.3814] 0.3752] 0.3464] 0.4219] 0.3543] 0.4328 20 0.5633] 0.5631] 0.5744] 0.5714] 0.5775] 0.5684 30 0.5789] 0.5724] 0.5880] 0.5761] 0.5882] 0.5761 % Dissolved 10 64.02 62.97 58.13 70.83 59.45 72.66 64.68 5.917 20 94.31 94.26 96.10 95.73 96.63 95.25 95.38 0.960 30 96.88 95.80 98.35 96.49 98.39 96.51 97.07 1.065 60Q00 rpm) Table 151 Dissolution raw data of coated tablets stored for 5 months at 25°C/0% Stirring time Number of trial (minutCS) 1 I 2 I 3 I 4 I 5 I 6 Avegge so Absorbance 7 10 0.1994] 0.1639] 0.0224] 0.3564] 0.0772] 0.0851 20 0.5558] 0.5690] 0.4960 I 0.5666] 0.5593] 0.5536 30 0.5722] 0.5907] 0.5634] 0.5776] 0.5710] 0.5718 * %Dissolved 10 33.39 27.42 3.61 59.81 12.84 14.16 25.21 20.053 20 92.76 94.89 82.49 94.81 93.13 92.19 91.71 4.649 30 95.46 98.47 93.62 96.63 95.06 95.20 95.74 1.647 60 (200 rpm) 96.29 99.04 97.42 96.99 95.54 96.79 97.01 1.184 Table 152 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/90% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Averaie SD 7 _ Absorbance 10 0.3347] 0.2884] 0.3440] 0.3078] 0.3352] 0.3098 20 0.4734] 0.4366] 0.4663] 0.448II 0.4543] 0.4419 30 0.5221] 0.4963] 0.5170] 0.5053] 0.4939] 0.4984 7 %Dissolved 7 7 10 56.15] 48.37] 57.67] 51.63] 56.23] 51.96 53.67 3.576 20 79.26] 73.05] 78.09] 74.99] 76.08] 73.97 75.91 2.401 30 87.29] 82.90] 86.45] 84.44] 82.60] 83.29 84.49 1.959 Table [53 Dissolution raw data of coated tablets stored for 6 months at 40°C/90% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 7 Absorbance 7 7 10 0.1348] 0.1542] 0.0612] 0.1260] 0.0711] 0.1083 20 0.3374] 0.3713] 0.2563] 0.3384] 0.2907] 0.3647 30 0.4468] 0.4617] 0.3676] 0.4414] 0.4100] 0.4606 7 7 %Dissolved 7 7 10 22.53] 25.79] 10.14] 21.05] 11.81] 18.06 18.23 6.169 20 56.27] 61.95] 42.63] 56.42] 48.38] 60.77 54.40 7.481 30 74.30] 76.85] 60.98] 73.40] 68.06] 76.58 71.70 6.132 217 Table 154 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/75% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I S I 6 Average SD Absorbance 7 10 0.1017] 0.0601] 0.0776] 0.0484] 0.0594] 0.0615 20 0.3135] 0.1347] 0.2319 @2898] 0.2224] 0.1717 30 0.4731] 0.4144] 0.4340] 0.4404] 0.4380] 0.3719 %Dissolved 10 16.96] 9.97] 12.91] 7.99] 9.85] 10.20 11.31 3.185 20 52.23] 22.38] 38.60] 48.19] 36.99] 28.55 37.82 11.323 30 78.54] 68.50] 71.93] 73.03] 72.53] 61.56 71.02 5.651 Table 155 Dissolution raw data of coated tablets stored for 6 months at 40°C/75% Stirring time Number of trial (minutes) 1, I 2 I 3 I 4 I 5 I 6 Average so Absorbance 7 10 0.0758] 0.0422 I 0.0359] 0.0580] 0.0646] 0.1022 20 0.2726] 0.1147] 0.1476] 0.2928] 0.4144] 0.4064 30 0.4926] 0.4421] 0.4625] 0.4955] 0.5439] 0.5229 %Dissolved I 10 12.59] 6.95] 5.89] 9.60] 10.72] 17.05 10.47 4.048 20 45.37] 19.03] 24.49] 48.72] 68.97] 67.70 45.71 20.959 30 8|.64I 73.00] 76.41] 82.14] 90.33] 86.92 81.74 6.410 Table 156 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 7 10 0.0530] 0.0447] 0.0495] 0.0415] 0.0458] 0.0431 20 0.0768] 0.1287] 0.1030] 0.0809] 0.2143] 0.1109 30 0.1175] 0.1994] 0.1641] 0.1169] 0.3015] 0.1719 _ %Dissolved 10 8.77] 7.37] 8.18] 6.82] 7.55] 7.11 7.63 0.720 20 12.72] 21.35] 17.08] 13.38] 35.62] 18.39 19.76 8.407 30 19.44] 33.01] 27.16] 19.33] 49.99] 28.46 29.57 11.341 Table 157 Dissolution raw data of coated tablets stored for 6 months at 40°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 7 10 0.0399] 0.0389] 0.0329] 0.0344] 0.0332] 0.0655 20 0.1236] 0.1937] 0.1261] 0.0744] 0.1581] 0.2740 30 0.3697] 0.3167] 0.3887] 0.3445] 0.3984] 0.4492 I %Dissolved 10 6.55] 6.39] 5.38] 5.64] 5.44] 10.88 6.71 2.098 20 20.50] 32.17] 20.90] 12.29] 26.23] 45.60 26.28 11.541 30 61.08] 52.45] 64.20] 56.84] 65.85] 74.48 62.48 7.651 218 Table 158 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/50% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD 7 7 Absorbance 10 0.0843] 0.0880] 0.0816] 0.0944] 0.0593] 0.0831 20 0.2465] 0.1250] 0.1184] 0.1290] 0.0854] 0.1099 30 0.3242] 0.1664] 0.1493] 0.1633] 0.1201] 0.1382 I "/6 Dissolved 10 14.04] 14.66] 13.58] 15.73] 9.83] 13.83 13.61 2.005 20 41.04] 20.81] 19.71] 21.49] 14.18] 18.29 22.59 9.406 30 53.85] 27.64] 24.81] 27.15] 19.89] 22.97 29.39 12.321 Table 159 Dissolution raw data of coated tablets stored for 6 months at 40°C/50% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 10 0.0503] 0.0339] 0.0276] 0.0523] 0.0372] 0.0390 20 0.0771] 0.0563] 0.0550] 0.2834] 0.1312] 0.0790 30 0.3111] 0.1203] 0.2171 I 0.4306] 0.3946] 0.1132 7 %Dissolved 10 8.31] 5.54] 4.50] 8.65] 6.11] 6.40 6.59 1.610 20 12.77] 9.28] 9.04] 47.14] 21.76] 13.07 18.84 14.610 30 51.36] 19.83] 35.78] 71.40] 65.19] 18.70 43.71 22.561 Table 160 Dissolution raw data of uncoated tablets stored for 6 months at 40°C/0% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 7 10 0.3873] 0.3776] 0.4023] 0.3780] 0.3672] 0.4273 20 0.5724] 0.5753] 0.5689] 0.5738] 0.5646] 0.5769 30 0.5869] 0.5817] 0.5776] 0.5676] 0.5617] 0.5683 %Dissolved 7 .10 65.01] 63.37] 67.53 I 63.44] 61.63] 71.74 65.45 3.663 20 95.83] 96.31] 95.27] 96.05] 94.51] 96.65 95.77 0.772 30 98.23] 97.35] 96.70] 95.03] 94.03] 95.23 96.10 1.591 Table 161 Dissolution raw data of coated tablets stored for 6 months at 40°C/0% Stirring time Number of trial (minutes) 1 I 2 ] 3 I 4 | 5 I 6 Avagge so 7 7 Absorbance 7 10 0.2171] 0.0618] 0.0305] 0.1440] 0.0547] 0.2623 20 0.5796] 0.5100] 0.4086] 0.5668] 0.5646] 0.5718 30 0.5990] 0.5790] 0.5349] 0.5858] 0.5837] 0.5883 7 %Dissolved 10 36.37] 10.24] 4.98] 24.08] 9.06] 43.98 21.45 16.046 20 96.75] 84.89] 67.96] 94.49] 93.98] 95.52 88.93 11.108 30 99.95] 96.27] 88.78] 97.63] 97.13 I 98.24 96.34 3.900 219 Table 162 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/90% Stirring time Number of trial (minutes) I I 2 I 3 I 4 L 5 I 6 Aveggg SD 7 Absorbance 7 10 0.5153] 0.4968 I ~ 0.4961] 0.4942] 0.5027] 0.5231 20 0.5607] 0.5401] 0.5374] 0.5385] 0.5401] 0.5517 30 0.5643] 0.5470] 0.5494] 0.5514] 0.5548] 0.5596 %Dissolved 7 10 86.54] 83.44] 83.32] 82.99] 84.42] 87.86 84.76 1.992 20 94.10] 90.65] 90.19] 90.38] 90.65] 92.62 91.43 1.575 30 94.70] 91.78] 92.16] 923M 93.07] 93.92 93.02 1.110 Table 163 Dissolution raw data of coated tablets stored for 6 months at 25°C/90% Stirring time Number Of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so 7 Absorbance 7 10 0.5097] 0.4844] 0.5077] 0.4951] 0.5094] 0.5017 20 0.5465] 0.5360] 0.5422] 0.5449] 0.5501] 0.5519 30 0.5560] 0.5485] 0.5497] 0.5542] 0.5603 0.5601 7 %Dissolved I 10 85.59] 81.35] 85.27] 83.14] 85.55] 84.25 84.19 1.681 20 91.72] 89.93] 91.01] 91.44] 92.33] 92.61 91.51 0.966 30 93.29] 92.00] 92.24] 92.97] 94.11] 93.97 93.10 0.869 Table 164 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/75% Stirring time Number of trial (minuteS) 1 I 2 I 3 I 4 ] 5 I 6 Average so Absorbance 10 0.5424] 0.5442] 0.5606] 0.5331] 0.5330] 0.5464 20 0.5671] 0.5660] 0.5710] 0.5587] 0.5609] 0.5661 30 0.5719] 0.5747] 0.5754] 0.5653] 0.5714] 0.5678 7 %Dissolved - 7 10 91.10] 91.41] 94.16] 89.54] 89.52] 91.77 91.25 1.714 20 95.22] 95.03] 95.90] 93.81] 94.16] 95.06 94.86 0.757 30 96.00] 96.46] 96.61] 94.88] 95.89] 95.33 95.86 0.661 Table 165 Dissolution raw data of coated tablets stored for 6 months at 25°C/75% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Averafl so Absorbance 7 10 0.3641] 0.1156] 0.0580] 0.4667] 0.3046] 0.2065 20 0.5553] 0.5398] 0.526II 0.5611] 0.5548] 0.5154 30 0.5703] 0.5659] 0.5555] 0.5729] 0.5688] 0.5412 7 %Dissolved 7 10 61.10] 19.30] 9.60] 78.37] 51.09] 34.60 42.34 26.037 20 92.95] 89.96] 87.56] 94.08] 92.76] 86.03 90.56 3.248 30 95.42] 94.25] 92.41] 96.03] 95.07] 90.30 93.91 2.170 220 Table 166 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 I 6 Average so Absorbance 10 0.4587] 0.5400] 0.5424] 0.5302] 0.5485] 0.5271 20 0.5789] 0.5680] 0.5714] 0.5734] 0.5763] 0.5799 30 0.5915] 0.5785] 0.5772] 0.5784] 0.5724] 0.5872 7 %Dissolved 10 77.02] 90.69] 91.09] 89.05] 92.12] 88.52 88.08 5.580 20 97.03] 95.37] 95.94] 96.25] 96.76] 97.33 96.44 0.732 30 99.12] 97.09] 96.88] 97.07] 96.11] 98.52 97.46 1.125 Table 167 Dissolution raw data of coated tablets stored for 6 months at 25°C/65% Stirring time Number of trial (minutes) 1 I 2 I 3 I 4 I 5 ] 6 Avgge so 7 Absorbance 10 0.2015] 0.1265] 0.1422] 0.1805] 0.0741] 0.3291 20 0.5582] 0.5608] 0.5592] 0.5781] 0.5590] 0.572 30 0.5781] 0.5831] 0.5750] 0.5893] 0.5921 I 0.5797 7 %Dissolved 10 33.75] 21.13] 23.77] 30.22] 12.32] 55.21 29.40 14.681 20 93.16] 93.47] 93.23] 96.43] 93.08] 95.69 94.18 1.483 30 96.43] 97.13] 95.83] 98.28] 98.53] 96.94 97.19 1.046 Table 168 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/50% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Avera e SD Absorbance 10 0.5312] 0.5538] 0.4973] 0.5526] 0.5457] 0.5601 20 0.5860] 0.5768] 0.5689] 0.5807] 0.5853] 0.5704 30 0.5919] 0.5835] 0.5777] 0.5907] 0.5845] 0.5827 _7 %Dissolved 10 89.21] 93.01] 83.51] 92.81] 91.65] 94.07 90.71 3.900 20 98.34] 96.85 I 95.43] 97.50] 98.25] 95.80 97.03 1.227 30 99.31] 97.95] 96.88] 99.15] 98.12] 97.83 98.21 0.903 Table 169 Dissolution raw data of coated tablets stored for 6 months at 25°C/50% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.3376] 0.1986] 0.0906] 0.4570] 0.1840] 0.0793 20 0.5675] 0.5685] 0.5628] 0.5709] 0.5685] 0.5458 30 0.5820] 0.5813] 0.5775] 0.5848] 0.5868] 0.5762 %DiSsolved 10 56.65] 33.26] 15.09] 76.73] 30.80] 13.19 37.62 24.744 20 94.94] 94.87] 93.73] 95.70] 94.85] 90.89 94.16 1.722 30 97.32] 96.97] 96.16] 98.00] 97.87] 95.90 97.04 0.868 221 Table 170 Dissolution raw data of uncoated tablets stored for 6 months at 25°C/0% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 7 10 0.4190] 0.3749] 0.4070] 0.3796] 0.4671] 0.4535 20 0.5809] 0.5950] 0.5858] 0.5822] 0.5940] 0.5863 30 0.5914] 0.5940] 0.5910] 0.5889I 0.5940] 0.5940 7 % Dissolved I 10 70.33] 62.93] 68.33] 63.71] 78.43] 76.15 69.98 6.345 20 97.30] 99.58] 98.10] 97.46] 99.57] 98.25 98.38 0.996 30 99.04] 99.41] 98.96] 98.57] 99.57] 99.53 99.18 0.393 Table 171 Dissolution raw data of coated tablets stored for 6 months at 25°C/0% Stirring time Number of trial (minutes) I I 2 I 3 I 4 I 5 I 6 Average SD Absorbance 10 0.2877] 0.3722] 0.3024] 0.2628] 0.2186] 0.3262 20 0.5811] 0.5758] 0.5873 I 0.5789] 0.5805] 0.5839 30 0.5909] 0.5845] 0.5933] 0.5893] 0.5908] 0.5925 %Dissolved 10 48.25] 62.47] 50.73] 44.06] 36.63] 54.72 49.48 8.874 20 97.12] 96.37] 98.17] 96.71] 96.90] 97.64 97.15 0.658 30 98.73] 97.80] 99.16] 98.43] 98.59] 99.07 98.63 0.492 222 2. Dissolution profiles of drug X uncoated tablets stored at 25°C 100% T -..-.- .._ ~— ~ 75% 8 2 50°/ 0 o 8 5 25% 0% . . - g 0 10 20 30 40 Stirring time (minutes) I t==initial x t=l month 0 t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 86 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/90% RH (each point is average value for 6 tablets) 100% . 75% 50% Dissolved 25% 0% I] r 1 20 30 40 Stirring time (minutes) I t=initial x t=l month 0 t=2 months + t=3 months 0 t=4 months A t=5 months * t=6 months Figure 87 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/75% RH (each point is average value for 6 tablets) 223 100% 75% 50% Dissolved 25% 0% r 1 1 O 1 0 20 30 4O Stirring time (minutes) I Finitial x t=l month I t=2 months + t=3 months 0 t=4 months I t=5 months * t=6 months Figure 88 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/65% RH (each point is average value for 6 tablets) 100% ,,,,,,,,,,,,,,,,,,, 75% 8 z o 50% .3 O 25% 0% r T , o 10 20 . 30 4o Stirring time (minutes) I t=initia| x t=l month 0 i=2 months + F3 months 0 t=4 months I t=5 months * t=6 months Figure 89 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/50% RH (each point is average value for 6 tablets) 224 1 00% 75% ‘8 2 g 50% 5 25% . 0% , T T o 10 20 30 4o Stirring time (minutes) I Finitial x t=l month I F2 months + F3 months 9 t=4 months A t=5 months * t=6 months Figure 90 Dissolution profiles of drug X uncoated tablets stored in open dishes for 6 months at 25°C/0% RH (each point is average value for 6 tablets) 225 3. Dissolution profiles of drug X coated tablets stored at 25°C 100% - ~ ~ ~~ A 75% 50% Dissolved 25% l r I 10 20 30 40 Stirring time (minutes) 0% I Finitial x F] month I F2 months + F3 months 0 F4 months A F5 months * F6 months Figure 91 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/90% RH (each point is average value for 6 tablets) 100% 75% --. AJL. _ A--- 50% Dissolved 25% r 0 10 20 30 40 Stirring time (minutes) 0% I Finitial x Fl month I F2 months + F3 months 0 F4 months A F5 months * F6 months Figure 92 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/75% RH (each point is average value for 6 tablets) 226 1 00% 75% 50% Dissolved 25% 0% r , I —1 0 10 20 30 40 Stirring time (minutes) I Finitial x Fl month I F2 months + F3 months 0 F4 months A F5 months * F6 months Figure 93 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/65% RH (each point is average value for 6 tablets) 100% ---—»-~-»—~——v—w-~ w. - ..--.----.-._-_ h __ 75% 50% Dissolved 25% 0% ! i l T l 0 10 20 30 40 Stirring time (minutes) I Finitial x Fl month I F2 months + F3 months 0 F4 months A F5 months * F6 months Figure 94 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/50% RH (each point is average value for 6 tablets) 227 100% ~~ ~-—~ 75% 50% Dissolved 25% 0% l’ T T j 0 10 20 30 40 Stirring time (minutes) I Finitial x Fl month I F2 months + F3 months 0 F4 months I F5 months * F6 months Figure 95 Dissolution profiles of drug X coated tablets stored in open dishes for 6 months at 25°C/0% RH (each point is average value for 6 tablets) 228 Appendix F Dimensions (Swelling) and Raw Data 229 In order to explain the tablet swelling, the dimensions of tablets were measured at each condition. Figures 96 and 97 show how the dimensions of drug X tablets increase as a function of moisture content because excipients such as croscarmellose sodium in tablets swell when they absorb moisture. The thickness dimensions at 90% RH were increased at most about 0.17mm and the diameter dimensions at 90% RH were increased at most about 0.15mm. Figure 96 shows the percent thickness increase and Figure 97 shows the percent diameter increase as a function of relative humidity at 25°C and 40°C. When tablets were stored at higher RH, they swelled quickly as they absorbed moisture. Afier the initial swelling, the dimensions did not increase further as a function of storage time. Drug X tablets are formulated with croscarmellose sodium that is a high swelling material. The croscarmellose sodium swells to 4-8 times its original volume on contact with water. The swollen croscarmellose reduce boundary strength among excipient granules. Therefore, the tablets disintegrate quickly in a short time when they are dropped into the dissolution medium. 230 5 i ‘‘‘‘‘‘‘‘‘‘ s “ E 4 i E a . g 5 3 ? 5 i U ‘ “ ? § 2 ' . i: x E 1 e H I f . i 0 ll . . a , . % 0 20 40 60 80 100 RH(%) I uncoated at 40°C A coated at 40°C I uncoated at 25°C X coated at 25°C Figure 96 Percent thickness dimension change of drug X tablets as a function of RH (each point is average value for 5 tablets) Q 2.0 u 2; . 2’ 1.5 x ,4 a i 5 ‘ z 2 g 1.0 .2 A O 0.5 O 1 A . I x , 0,0 '— 1 T . r 7" i 1 0 20 40 60 80 100 RH(%) O uncoated at 40°C A coated at 40°C I uncoated at 25°C X coated at 25°C Figure 97 Percent diameter dimension change of drug X tablets as a function of RH (each point is average value for 5 tablets) 231 Table 172 shows the dimensions of initial drug X tablets and Tables 173-202 show the dimensions of drug X tablets stored at 25/40°C, 0%, 50%, 65%, 75%, and 90% RH for 6 months. 232 Table 172 Dimensions (mm) of initial tablets Uncoated Coated thickness diameter thickness diameter 1 4.01 9.07 4.09 9.22 2 4.04 9.04 4.11 9.11 3 4.01 9.06 4.10 9.12 4 4.01 9.04 4.10 9.18 5 4.01 9.03 4.09 9.10 Avg. 4.02 9.048 4.098 9.146 SD 0.013 0.016 0.008 0.052 Table 173 Dimensions (mm) of tablets stored for 20 days at 40°C/90% Uncoated Coated thickness diameter thickness diameter 1 4.22 9.18 4.26 9.23 2 4.20 9.18 4.24 9.26 3 4.18 9.19 4.26 9.28 4 4.18 9.19 4.24 9.27 5 4.18 9.18 4.24 9.25 Avg. 4.192 9.184- 4.248 9.258 SD 0.018 0.005 0.01 1 0.019 Table 174 Dimensions (mm) of tablets stored for 20 days at 40°C/75% Uncoated Coated thickness diameter thickness diameter 1 4.12 9.12 4.14 9.19 2 4.12 9.14 4.15 9.19 3 4.13 9.11 4.14 9.19 4 4.12 9.12 4.14 9.20 5 4.12 9.11 4.14 9.20 Avg. 4.122 9.12 4.14 9.19 SD 0.004 0.012 0.004 0.005 Table 175 Dimensions (mm) of tablets stored for 20 days at 40°C/65% Uncoated Coated thickness diameter thickness diameter 1 4.12 9.1 4.15 9.16 2 4.08 9.08 4.15 9.20 3 4.11 9.09 4.15 9.19 4 4.09 9.08 4.14 9.17 5 4.09 9.1 4.13 9.17 Avg. 4.098 9.09 4.14 9.18 SD 0.016 0.010 0.009 0.016 233 Table 176 Dimensions (mm) of tablets stored for 20 days at 40°C/50% Uncoated Coated thickness diameter thickness diameter 1 4.04 9.09 4.12 9.15 2 4.03 9.04 4.11 9.13 3 4.06 9.09 4.10 9.13 4 4.04 9.08 4.12 9.12 5 4.04 9.06 4.10 9.13 Avg. 4.042 9.072 4.1 l 9.13 SD 0.01 1 0.022 0.010 0.011 Table 177 Dimensions (mm) of tablets stored for 20 days at 40°C/0% Uncoated Coated thickness diameter thickness diameter 1 4.03 9.05 4.09 9.15 2 4.02 9.06 4.05 9.08 3 4.00 9.04 4.10 9.14 4 4.00 9.02 4.10 9.12 5 4.00 9.04 4.10 9.12 Avg. 4.01 9.042 4.09 9.12 SD 0.014 0.015 0.022 0.027 Table 178 Dimensions (mm) of tablets stored for 20 days at 25°C/90% Uncoated Coated thickness diameter thickness diameter 1 4.17 9.21 4.22 9.24 2 4.17 9.22 4.21 9.29 3 4.17 9.20 4.25 9.27 4 4.18 9.20 4.25 9.29 5 4.16 9.20 4.20 9.25 Avg. 4.17 9.206 4.226 9.268 SD 0.007 0.009 0.023 0.023 Table 179 Dimensions (mm) of tablets stored for 20 days at 25°C/75% Uncoated Coated thickness diameter thickness diameter 1 4.12 9.11 4.20 9.2 2 4.12 9.12 4.16 9.2 3 4.10 9.11 4.16 9.16 4 4.07 9.11 4.16 9.19 5 4.14 9.13 4.16 9.19 Avg. 4.11 9.116 4.17 9.19 SD 0.026 0.009 0.018 0.016 234 Table 180 Dimensions (mm) of tablets stored for 20 days at 25°C/65% Uncoated Coated thickness diameter thickness diameter 1 4.07 9.09 4.16 9.16 2 4.11 9.11 4.14 9.18 3 4.11 9.08 4.18 9.18 4 4.09 9.08 4.16 9.18 5 4.09 9.09 4.12 9.15 Avg. 4.094 9.09 4.15 9.17 SD 0.017 0.012 0.023 0.014 Table 181 Dimensions (mm) of tablets stored for 20 days at 25°C/50% Uncoated Coated thickness diameter thickness diameter 1 ' 4.05 9.06 4.08 9.15 2 4.04 9.06 4.09 9.12 3 4.05 9.07 4.11 9.15 4 4.05 9.05 4.10 9.15 5 4.05 9.05 4.16 9.16 Avg. 4.048 9.058 4.1 1 9.15 SD 0.004 0.008 0.031 0.015 Table 182 Dimensions (mm) of tablets stored for 20 days at 25°C/0% Uncoated Coated thickness diameter thickness diameter 1 4.01 9.05 4.06 9.1 1 2 4.02 9.02 4.11 9.1 l 3 4.01 9.03 4.10 9.11 4 4.02 9.03 4.10 9.1 l 5 4.02 9.02 4.10 9.1 1 Avg. 4.016 9.03 4.09 9.1 1 SD 0.005 0.012 0.019 0.000 Table 183 Dimensions (mm) of tablets stored for 70 days at 40°C/90% Uncoated Coated thickness diameter thickness diameter 1 4.16 9.18 4.26 9.24 2 4.22 9.18 4.22 9.26 3 4.17 9.19 4.24 9.25 4 4.17 9.18 4.22 9.25 5 4.21 9.18 4.23 9.27 Avg. 4.186 9.182 4.234 9.254 SD 0.027 0.004 0.017 0.01 l 235 Table 184 Dimensions (mm) of tablets stored for 70 days at 40°C/75% Uncoated Coated thickness diameter thickness diameter 1 4.10 9.10 4.14 9.16 2 4.09 9.13 4.17 9.17 3 4.10 9.10 4.21 9.19 4 4.10 9.10 4.19 9.21 5 4.11 9.12 4.18 9.19 Avg. 4.10 9.11 4.18 9.18 SD 0.007 0.014 0.026 0.019 Table 185 Dimensions (mm) of tablets stored for 70 days at 40°C/65% Uncoated Coated thickness diameter thickness diameter 1 4.10 9.09 4.17 9.17 2 4.09 9.09 4.13 9.16 3 4.09 9.10 4.16 9.16 4 4.10 9.07 4.14 9.16 5 4.09 9.12 4.13 9.17 Avg. 4.094 9.094 4.15 9.16 SD 0.005 0.018 0.018 0.005 Table 186 Dimensions (mm) of tablets stored for 70 days at 40°C/50% Uncoated Coated thickness diameter thickness diameter 1 4.04 9.04 4.12 9.13 2 4.04 9.05 4.12 9.10 3 4.03 9.05 4.09 9.10 4 4.02 9.03 4.09 9.12 5 4.05 9.04 4.07 9.1 1 Avg. 4.036 9.042 4.10 9.1 1 SD 0.01 1 0.008 0.022 0.013 Table 187 Dimensions (mm) of tablets stored for 70 days at 40°C/0% Uncoated Coated thickness diameter thickness diameter 1 4.00 9.02 4.08 9.12 2 4.01 9.01 4.08 9.12 3 4.01 9.02 4.04 9.07 4 4.02 9.01 4.06 9.09 5 3.98 9.01 4.07 9.12 Avg. 4.004 9.014 4.07 9.10 SD 0.015 0.005 0.017 0.023 236 Table 188 Dimensions (mm) of tablets stored for 70 days at 25°C/90% Uncoated Coated thickness diameter thickness diameter 1 4.22 9.23 4.24 9.33 2 4.19 9.22 4.24 9.29 3 4.23 9.22 4.28 9.34 4 4.17 9.23 4.23 9.26 5 4.20 9.22 4.26 9.28 Avg. 4.202 9.224 4.25 9.30 SD 0.024 0.005 0.020 0.034 Table 189 Dimensions (mm) of tablets stored for 70 days at 25°C/75% Uncoated Coated thickness diameter thickness diameter 1 4.10 ' 9.10 4.17 9.24 2 4.07 9.13 4.17 9.17 3 4.08 9.12 4.16 9.20 4 4.06 9.09 4.17 9.17 5 4.09 9.13 4.16 9.19 Avg. 4.08 9.114 4.17 9.19 SD 0.016 0.018 0.005 0.029 Table 190 Dimensions (mm) of tablets stored for 70 days at 25°C/65% Uncoated Coated thickness diameter thickness diameter 1 4.04 9.07 4.13 9.16 2 4.08 9.07 4.17 9.17 3 4.06 9.07 4.13 9.15 4 4.09 9.09 4.13 9.17 5 4.08 9.07 4.17 9.18 Avg. 4.07 9.074 4.15 9.17 SD 0.020 0.009 0.022 0.01 l Table 191 Dimensions (mm) of tablets stored for 70 days at 25°C/50% Uncoated Coated thickness diameter thickness diameter 1 4.03 9.08 4.10 9.13 2 4.04 9.05 4.09 9.14 3 4.05 9.05 4.08 9.10 4 4.04 9.04 4.08 9.13 5 4.09 9.09 4.08 9.13 Avg. 4.05 9.062 4.09 9.13 SD 0.023 0.022 0.009 0.015 237 Table 192 Dimensions (mm) of tablets stored for 70 days at 25°C/0% Uncoated Coated thickness diameter thickness diameter 1 4.00 9.00 4.09 9.12 2 4.00 9.01 4.08 9.10 3 4.00 9.01 4.04 9.09 4 4.00 9.01 4.07 9.09 5 4.03 9.02 4.10 9.11 Avg. 4.006 9.01 4.08 9.10 SD 0.013 0.007 0.023 0.013 Table 193 Dimensions (mm) of tablets stored for 180 days at 40°C/90% Uncoated Coated thickness diameter thickness diameter 1 4.20 9.21 4.20 9.24 2 4.19 9.20 4.24 9.26 3 4.16 9.19 4.26 9.25 4 4.21 9.20 4.23 9.27 5 4.16 9.18 4.23 9.26 Avg. 4.184 9.196 4.232 9.256 SD 0.023 0.011 0.022 0.01 1 Table 194 Dimensions (mm) of tablets stored for 180 days at 40°C/75% Uncoated Coated thickness diameter thickness diameter 1 4.11 9.10 4.19 9.22 2 4.12 9.10 4.17 9.22 3 4.09 9.10 4.22 9.20 4 4.10 9.10 4.20 9.20 5 4.10 9.l0 4.20 9.20 Avg. 4.104 9.10 4.20 9.21 SD 0.011 0.000 0.018 0.011 Table 195 Dimensions (mm) of tablets stored for 180 days at 40°C/65% Uncoated Coated thickness diameter thickness diameter 1 4.10 9.09 4.15 9.15 2 4.08 9.09 4.16 9.17 3 4.08 9.09 4.18 9.17 4 4.08 9.09 4.16 9.17 5 4.08 9.09 4.16 9.17 Avg. 4.084 9.09 4.16 9.17 SD 0.009 0.000 0.01 1 0.009 238 Table 196 Dimensions (mm) of tablets stored for 180 days at 40°C/50% Uncoated Coated thickness diameter thickness diameter 1 4.07 9.04 4.12 9.10 2 4.04 9.04 4.14 9.15 3 4.05 9.04 4.14 9.14 4 4.04 9.04 4.14 9.14 5 4.04 9.04 4.14 9.14 Av . 4.048 9.04 4.14 9.13 ‘ so 0.013 0.000 0.009 0.019 Table 197 Dimensions (mm) of tablets stored for 180 days at 40°C/0% Uncoated Coated thickness diameter thickness diameter . 1 4.00 9.00 4.13 9.12 2 4.00 9.00 4.09 9.12 3 4.00 9.00 4.10 9.12 4 4.00 9.00 4.09 9.12 5 4.00 9.00 4.09 9.12 M. 4.00 9.00 4.10 9.12 SD 0.000 0.000 0.017 0.000 Table 198 Dimensions (mm) of tablets stored for 180 days at 25°C/90% Uncoated Coated thickness diameter thickness diameter 1 4.21 9.22 4.25 9.29 2 4.21 9.24 4.24 9.28 3 4.21 9.22 4.25 9.28 4 4.22 9.22 4.25 9.28 5 4.22 9.22 4.25 9.28 , fig. 4.214 9.224 4.248 9.282 SD 0.005 0.009 0.004 0.004 Table 199 Dimensions (mm) of tablets stored for 180 days at 25°C/75% Uncoated Coated thickness diameter thickness diameter 1 4.06 9.07 4.16 9.19 2 4.04 9.06 4.20 9.20 3 4.07 9.07 4.16 9.17 4 4.06 9.08 4.17 9.19 5 4.07 9.08 4.17 9.19 ALg. 4.06 9.072 4.17 9.19 SD 0.012 0.008 0.016 0.01 1 239 Table 200 Dimensions (mm) of tablets stored for 180 days at 25°C/65% Uncoated Coated thickness diameter thickness diameter 1 4.05 9.04 4.14 9.15 2 4.02 9.05 4.14 9.15 3 4.05 9.05 4.14 9.15 4 4.05 9.05 4.14 9.15 5 4.06 9.05 4.14 9.15 Avg. 4.046 9.048 4.14 9.15 SD 0.015 0.004 0.000 0.000 Table 201 Dimensions (mm) of tablets stored for 180 days at 25°C/50% Uncoated Coated thickness diameter thickness diameter 1 4.02 9.05 4.09 9.10 2 4.02 9.06 4.10 9.09 3 3.99 9.05 4.07 9.09 4 4.02 9.05 4.06 9.10 5 4.02 9.05 4.11 9.09 Avg. 4.014 9.052 4.09 9.09 SD 0.013 0.004 0.021 0.005 Table 202 Dimensions (mm) of tablets stored for 180 days at 25°C/0% Uncoated Coated thickness diameter thickness diameter 1 3.99 9.02 3.95 9.10 2 4.03 9.02 4.00 9.09 3 4.05 9.02 3.97 9.10 4 4.01 9.02 3.96 9.09 5 4.03 - 9.02 3.97 9.13 Avg. 4.022 9.02 3.97 9.10 SD 0.023 0.000 0.019 0.016 240 Appendix G Hardness and Raw Data 241 In order to help explain the effect of intermolecular forces among ingredients in tablets, the hardness of tablets was measured at each condition for 190 days. Table 203 shows the average hardness of tablets measured for 190 days. Table 203 Average hardness of drug X uncoated and coated tablets Hardness (kp) Uncoated tablets Storage time (da 8) Temp (°C) RH (%) 0 6 18 70 100 130 170 190 90 8.9 2.2 1.6 1.6 1.7 1.9 1.7 1.8 75 8.9 5.9 6.5 7.0 7.3 7.6 6.8 6.8 25 65 8.9 6.9 7.4 8.3 8.5 8.7 8.4 8.1 50 8.9 7.2 7.5 7.8 7.8 8.1 7.8 8.2 0 8.9 7.4 7.1 7.4 7.1 7.3 7.1 7.1 90 8.9 2.5 2.6 2.6 3.0 2.7 3.0 3.1 75 8.9 6.7 7.4 7.5 7.4 7.8 8.1 7.7 40 65 8.9 8.0 8.5 8.9 8.8 8.9 9.7 9.5 50 8.9 8.0 8.8 9.4 9.2 9.8 10.1 10.1 0 8.9 7.1 7.5 7.4 7.2 7.3 7.0 7.4 Uncoated tablets Stora e time (da 8) Temj (°C) RH (%) 0 6 18 70 100 130 170 190 90 9.2 2.4 1.8 1.8 1.6 1.9 1.9 1.9 75 9.2 7.6 7.3 8.0 7.5 7.9 7.9 8.4 25 65 9.2 8.0 8.2 9.5 9.0 9.2 9.7 9.6 50 9.2 8.2 8.2 8.8 9.0 9.3 9.2 9.2 0 9.2 8.4 8.2 8.3 8.0 8.4 8.0 8.0 90 9.2 2.5 2.6 2.5 2.6 2.8 3.0 3.0 75 9.2 7.5 8.0 8.4 8.7 9.0 9.2 9.3 40 65 9.2 8.6 9.1 9.7 9.9 10.0 10.9 10.3 50 9.2 8.9 10.2 10.6 10.3 10.8 1 1.2 1 1.2 0 9.2 8.2 8.4 8.4 8.3 8.6 8.4 8.6 After 6 days storage time, the hardness of tablets obtained from all conditions decreased. The hardness of coated and uncoated tablets stored at 90% decreased 3 lot; 242 around 2.2-2.5 kp (kilopond) from 8.9-9.2 kp initial hardness. The hardness of tablets stored at 0% and 75% dropped to around 6-7 kp, then it increased a little as a function of storage time as shown in Figures 98-101. The hardness of tablets stored at 50% and 65% decreased a little (about 1-2 kp) from 9 kp to about 7-8 kp, then it increased as a function of storage time to a value higher than the initial hardness. The hardness values at the initial and 7 day storage times were analyzed statistically using t-tests (see Table 204). Table 204 p-values from t-test between initial and 7 day aged tablet hardness p-value p-value 40°C uncoated coated 25°C uncoated coated 90% 4.1E-19 3 .5E-20 90% 4.2E-19 2.3E-20 75% 1813-08 6.2E-O6 75% 1 .1 E-l l 2.7E-05 65% 6.4E-03 2.1E-02 65% 1.1E-05 2113-04 50% 3 .9E-04 9.0E-02 50% 6615-08 3. 1 E-03 0% 2.6E-08 2.5E-05 0% 5.2E-08 2.1 E-03 As shown in Table 204, the p-values are all less than 0.05 except for coated tablets stored at 40°C/50%. Therefore, it could be concluded that all hardness values from initial tablets to 6 day aged tablets changed significantly except for coated tablets stored at 40°C/50%. The hardness of coated tablets stored for 7 days at 40°C/50% is not significantly different statistically or visually in comparison with the hardness of initial coated tablets. It can be concluded that the hardness at 50% RH was not changed because it is close to the initial condition (42.6% RH). Second, the hardness values from 7 days to 190 days were analyzed statistically using ANOVA. Table 205 shows the p-values from ANOVA. 243 Table 205 p—values from AN OVA between 7 to 190 day aged tablet hardness p-value p-value 40°C uncoated coated 25°C uncoated coated 90% l .1 E-03 1.0E-O9 90% 1 .4E-1 1 8.3E-20 75% 2.6E-05 6.1E-O4 75% 9.18-05 1.5E-02 65% 2.1 E-O8 8.1E-07 65% 5.3E-08 2.8E-O6 50% 1.2E-12 1.3E-1 1 50% 1.2E-O6 2.2E-05 0% 1.0E-02 3.2E-01 0% 2.8E-01 2.6E-01 25°C/0% are greater than 0.05. Therefore, they are not significantly different for 7 to 190 days. However, the hardness of tablets stored at other conditions is significantly different for 7 to 190 days because the p-values are less than 0.05. This can also be recognized by inspecting Figures 98-105. also be explained by the swelling property. The swollen croscarmellose make boundary strength among excipients weak. Therefore, the hardness of tablets decreases quickly at a high relative humidity. 244 As shown in Table 205, p-values of coated/uncoated tablets stored at 40°C, When tablets were stored at higher RH, the hardness decreased quickly. It can 10.0 8.0 2 g 6.0 ~ ‘ : § 4.0 « I 1 I ; 2.0 _, v 4 :W i 1 0.0 r . 1 i 0 50 100 150 200 Storage time (days) O90%RH I 75%RHA65%RHX50%RH*0%RH Figure 98 Hardness of drug X uncoated tablets stored at 25°C as a function of storage time (each point is average value for 10 tablets) 12.0 --.--.__-.._._,-_-,___._ ,,. Hardness (kp) 2,0 1 f W 0.0 0 50 100 150 200 Storage time (days) 990%RH I 75%RHA65%RHX50%RH*0%RH Figure 99 Hardness of drug X coated tablets stored at 25°C as a function of storage time (each point is average value for 10 tablets) 245 1:! 0 ..., ~...........--i__._um_1“--....M,___...__.-..__...H.___F,_-_,,~-...a_..._.___--__.a._.-_.__-.. . 10.0 - g 8.0 — § 6.0- t: E a: 4.0 ~ I 2.0 . 0.0 1 1 1 1 0 50 100 150 200 Storage time (days) 990%RH I 75%RHA65%RH X50%RH7K0%RH Figure 100 Hardness of drug X uncoated tablets stored at 40°C as a function of storage time (each point is average value for 10 tablets) Hardness (kp) 0.0 3 0 50 100 150 200 Storage time (days) 090%RH I 75%RHA65%RHX50%RH*O%RH Figure 101 Hardness of drug X coated tablets stored at 40°C as a function of storage time (each point is average value for 10 tablets) 246 Also, there is evidence for differences in tablet hardness at different temperatures. Figures 102 and 104, and 103 anleS show the hardness values of tablets stored at 40°C are higher than those of tablets stored at 25°C, and they also show the hardness increased as a function of storage time, as concluded before. The tablets stored around 50-65% RH have the greatest hardness. 120 - “we.--” ”_.-._...“mz_---_”--- ”_..._--L--- _ _MM . _ _-., _---..,-._-W.,,,- - _.-.. .. . - --fi- _MWH ..- 10.0 . 8.0 ~ 6.0 ~ Hardness (kp) 4.0 - 2.0 4 0.0 T T 1 l 1 0 20 40 60 80 100 RH(%) — initial tablets It = 6 days At = 18 days Xt = 70 days in = 100 days 0t = 130 days +t = 170 days .t = 190 days Figure 102 Hardness of drug X uncoated tablets at 25°C as a function of RH (%) (each point is average value for 10 tablets) 247 12.0 ~ 10.0 « 8.0 6.0 « Hardness (kp) 4.0 < 2.0 « 0.0 T i f 0 20 40 60 80 100 RH(%) — initial tablets It = 6 days At = 18 days Xt = 70 days *t = 100 days 0t = 130 days +t = 170 days .t = 190 days Figure 103 Hardness of drug X coated tablets at 25°C as a function of RH (%) (each point is average value for 10 tablets) 10.0 « 8.0 « 6.0 ~ Hardness (kp) 4.0 4 2.0 4 0.0 . T , . 0 20 40 60 80 100 RH(%) — initial tablets It = 6 days At = 18 days Xt = 70 days *t = 100 days 0t = 130 days +t = I70 days .t = 190 days Figure 104 Hardness of drug X uncoated tablets at 40°C as a fimction of RH (%) (each point is average value for 10 tablets) 248 Hardness (kp) 0.0 20 T 40 T 60 80 100 RH(%) — initial tablets It=6days At= 18 days Xt= 70 days *t= 100 days Ot= 130 days +t= 170 days Ot= 190 days Figure 105 Hardness of drug X coated tablets at 40°C as a fimction of RH (%) (each point is average value for 10 tablets) Inspection of Figures 102-105 shows that the hardness of tablets stored at 40°C was greater than those stored at 25°C. Table 206 shows p-values from t-test analysis. Table 206 p-values from t-test between hardness of tablets stored at 25’C and 40°C (p- values greater than 0.05 are bold-faced) p-values from t-test RH (%) l month 2 months 3 months 4 months 5 months 6 months uncoated 1.3 308 4.05-07 1.75-09 4.6E-09 l . I E— 10 l .ZE- 10 90 coated 2.8E-08 1.25-12 5.2E-l 1 2613-1 1 3.85-12 2.0E-1 l uncoated 1 08-02 1.7E—01 6.6E-01 3.7E-01 3 .3 E-03 2513-03 75 coated 1. l E-02 228-0| 2.4E-03 l .213-02 4.05-03 5.2 E-02 uncoated 1.8E-05 4.0E-03 2.3E-01 3.4E-01 2.2E-04 7.55-06 65 coated l .0E-O3 6.9E-01 l .9E-02 4.05-05 4.3 E-OZ 1.0E-01 uncoated 7.25-09 5.0Eo06 1.3E-05 l .4 132-07 8.3 E-i l 8.25-10 50 coated 5.05—06 8.0E-07 4.8E-06 3.0504 4.3 E-07 2.2E-08 uncoated 1.5E-01 9.5E-01 5.5E-01 7.4E-0l 3.1 E—Ol 7.8E-02 0 coated 7.8 E-02 4.1 E-01 2.7 E-01 4.2 E-01 6.3 E-02 5 .5 E-03 249 The hardness at 0% RH is not significantly different between 25°C and 40°C because the p-values are greater than 0.05 during most of the storage time. The hardness at 50% and 90% is significantly different between 25°C and 40°C because the p-values are less than 0.05 at all storage times. Five p-values at 75% and four p-values at 65% are greater than 0.05, but more p-values are less than 0.05. Figures 102-105 show that the hardness of tablets stored at 40°C/75% and 65% is greater than hardness of those stored at 25°C/75% and 65%. Therefore, it can be concluded that the hardness of tablets stored at 40°C is greater than those stored at 25°C, except for 0% RH. This may explain why the dissolution of tablets stored at 40°C decreased a lot more quickly than for tablets stored at 25°C. See Chapter 4.4. Propgsed theog of dissolution retardation as a function of relative humidity for a more detailed explanation. The hardness of tablets is decreased by moisture absorption. The hardness at 25°C/90% and 40°C/90% changed to 2 kp from 9 kp. The tablets at those conditions are still hard if they are squeezed as shown in Figure 106. However, if they are bent as shown in Figure 107, they can be broken very easily in comparison to initial tablets. 250 \ \. (a) Squeeze in the thickness direction (b) Squeeze in the diameter direction Figure 106 Graphical representation of the tablet squeezing in the thickness and diameter directions by fingers I.' \'\ . .' ..i I ( ’ 3&8...” '. / (A ,I.\\ fiat" \Eiii' // / . s .\ .I '- I \ ‘ Figure 107 Graphical representation of the tablef breaking by fingers Tablets will soften in a short time if they are packaged in PVC blisters and stored at a high relative humidity. Therefore, pharmaceutical companies may not want to use PVC blisters for solid dosage forms even if dissolution is high enough for a long time. It must be determined whether 2 kp hardness is enough for use of blister packages or not. Tablets obtained from the open dish study (0%, 50%, 65%, 75%, 90% at 25/40°C) were packaged in PVC blisters by using a blister thermoform heat sealing machine. The thickness of PVC film was 10 mil, and the thickness of the backing film (paper/Al laminate) was 1.9 mil. 251 As shown in Table 207, some of the tablets from 90% RH were broken when the blister packages were opened. Therefore, the hardness of tablets stored at 90% RH was not enough for the blister packaging. Though the hardness also decreased at the other conditions, the tablets were still hard enough to be used with the blisters since none of them broke, as shown in Table 207. Table 207 The results of PVC blister opening tests (the number of broken tablets/the number of trials) Temp. “11%) 0% 50% 65% 75% 90% Hardness of uncoated tablets (kp) 7.12 7.51 7.43 6.48 1.59 25°C Opening test with PVC blisters 0/10 0/10 0/10 0/10 6/10 Hardness of coated tablets (kp) 8.18 8.19 8.16 7.25 1.83 Openingtest with PVC blisters 0/10 0/10 0/10 0/10 2/10 Hardness of uncoated tablets (kp) 7.51 8.81 8.45 7.44 2.63 40°C Opening test with PVC blisters 0/10 0/10 0/10 0/10 2/10 Hardness of coated tablets (kp) 8.44 10.17 9.1 8.02 2.6 Opening test with PVC blisters 0/10 0/10 0/10 0/10 0/10 Table 208 shows the hardness of the initial tablets and Tables 209-218 show the hardness of tablets stored at 25/40°C, 0%, 50%, 65%, 75%, 90% RH for 190 days. 252 Table 208 Hardness (kp) of initial tablets | [1 2 3 4 5 6 7 8 9 10|avg.|sol [uncoated ] 9.8 9 9.2 8.4 8.6 8.7 8.9 9.5 8.6 8.3 | 8.9| 0.48| [coated I 9.1 8.6 9.7 9.7 9.5 9.2 9.7 8.6 9.1 8.9 I 9.21 | 0.43 | Table 209 Hardness (kp) of tablets stored at 40°C/90% as a function of storage time Uncoated ' Coated . 7 21 70 100 130 170 190 7 21 70 100 I30 I70 190 l 2.8 2.8 2.9 2.8 2.8 2.7 2.9 2.5 2.7 2.4 2.6 2.7 3.2 2.8 2 2.5 2.6 2.5 2.6 2.8 2.7 2.6 2.4 2.9 2.6 2.5 2.7 2.9 3.4 3 2.5 2.8 3.2 2.7 2.9 2.9 3.1 2.7 2.9 2.5 2.8 2.8 3.2 2.9 4 2.4 3.3 2.8 3.0 2.9 2.8 3.2 2.5 2.8 2.7 3.0 2.9 2.9 3.1 5 2.5 2.5 2.8 2.7 2.5 3.0 2.7 2.6 2.6 2.6 2.5 2.7 3.0 2.8 6 2.5 2.5 3.2 3.2 2.6 3.1 3.1 2.2 2.4 2.6 2.6 2.8 3.2 2.8 7 2.4 2.4 2.0 3.5 2.5 3.0 3.1 2.6 2.6 2.4 2.8 2.9 3.2 3.1 8 2.5 2.5 2.8 2.8 2.8 2.7 3.3 2.6 2.3 2.5 2.6 2.9 3.1 3.1 9 2.6 2.7 2.0 2.7 2.4 3.5 3.4 2.7 2.6 2.5 2.6 2.4 2.8 3.0 10 2.3 2.2 2.8 3.2 3.0 2.9 2.8 2.5 2.2 2.4 2.2 3.0 2.7 3.3 M 2.5 2.6 2.6 3.0 2.7 3.0 3.1 2.5 2.6 2.5 2.6 2.8 3.0 3.0 SD 0.2 0.3 0.4 0.3 0.2 0.2 0.3 0.1 0.2 0.1 0.2 0.2 0.2 0.2 Table 210 Hardness (kp) of tablets stored at 40°C/75% as a function of storage time Uncoated Coated 8 21 70 100 130 170 190 8 21 70 100 130 170 190 6.3 7.3 6.8 7.3 7.6 7.4 7.8 7.7 9.6 9.0 9.0 8.5 7.9 8.4 6.1 7.1 8.5 7.4 7.4 8.2 7.6 6.9 8.4 7.6 9.4 8.4 10.2 7.9 7.1 8.9 7.1 8.5 8.5 8.1 7.7 7.8 7.4 8.1 9.0 8.3 10.0 9.9 6.6 7.5 7.5 7.1 7.8 7.9 7.3 7.6 8.5 9.2 7.6 10.8 8.6 9.9 6.6 6.9 7.6 7.2 7.3 8.4 8.3 6.7 7.6 7.9 7.9 10.4 11.0 8.4 6.3 7.4 7.0 8.2 7.4 8.1 7.5 7.5 7.7 8.3 9.5 9.0 9.1 9.3 6.9 8.8 7.5 7.3 7.6 8.1 7.5 6.8 8.2 10.2 7.4 8.1 10.3 8.4 6.4 6.8 7.7 ' 7.2 7.8 7.0 7.6 7.1 7.8 7.4 8.7 8.5 8.4 9.3 8.0 6.8 7.5 6.9 8.3 9.9 7.4 9.0 7.2 7.6 9.9 8.1 8.0 10.5 OOQQOKM-wa—I — 6.2 6.9 7.3 7.1 8.0 7.8 8.0 8.3 7.8 8.8 8.9 10.0 8.5 l 1.3 Avg. 6.7 7.4 7.5 7.4 7.8 8.1 7.7 7.5 8.0 8.4 8.7 9.0 9.2 9.3 SD 0.6 0.8 0.5 0.5 0.4 0.8 0.3 0.7 0.7 0.9 (1.8 I .0 1.1 1.1 253 Table 211 Hardness (kp) of tablets stored at 40°C/65% as a function of storage time Uncoated Coated 6 19 70 100 130 170 190 6 19 70 100 130 170 190 1 8.1 8.7 8.5 8.1 9.1 9.1 9.9 8.7 9.1 9.8 9.4 9.6 13.8 9.6 2 7.6 8.0 8.3 8.4 9.0 9.6 8.9 9.4 8.8 9.6 1 1.0 10.1 10.0 10.6 3 8.3 8.9 9.3 8.7 8.8 9.3 9.7 8.3 8.2 9.5 9.3 10.0 1 1.1 10.4 4 8.0 8.1 9.5 8.4 9.1 9.7 9.1 9.8 8.4 9.0 10.2 9.6 9.5 10.3 5 7.3 8.5 8.7 9.5 8.2 l 1.5 9.7 8.6 9.4 9.6 1 1.4 10.0 9.8 10.4 6 9.9 8.3 9.1 9.3 9.2 9.7 9.4 7.6 8.8 9.8 8.5 10.7 9.6 9.5 7 7.4 8.6 8.3 9.2 9.3 9.8 9.5 8.8 9.2 9.4 9.8 10.4 10.0 10.7 8 7.2 8.7 8.8 8.8 8.8 9.1 9.5 8.0 9.1 9.0 9.1 9.7 11.1 9.8 9 7.8 7.8 9.4 8.9 8.9 9.5 9.0 8.6 10.6 1 1.8 9.7 10.4 12.0 10.1 10 8.4 8.9 8.6 9.0 8.5 9.2 9.8 7.9 9.4 9.3 10.4 9.4 12.1 1 1.6 Avg. 8.0 8.5 8.9 8.8 8.9 9.7 9.5 8.6 9.1 9.7 9.9 10.0 10.9 10.3 so 0.8 0.4 0.4 0.4 0.3 0.7 0.3 0.7 0.7 0.8 0.9 0.4 1.4 0.6 Table 212 Hardness (kp) of tablets stored at 40°C/50% as a function of storage time Uncoated Coated 6 19 70 100 130 170 190 6 19 70 100 130 170 190 l 8.2 8.4 9.4 8.1 9.4 10.5 10.0 9.0 9.3 9.7 10.0 9.9 1 1.4 l 1.0 2 7.2 8.7 10.4 10.3 9.4 10.8 9.1 9.0 10.6 11.2 10.5 12.4 12.4 11.6 3 7.8 9.0 9.9 8.9 10.2 9.6 10.4 8.3 9.8 10.0 10.6 1 1.6 l 1.1 1 1.0 4 7.1 9.2 9.0 9.2 9.4 10.6 10.4 9.2 10.4 10.9 10.1 10.5 10.7 10.9 5 8.6 8.8 10.0 9.4 9.8 9.8 10.4 8.4 10.4 10.5 9.6 10.3 10.5 1 1.3 6 8.2 8.8 9.5 10.0 9.8 10.0 10.3 9.5 10.5 1 1.4 10.2 1 1.4 10.8 1 1.1 7 8.1 8.4 8.6 9.1 10.0 10.0 10.4 8.6 9.2 10.9 10.7 10.2 12.4 1 1.4 8 8.2 8.8 9.0 8.8 10.4 10.0 9.5 8.8 9.9 10.1 10.1 10.8 1 1.3 10.7 9 7.7 9.4 9.4 9.4 9.3 9.1 10.5 8.7 12.1 1 1.2 10.3 1 1.2 l 1.6 10.8 10 8.4 8.6 8.5 9.2 10.6 10.2 9.9 9.3 9.5 10.2 10.7 9.5 10.2 12.2 Avg. 8.0 8.8 9.4 9.2 9.8 10.1 10.1 8.9 10.2 10.6 10.3 10.8 1 1.2 l 1.2 SD 0.5 0.3 0.6 0.6 0.5 0.5 0.5 0.4 0.8 0.6 0.4 0.9 0.7 0.4 Table 213 Hardness (kp) of tablets stored at 40°C/0% as a function of storage time Uncoated Coated 5 18 70 100 130 170 190 5 18 70 100 130 170 190 1 6.8 7.4 7.8 7.1 6.9 7.1 7.6 7.9 8.7 8.8 7.5 8.5 8.1 8.0 2 7.9 7.1 7.2 7.8 7.2- 7.4 7.1 8.1 8.2 8.6 8.4 8.6 8.4 8.8 3 7.2 8.1 7.4 7.3 7.6 6.4 7.8 8.2 8.1 8.6 8.2 8.8 9.6 8.6 4 6.7 7.1 7.4 7.5 8.0 6.8 7.7 8.4 8.3 7.6 8.6 8.1 8.6 8.1 5 7.1 7.6 6.5 6.6 7.3 7.3 7.3 8.1 8.5 8.9 9.2 8.6 8.4 8.6 6 7.2 9.3 7.8 7.3 6.9 6.7 7.1 8.4 8.9 8.3 8.7 8.6 8.4 8.4 7 7.4 7.0 7.6 7.3 7.1 7.3 6.8 8.6 8.0 8.7 8.1 9.1 7.7 9.4 8 7.0 7.3 7.3 6.8 7.4 6.6 7.9 7.8 8.0 8.2 7.8 8.5 8.4 8.9 9 6.6 7.2 7.6 6.7 7.4 7.2 7.5 8.8 9.0 8.2 8.1 8.5 7.9 8.5 10 6.7 7.0 7.5 8.0 6.9 6.8 7.4 7.5 8.7 8.0 8.0 8.4 8.6 8.2 Avg. 7.1 7.5 7.4 7.2 7.3 7.0 7.4 8.2 8.4 8.4 8.3 8.6 8.4 8.6 SD 0.4 0.7 0.4 0.5 0.4 0.3 0.3 0.4 0.4 0.4 0.5 0.3 0.5 0.4 254 Table 214 Hardness (kp) of tablets stored at 25°C/90% as a function of storage time Uncoated Coated 7 20 70 100 130 170 190 7 20 70 100 130 170 190 1 2.2 1.7 1.5 1.6 1.9 1.9 1.5 2.4 1.9 1.8 1.6 2.0 1.9 1.9 2 2.1 1.5 1.7 2.1 1.9 1.6 1.7 2.6 1.9 1.8 1.5 1.8 1.8 2.0 3 2.6 1.4 1.6 1.7 1.8 1.6 1.9 2.2 1.9 1.8 1.7 1.7 2.0 1.7 4 2.5 1.9 1.8 1.8 1.6 1.6 1.8 2.3 1.8 1.6 1.8 1.9 1.9 1.6 5 2.4 1.8 1.6 1.6 2.0 1.7 1.6 2.4 1.8 1.8 1.6 2.0 1.9 1.9 6 2.1 1.5 1.8 1.7 1.8 1.8 1.8 2.5 2.0 1.9 1.5 1.9 2.1 1.9 7 2.2 1.5 1.6 1.8 2.1 2.0 2.0 2.5 1.8 1.9 1.6 2.0 1.9 1.8 8 2.1 1.5 1.5 1.5 1.9 1.5 1.9 2.5 1.8 1.8 1.5 1.8 1.7 2.1 9 2.1 1.6 1.7 1.8 2.0 1.5 1.7 2.2 1.8 1.8 1.5 1.9 1.7 1.8 10 2.0 1.5 1.4 1.5 2.0 1.5 1.8 2.2 1.6 1.8 1.5 1.8 1.8 1.8 Avg. 2.2 1.6 1.6 1.7 1.9 1.7 1.8 2.4 1.8 1.8 1.6 1.9 1.9 1.9 SD 0.2 0.2 0.1 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 Table 215 Hardness (kp) of tablets stored at 25°C/75% as a function of storage time Uncoated Coated 7 20 70 100 130 170 190 7 20 70 100 130 170 190 1 5.6 5.8 7.0 9.1 7.6 8.9 7.2 8.4 7.1 7.5 7.7 8.0 7.7 8.9 2 6.6 6.4 7.1 6.8 7.3 6.4 7.5 7.6 7.5 8.2 6.8 7.3 7.8 8.6 3 6.3 5.8 7.2 6.7 7.6 6.5 6.4 8.0 6.9 7.8 7.7 8.7 7.1 9.6 4 5.6 6.0 6.0 6.6 7.4 6.6 6.9 8.0 6.8 7.6 8.3 ' 7.7 8.6 7.7 5 6.2 6.5 8.3 6.7 7.7 6.4 6.1 6.5 7.2 7.3 7.6 8.4 8.8 8.8 6 6.1 7.6 6.3 9.2 8.6 6.1 8.4 6.8 8.2 8.1 8.2 7.2 8.1 8.3 7 5.7 5.5 6.4 6.8 7.8 8.0 6.3 6.5 7.3 8.5 6.4 9.1 6.7 6.9 8 5.4 6.9 6.8 6.9 7.4 6.5 6.4 7.5 7.5 9.0 7.7 8.5 8.5 8.5 9 5.4 6.9 6.4 6.9 7.4 6.8 6.5 9.0 6.4 8.2 8.2 7.3 8.0 7.6 10 5.9 7.4 8.6 6.9 7.3 5.9 6.5 7.5 7.6 7.8 6.5 6.9 7.3 9.4 ‘ _Avg 5.9 6.5 7.0 7.3 7.6 6.8 6.8 7.6 7.3 8.0 7.5 7.9 7.9 8.4 SD 0.4 0.7 0.9 1.0 0.4 0.9 0.7 0.8 0.5 0.5 0.7 0.7 0.7 0.8 Table 216 Hardness (kp) of tablets stored at 25°C/65% as a function of storage time Uncoated Coated 5 19 70 100 130 170 190 5 19 70 100 130 170 190 l 6.9 6.8 7.8 8.2 8.4 9.5 8.5 7.7 7.7 9.0 8.7 9.4 10.2 8.3 2 6.5 8.0 8.2 8.9 8.6 8.3 8.1 8.0 8.6 8.5 8.8 9.4 9.3 8.5 3 7.1 7.5 8.6 7.2 8.0 7.9 8.2 7.6 8.1 8.9 8.6 9.0 l 1.0 10.5 4 6.5 7.3 8.2 8.2 7.8 8.4 7.7 9.4 7.8 8.7 9.6 8.9 8.5 12.0 5 6.5 7.6 8.3 8.0 8.9 8.3 6.8 8.3 8.7 9.8 8.7 9.4 8.4 10.0 6 6.7 7.8 7.9 10.4 8.8 8.1 7.6 8.9 8.2 10.5 9.2 9.0 8.6 9.6 7 6.3 7.2 8.4 8.3 8.8 8.5 8.2 7.3 8.0 8.5 8.6 9.2 10.0 9.1 8 6.4 7.9 7.8 8.1 9.1 8.5 8.6 7.3 7.9 9.6 10.0 9.4 9.4 9.8 9 9.4 7.3 8.7 9.0 9.2 7.9 8.8 8.1 8.7 1 1.1 8.6 9.1 10.7 9.5 10 7.1 6.9 8.7 8.3 9.4 8.8 8.5 7.4 7.9 10.6 9.6 9.2 1 1.0 9.0 Avg. 6.9 7.4 8.3 8.5 8.7 8.4 8.1 8.0 8.2 9.5 9.0 9.2 9.7 9.6 SD 0.9 0.4 0.3 0.8 0.5 0.5 0.6 0.7 0.4 0.9 0.5 0.2 1.0 1.1 255 Table 217 Hardness (kp) of tablets stored at 25°C/50% as a function of storage time Uncoated Coated 5 19 70 100 130 170 190 5 19 70 100 130 170 190 1 7.3 7.3 8.5 7.9 8.4 7.7 8.3 9.7 7.4 8.2 8.7 10.2 8.8 8.6 2 6.7 7.3 7.2 7.7 7.2 8.0 8.1 7.0 7.7 8.6 8.5 9.9 9.2 8.9 3 7.5 7.9 7.5 7.9 8.5 7.5 7.7 8.1 7.7 9.6 9.4 8.7 9.4 8.4 4 7.0 7.6 8.0 8.0 8.2 7.7 8.1 8.0 8.7 8.4 8.9 8.8 8.7 8.8 5 7.0 7.7 7.4 7.1 8.6 7.5 8.3 7.7 7.9 8.1 10.1 9.4 8.7 9.5 6 8.0 7.4 7.5 8.5 7.7 8.0 8.4 8.8 8.2 8.5 8.6 9.1 9.3 10.0 7 6.9 7.7 7.9 7.8 7.4 8.1 8.0 8.4 8.6 9.2 8.7 9.1 9.3 9.4 8 7.3 7.4 8.1 7.8 8.4 7.7 8.3 7.5 8.8 9.1 8.4 8.6 9.1 9.1 9 7.4 7.7 7.7 7.3 8.2 7.7 8.4 8.0 8.5 9.4 9.5 10.0 9.1 9.8 10 7.0 7.1 8.5 8.4 8.2 7.7 8.3 9.1 8.4 8.8 9.0 9.3 10.1 9.2 .515: 7.2 7.5 7.8 7.8 8.1 7.8 8.2 8.2 8.2 8.8 9.0 9.3 9.2 9.2 SD 0.4 0.2 0.4 0.4 0.5 0.2 0.2 0.8 0.5 0.5 0.5 0.6 0.4 0.5 Table 218 Hardness (kp) of tablets stored at 25°C/0% as a fimction of storage time Uncoated Coated 5 18 70 100 130 170 190 5 18 70 100 130 170 190 1 7.4 7.0 7.1 7.3 7.8 7.2 7.8 8.5 8.0 7.7 7.4 8.6 8.4 8.4 2 7.2 7.4 6.7 6.9 8.1 7.8 6.8 8.5 8.0 8.4 7.6 7.9 8.8 7.6 3 7.3 6.8 7.3 7.3 7.4 7.3 7.3 8.6 8.0 7.9 8.4 8.2 7.9 8.2 4 7.4 6.5 7.8 7.0 7.1 7.3 7.4 7.9 8.2 8.5 8.0 8.1 7.5 7.9 5 7.5 7.1 7.5 6.8 7.2 7.3 7.3 7.9 8.1 8.5 7.9 7.9 7.8 8.2 6 7.9 6.7 7.3 7.0 6.6 6.6 6.9 7.7 8.0 8.6 8.6 7.9 7.8 7.9 7 7.2 7.8 7.5 7.6 7.6 7.1 6.8 7.7 8.6 8.7 8.1 8.7 8.5 7.8 8 7.6 7.3 8.0 7.1 7.4 6.5 7.4 9.5 8.1 8.0 7.9 9.3 7.9 8.0 9 7.1 7.2 7.1 7.2 6.9 7.3 6.6 8.3 8.6 8.2 8.0 7.7 7.5 8.6 10 7.1 7.4 7.7 7.2 7.2 6.9 6.9 9.1 8.2 8.0 8.5 9.6 7.8 7.6 _A_vg. 7.4 7.1 7.4 7.1 7.3 7.1 7.1 8.4 8.2 8.3 8.0 8.4 8.0 8.0 SD 0.2 0.4 0.4 0.2 0.4 0.4 0.4 0.6 0.2 0.3 0.4 0.6 0.4 0.3 256 BIBLIOGRAPHY Abdou, H.M., 1989, Dissolution, Bioavailability & Bioequivalence, Mack Publishing, Eaton, PA. Adams, 8., 1999, Dissolution Shelf Life of Hydroxypropyl Methyl Cellulose Coated Aspirin Tablets at I.C.H. Temperatures and Various Relative Humidities. MS. Thesis, Michigan State University. Almeida, L.P., Simoes, S., Brito, P, Portugal A., and Figueiredo, M., 1997, Modeling Dissolution of Sparingly Soluble Multisized Powders, Journal of Pharmaceutical Sciences, 86(6), pp. 726-732 ASAE D271 , Psychrometric Data, American Society of Agricultural Engineers, St Joseph, MI ASTM D 895-94, Standard Test Method for Water Vapor Permeability of Packages, American Society for Testing and Materials, West Conshohocken, PA ASTM E 96, Standard Test Methods for Water Vapor Transmission of Materials, American Society for Testing and Materials, West Conshohocken, PA ASTM E 104-85, Standard Practice for Maintaining Constant Relative Humidity by Means of Aqueous Solutions, American Society for Testing and Materials, West Conshohocken, PA Banker, (3.8. and Rhodes, C.T., 1989, Modern Pharmaceutics (2“! ed), Ch.10. Tablet Dosage Forms, Marcel Dekker, Inc., New York, NY Bell, L.N. and Labuza, T.P., 2000, Moisture Sorption: Practical Aspects of Isotherm Measurement and Use (2"d edition), American Association of Cereal Chemists, Inc., St. Paul, MN Bizot, H., 1983, Using the ‘G.A.B.’ model to construct sorption isotherms, Physical Properties of Foods, pp. 43-53, Applied Sciences Publishers, New York, NY Bluhm, T., Deslandes, Y., Marchessault, RH, and Sundararajan, RR, 1980, Water in Polymers, ACS Symposium Series 127, American Chemical Society, Washington, DC, pp. 253-272 Bolhuis, G.K., Smallenbroek, A.J., and Lerk, C.F., 1981, Interaction of Tablet Disintegrants and Magnesium Stearate During Mixing, I. Effect on Tablet Disintegration, Journal of Pharmaceutical Science, 70, 1328 257 Carstensen, J.T., Kothari, R., and Chowhan, Z.T., 1980, Correlation Between Tablet Disintegration and in Vitro Dissolution, Drug Development and Industrial Pharmacy, 6(6), pp. 569-571 Carstensen, J.T., 1993, Pharmaceutical Principles of Solid Dosage Forms, Technomic Publishing Company, Inc., Lancaster, PA Carstensen, J. T. and Rhodes, C. T., 2000, Drug Stability. Principles and Practices (3” edition), Marcel Dekker, Inc., New York, NY Chowan, Z.T., 1980, The Effect of Low and High Humidity Aging on the Hardness, Disintegration Time and Dissolution Rate of Dibasic Calcium Phosphate-Based Tablets, Journal of Pharm Pharmacol, 32(10) Chowhan, Z.T. and Chi, L., 1986, Drug - Excipient Interactions Resulting from Powder Mixing 111: Solid State Properties and Their Effect on Drug Dissolution. Journal of Pharmaceutical Sciences. 75(6), pp. 534-541 Chowhan, Z.T., March 1994, Drug Substance Physical Properties and Their Relationship to the Performance of Solid Dosage Forms. Pharmaceutical Technology. pp. 44-60. Chowhan, Z.T., September 1994, Factors Affecting Dissolution of Drugs and Their Stability Upon Aging in Solid Dosage Forms. Pharmaceutical Technology. pp. 60-73. Derbyshire, H.M., Feldman, Y., Bland, C.R., Broadhead, J., and Smith, G., 2001, A Study of the Molecular Properties of Water in Hydrated Mannitol. Journal of Pharmaceutical Science. 91(4), pp. 1080-1088 Diosady, L.L., Rizvi, S.S.H., Cai, W., and Jagdeo, D.J., 1996, Moisture Sorption Isotherms of Canola Meals, and Applications to Packaging, Journal of Food Science, 61(1), pp. 204-208 Downes, T.W. and Lee, J ., 1989, DOS-based shelf life computer program, School of Packaging, Michigan State University El-Yazigi, A., 1981, Disintegration-Dissolution Analysis of Percent Dissolved-Time Data, Journal of Pharmaceutical Science, 70(5), pp. 535-537 Fu, J .C., Hagemeir, C., and Moyer, D.L., 1976, A Unified Mathematical Model for Dissusion from Drug-Polymer Composite Tablets, Journal of Biomedical and Material Research, 10, pp. 743-758 Guidance for Industry, June 1998, Stability Testing of Drug Substances and Drug Products, U.S. Food and Drug Administration, Rockville, MD 258 Hernandez, R., 1998, PKG 815 Class Note, School of Packaging, Michigan State University Higuchi, W.I. and Hiestand, EN, 1963, Dissolution Rates of Finely Divided Drug Powders I. Effect of a Distribution of Particle Size in a Diffusion-Controlled Process, .1. of Pharmaceutical Science, 52, pp. 67-71 Kadir, S., Yata, N., Kawata, M., and Goto, S., 1986, Effect of Humidity Aging on Disintegration, Dissolution and Cumulative Urinary Excretion of Calcium p- Aminosalicylate Formulations, Chem. Pharm. Bull, 34, pp. 5102-5109 Kibbe, H., 2000, Handbook of Pharmaceutical Excipients (3’d edition), American Pharmaceutical Association and Pharmaceutical Press, Kokitkar, MP, 1997, Prediction of Shelf Life of a Moisture Sensitive Drug at high Relative Humidity and Temperature Using Dissolution as a Function of Moisture Content. MS. Thesis, Michigan State University. Kontny, M.J., Koppenol, S., and Graham, E.T., 1992, Use of the sorption-desorption moisture transfer model to assess the utility of a desiccant in a solid product, International Journal of Pharmaceutics, 84, pp. 261-271 Labuza, T.P., Mizrahi, S., and Karel, M., 1972, Mathematical models for optimization of flexible film packaging of foods for storage. Trans. Am. Soc. Agric. Eng. 15, pp. 150-155 Marshall, K. and Rudnic M. 13., 1989, Modern Pharmaceutics (2“! ed), Cth. Tablets Dosage Forms, Marcel Dekker, Inc., New York, NY Moore, J.W. and F lanner, H.H., June 1996, Mathematical Comparison of Dissiolution Profiles, Pharmaceutical Technology, pp. 64-74 Nakabayashi, K., Shimanoto T., and Hanatani S., 1981, Stability of Packaged Solid Dosage Forms. VI. Shelf Life Prediction of Packaged Prednisolone Tablets in Relation to Dissolution Properties. Chem. Pharm. Bull, 29(7), pp. 2057-2061 Nakai, Y., Fukuoka, 13., Nakajima, S., and Hasegawa, J ., 1977, Crystallinity and Physical Characteristics of Microcrystalline Cellulose. Chem. Pharm. Bull, 25(1), pp. 96-99 Pocas, M., 1995, Modeling the Moisture Transfer of Two-Component Food Products in a Flexible Package. MS. Thesis, Michigan State University. Qian, X., 1996, Dissolution Stability for Packaging Application. MS. Thesis, Michigan State University. 259 Ross MS. and Rasis M., 1998, Mega Paddle-A Recommendation to Modify Apparatus 2 Used in the USP General Test for Dissolution <711>, Pharmacopeial Forum, 24(3), pp. 6351-6359 Siegel, J., 2001, ASHRAE Handbook: Fundamentals, American Society of Heating, Refrigeration and Air-Conditioning Engineers, Atlanta, GA Siepmann, J ., Podual, K., Sriwongianya, M., Peppas, N.A., and Bodmeier, R., 1999, A New Model Describing the Swelling and Drug Relaease Kinetics from Hydroxypropyl Methylcellulose Tablets, Journal of Pharmaceutical Sciences, 88(1), pp. 65-72 Suemag, .1 ., 2001, Dissolution Shelf Life of Packaged Pharmaceutical Tablet by Prediction and Experiment, MS. Thesis, Michigan State University. Taborsky-Urdinola, C.T., Gray V.A., and Grady L.T., 1981, Effect ‘of Packaging and Storage on the Dissolution of Model Prednisone Tablets. Am. J. Hosp. Pharm., 38: 1322. Thibert, R. and Hancock, B.C., 1996, Direct Visualization of Superdisintegrant Hydration Using Environmental Scanning Electron Microscopy, J of Pharmaceutical Sciences, 85(11), pp. 1255-1258 Thomas, M., 2000, Dissolution Shelf Life of Prednisone Therapeutic Dosage Form Tablet, MS. Thesis, Michigan State University. U.S. Pharmac0peia-NF. 2000. USP 24 <671> Containers-Permeation, p. 1936 U.S. Pharmacopeia-NF. 2000. USP 24 <711> Dissolution, p. 1941 U.S. Pharmacopeia-NF. 2000. USP 24 <1191> Stability Considerations in Dispensing practice, p. 2128 U. S. Pharmacopeia-NF. 1995. USP 23 <1196> The Stability Testing of New Drug Substances and Products, p. 1959 ' Van Den Berg, C. and Bruin, S., 1981, Water activity and its estimation in food systems: Theoretical aspects In: Water Activity: Influence on Food Quality, L.B. Rockland and GR Stewart (eds): Academic Press, New York, pp. 1-62 Wang J. and Flanagan DR, 1999, General Solution for Diffusion-Controlled Dissolution of Spherical Particles. 1. Theory, Journal of Pharmaceutical Science, 88(7), pp. 731-738 Wu, 8., 1996, Dissolution Shelf Life of Unpackaged Solid Oral Drug Products. MS. Thesis, Michigan State University. 260 Yoon, S., 2000, Shelf Life Estimation of USP 10mg Prednisone Calibrator Tablets in Relation to Dissolution & New Windows-based Shelf Life Computer Program. M.S. Thesis, Michaigan State University. Zografi, G., and Kontny, M.J., 1986, The Interactions of Water with Cellulose- and Starch-Derived Pharmaceutical Excipients. Pharmaceutical Research, 3(4), pp. 187-194. Zografi, G. etal., 1988, Prediction of moisture transfer in mixtures of solids: transfer via the vapor phase, International Journal of Pharmaceutics, 42, pp. 77-88 261 11111111111111